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Lanthanide phosphate (LnPO4) and lanthanide vanadate (LnVO4) nanoparticles (NPs) are 
promising platforms for theranostic applications because of their chemical stability, low solubility, 
low toxicity, and unique luminescence and magnetic properties. Motivated by the high radiation 
resistance and ability to host actinides of naturally occurring lanthanide-based compounds, LnPO4 
and LnVO4 NPs were studied as radionuclide carriers for targeted radionuclide therapy using in 
vivo α-generators, 223Ra, 225Ac, and 227Th. The implementation of these radionuclides has shown 
potential for the treatment of micrometastases and solid tumors as well as challenges in the 
retention of decay daughters at the target site to minimize unwanted radiotoxicity. LnPO4 and 
LnVO4 core-shell NPs doped with either 156Eu, a “cocktail” of 85, 89Sr and 156Eu, or in vivo α-
generators 223Ra, 225Ac, and 227Th were synthesized in aqueous media. In vitro retention of 
 xxvi 
radionuclides was investigated by dialyzing the radionuclide-doped NPs suspensions against 
deionized water and quantifying the activity in dialysate aliquots over time. The crystal structure, 
morphology, physical stability, luminescence and magnetic properties were evaluated. Partial 
retention of 156Eu (~70–95%) and 85, 89Sr (>80%) was evidenced in LnPO4 core NPs, while 227Th 
and decay daughters were quantitatively retained in LaPO4 core + 2 shells NPs (>99%). 
Gd0.8Eu0.2VO4 and GdVO4 core-shell NPs showed partial retention of 223Ra (~75%), 225Ac (75–
95%), 227Th (>96%), and decay daughters. Radionuclide retention was influenced by the 
lanthanide concentration, crystal structure, and number of shells. The partial retention of 
radionuclides in both LnPO4 and LnVO4 core-shell NPs may enhance the treatment efficacy while 
minimizing unwanted toxicity. LnVO4 core and core-shell NPs have potential as carriers of short-
lived radionuclides for both diagnostic and therapeutic applications. Emission intensities were 
higher for LnVO4 with respect to LnPO4 NPs, whereas no significant difference was observed in 
the magnetic susceptibilities. GdVO4 core NPs displayed enhancement of the signal intensity in 
T1-weighted images. This work evidences the promising application of both LnPO4 and LnVO4 
NPs as platforms for targeted radionuclide therapy and multimodal molecular imaging. 
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1 Introduction 
1.1 Motivation 
Nanotechnology is contributing to achieve a major goal in medicine through the 
development of platforms that allow for an early detection and efficient treatment of clinical 
conditions with minimum side effects [1]. Multifunctional lanthanide-based nanoparticles (NPs) 
such as lanthanide phosphate (LnPO4) and lanthanide vanadate (LnVO4) are expected to have a 
key impact in nanomedicine because of the unique luminescence and magnetic properties of 
lanthanide ions [2], [3]. This is supported by the extensive number of studies that have reported 
the synthesis, characterization, and development of lanthanide-based NPs for biomedical 
applications [4]–[21]. A significant fraction of these studies has focused on exploiting lanthanide-
based NPs as contrast agents for fluorescence imaging (FI) and/or magnetic resonance imaging 
(MRI). For FI, the adjustment of the elemental composition and concentration of Ln3+ ions can 
result in either downshifting, downconversion, or upconversion luminescence, where the latter is 
preferable for in vivo biomedical applications due to the penetration depth of infrared light in tissue 
(~5 mm) and minimal photodamage to cells [22]–[24]. For MRI, Gd3+ is the lanthanide of choice 
for the development of positive-T1 contrast agents because of its large spin magnetic moment (r1 ∝ µs2), while either Dy3+ or Ho3+ may be used as negative-T2 contrast agents thanks to their large 
magnetic moment (r2 ∝ μ2) [25]. 
The radiation resistance and ability to host actinides of naturally occurring lanthanide-
based compounds [26]–[28] have encouraged the development of synthetic lanthanide-based NPs 
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as radionuclide carriers for either nuclear imaging or targeted radionuclide therapy (TRT). The 
addition of radionuclides as dopants in lanthanide-based NPs has the potential of combining the 
sensitivity of either single photon emission computed tomography (SPECT) or positron emission 
tomography (PET) with the spatial resolution of MRI within a single platform [29]–[31]. Although 
multimodal PET/SPECT/FI/MRI platforms may improve the diagnostic and monitoring of 
multiple diseases, only a limited number of studies have reported the synthesis, characterization, 
and evaluation of radionuclide-doped lanthanide-based NPs [32]–[37]. The development of 
lanthanide-based NPs for TRT has focused primarily on using LnPO4 core-shell NPs doped with 
in vivo α-generators 223Ra and 225Ac [38]–[42] or β–-emitter 177Lu [43]. Both 225Ac and 223Ra have 
evidenced promising efficacy as in vivo α-generators for the treatment of metastatic castration-
resistant prostate cancer [44], [45]. Nonetheless, the leakage of decay daughters from the 
radioimmunoconjugate and the affinity of RaCl2 to bone tissues may limit the application of 225Ac 
and 223Ra to different types of cancer. Thus, the partial retention of decay daughters and high 
radiochemical yield of α-generators shown by LnPO4 NPs is contributing towards the spread of 
TRT [38]–[42]. 
LnVO4 NPs are alternative platforms for the retention of therapeutically relevant 
radionuclides based on the radiation resistance evidenced by their crystal structure [26], [46]. In 
addition, the fact that LnVO4 NPs can be prepared by simple aqueous synthesis routes makes them 
suitable for radiochemical settings [47]. LnVO4 NPs are likely to have comparable radionuclide 
retention capabilities to that of LnPO4 NPs, while the ability to synthesize them in a fraction of the 
time required for LnPO4 NPs may open the possibility to use short half-lived radionuclides. The 
encouraging characteristics of LnVO4 NPs, the promising use of 225Ac, 223Ra, and 227Th as in vivo 
α-generators for TRT, and the limited studies that have been carried out with radionuclide-doped 
lanthanide-based NPs provide a motivation to explore and study lanthanide-based NPs as 
 3 
multifunctional platforms for both molecular imaging and TRT applications. Furthermore, the 
retention of 227Th and its first decay daughter 223Ra has not been assessed yet in LaPO4 core and 
core + 2 shells NPs, which have shown partial retention of 223, 225Ra, 225Ac, and decay daughters 
[38]–[42]. The successful completion of this study will contribute to the development of 
radionuclide-doped LnPO4 and LnVO4 NPs as theranostic platforms for an early detection, a better 
treatment planning, and an efficient treatment of tumors [48]. 
1.2 Purpose 
The purpose of this dissertation is to develop and investigate LnPO4 and LnVO4 core-shell 
NPs as multifunctional platforms for TRT and multimodal molecular imaging. The in vitro 
retention of in vivo α-generators 223Ra, 225Ac, 227Th, and decay daughters was assessed in LnPO4 
and LnVO4 core-shell NPs. Additional isotopes such as 156Eu and 85, 89Sr were also used to 
demonstrate the versatility of LnPO4 and LnVO4 NPs to host and retain radionuclides for 
diagnostic and therapeutic applications. The influence of the crystal structure, lanthanide 
concentration, and core-shell structure in the retention of radionuclides was studied in both LnPO4 
and LnVO4 core and core-shell NPs. Particularly, the lanthanide concentration in LnPO4 and 
LnVO4 NPs was tailored to provide luminescence and/or magnetic properties for their application 
as contrast agents in FI and/or MRI, while core-shell structures were developed to enhance the 
retention of radionuclides. 
1.3 Approach 
Four phases were proposed and explored to assess the in vitro retention of in vivo α-
generators and decay daughters in LnVO4 and LnPO4 core-shell NPs synthesized with either 
luminescence and/or magnetic functionalities. In phase I, LnPO4 core-shell NPs were synthesized 
via an aqueous route that have been previously used to prepare radionuclide-doped NPs. The 
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influence of temperature and heating time on the growth kinetics and core-shell formation of 
LnPO4 NPs was evaluated to reduce the time consumed during synthesis toward the 
implementation of short-lived radionuclides. The dependence of luminescence and magnetic 
properties on the lanthanide concentration was also studied to provide functionalities for FI and/or 
MRI. A similar approach was followed in phase II for LnVO4 core-shell NPs, which were 
synthesized by two precipitation routes in water. Each route is suitable for radiochemical settings 
and yielded NPs with distinctive morphology, physical stability, and surface chemistry. 
Characterization of the crystal structure, morphology, luminescence properties, magnetic 
susceptibility, surface chemistry, physical stability, among others, was carried out for both LnPO4 
and LnVO4 NPs. Particular attention was given to the development of core-shell structures in 
LnVO4 NPs to enhance the retention of radionuclides, whereas the adjustment of the lanthanide 
concentration within LnPO4 and LnVO4 NPs was done to provide luminescence and magnetic 
properties. 
In phase III, the experiments and characterization carried out in phases I and II were used as 
a reference to define the optimal synthesis conditions and concentration of lanthanide ions for the 
synthesis of radionuclide-doped LnVO4 and LnPO4 core-shell NPs. The in vitro retention of 223Ra, 
225Ac, 227Th, and decay daughters was studied for LnVO4, whereas 227Th and 85, 89Sr, 156Eu were 
tested in LnPO4 NPs. The purification of radionuclides, radiochemical synthesis, and evaluation 
of the in vitro retention were carried out at Oak Ridge National Laboratory (ORNL). Lastly in 
phase IV, current efforts are being focused on the surface characterization and assessment of the 
physical stability of LnVO4 and LnPO4 core-shell NPs. Phases I, II, and IV were completed at 
Virginia Commonwealth University (VCU). 
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1.4 Organization of the Dissertation 
This dissertation consists of 7 chapters in total. Chapter 2 starts with a general description of 
the synthesis methods that have been used to produce LnVO4 and LnPO4 NPs and their 
multifunctional properties for nanomedicine. An overview of TRT and the carriers that have been 
tested, particularly for in vivo α-generators and decay daughters, is also presented in this chapter. 
In Chapter 3, the chemicals, radionuclides, materials, and synthesis routes used to prepare LnPO4 
and LnVO4 NPs are described. In addition, the sample preparation, techniques, and equipment 
used for the characterization of both nonradioactive and radionuclide-doped NPs are presented. 
The characterization of nonradioactive LnPO4 and LnVO4 core-shell NPs, after varying synthesis 
parameters such as temperature, heating time, lanthanide concentration, among others, is 
summarized in Chapters 4 and 5, respectively. Chapter 6 describes the in vitro retention of 
radionuclides in LnPO4 and LnVO4 core-shell NPs synthesized with either luminescence and/or 
magnetic functionalities. The last chapter (Chapter 7) summarizes the conclusions of this 
dissertation and suggests future steps for testing the multifunctional capabilities of LnPO4 and 
LnVO4 NPs.
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2 Literature Review 
2.1 Multifunctional LnPO4 and LnVO4 NPs 
The unique optical and magnetic properties of lanthanide-based NPs, arising from the 4f 
electronic configuration of Ln3+ ions, as well as their low toxicity have prompted their 
development for biomedical applications [49]. The ability of lanthanide-based NPs to have both 
diagnostic and therapeutic functionalities within a single platform is contributing to the 
development of non-invasive, specific, and individualized therapies [50], [51]. These 
functionalities may be tailored based on the choice of host matrix, concentration of Ln3+ ions, 
surface functionalization, or morphology [52], [53].  This versatility has made of lanthanide-based 
NPs one of the most engineered materials for biomedical applications [2]. Among matrices, oxides 
such as orthophosphate (PO4) and orthovanatate (VO4) have shown high chemical and thermal 
stability [54], [55], low toxicity [5], [56], and adaptable functionalization strategies [9], [52], [57]–
[59]. Furthermore, the existence of multiple synthesis methods that could be used for 
pharmaceutical preparations of LnVO4 and LnPO4 NPs have encouraged their application in 
nanomedicine [55]. Different synthesis methods, those that may be suitable for either biomedical 
applications or radiochemical settings are presented in Table 2-1 with their advantages and 
disadvantages. 
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Table 2-1 Summary of synthesis methods used for LnPO4 and LnVO4 NPs with their advantages 
and disadvantages for either biomedical or radiochemical applications (adapted from [2]). 
Method Advantages Disadvantages 
Precipitation 
§ Tunable morphology 
§ Narrow size distribution 
§ Simple procedure 
§ Low costs 
§ Low crystallinity 
§ Calcination or annealing may 
be required 
Hydrothermal, 
solvothermal 
§ Tunable morphology 
§ Highly crystalline NPs 
§ Specialized reaction vessels 
§ Long reaction times 
Sol-gel § Simple procedure 
§ Tunable morphology 
§ Broad particle size distribution 
§ Calcination or annealing may 
be required 
§ Long reaction times 
Microwave assisted 
§ Clean, fast, and energy 
efficient 
§ Tunable morphology 
§ Specialized microwave 
reactors 
Sonochemical § Tunable morphology 
§ Simple setup 
§ Specialized high-intensity 
ultrasonic probe 
 
The application of lanthanide-based NPs for diagnostics has been focused primarily on 
fluorescence, magnetic resonance, and/or computed tomography imaging [60], [61]. The large 
Stoke’s shifts, an absence of blinking, narrow emission bands, and a high resistance to 
photobleaching of lanthanide-based NPs have made them an alternative to fluorescence dyes or 
quantum dots [49], [52], [60]. The fluorescence or emission wavelength of lanthanide-based NPs 
is independent of their size and either downconversion or upconversion luminescence can be 
obtained by tailoring the composition and concentration of Ln3+ ions [62]–[64]. Application of 
lanthanide-based NPs as MRI contrast agents is related to the unpaired electrons of Gd3+ and the 
large magnetic moments of Dy3+ and Ho3+ ions [25], [65]. Although Gd-chelates are extensively 
used as MRI contrast agents, a higher image contrast can be obtained using gadolinium-based NPs 
with only a fraction of the applied dose required for commercial contrast agents [21]. Moreover, 
the toxicity associated to the transmetallation of Gd3+ ions with endogenous cations can be 
minimized using Gd-based NPs, where the Gd cations are bound within an inorganic crystal [22], 
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[66]. Dysprosium- or holmium-based NPs have proven to be promising contrast agents for 
applications at high magnetic field strengths since saturation of their magnetic moment is not 
achieved as in the case of superparamagnetic iron oxide NPs [25], [61], [65]. Lastly, lanthanide-
based NPs have been proposed as contrast agents for x-ray computed tomography because of their 
atomic number and low toxicity with respect to barium and iodine-based compounds [61], [67]. 
As therapeutic agents, lanthanide-based NPs may be used for photodynamic therapy, 
radiation therapy, and/or drug delivery [49]. The luminescence properties, absorption and 
emission, of lanthanide-based NPs allow the excitation of a photosensitizer using either ultraviolet 
(UV) or near-infrared (NIR) radiation to produce reactive oxygen species (ROS) intended to kill 
cancer cells [68]. X-rays can also be used as a source of excitation thanks to the atomic number of 
Ln3+ ions, while providing a greater penetration depth to that of UV or NIR [69]. A similar rationale 
is used for radiation therapy, where lanthanide-based NPs interact with x-rays inducing a localize 
dose enhancement [70]. Lanthanide-based NPs have also been investigated as carriers of either 
anticancer drugs or radionuclides [9], [13], [15], [38]–[43], [71]. Surface modification of 
lanthanide-based NPs has been carried out by adding a shell of mesoporous silica, whose large 
surface area and porous structure will ensure a high adsorption of anticancer drugs [9], [15]. The 
mesoporous shell not only provides drug carrier capabilities, but it also enhances the physical and 
chemical stability, reduces the toxicity, and facilitates the functionalization and bioconjugation of 
lanthanide-based NPs [61], [72]. The interest of lanthanide-based NPs as radionuclide carriers has 
been encouraged by the radiation resistance and ability to host multivalent ions, particularly 
actinides, of naturally occurring lanthanide-based compounds [26]–[28]. The encapsulation of 
radionuclides has been carried out by substituting a Ln3+ ion with a radioactive isotope within the 
crystal structure of lanthanide-based NPs [38]–[43]. The performance of lanthanide-based NPs as 
radionuclide carriers for TRT applications will be introduced in section 2.2 and discussed in detail 
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in Chapter 6. It is important to highlight that lanthanide-based compounds have been suggested as 
alternative nuclear waste forms for the conditioning of radioactive waste streams based on their 
ability to contain high waste load, their high thermal and chemical stability, and the radiation 
resistance evidenced by their crystal structure [26], [27], [46], [73], [74]. 
Multifunctional lanthanide-based NPs with diagnostic and therapeutic functionalities can be 
developed to recognize cancer cells, deliver therapeutic drugs, and visualize the evolution of the 
tumor [75]. Lanthanide-based NPs may also include nuclear imaging capabilities by incorporating 
radionuclides within their crystal structure or having them adsorbed on their surface. The high 
sensitivity of either computed tomography, SPECT, or PET, the excellent spatial resolution of 
MRI, and the low-cost and easy operation of near-infrared fluorescence can be combined by 
designing multimodal imaging platforms [31]. A similar approach could be followed for 
therapeutic purposes, where lanthanide-based NPs can be used as a platform to enhance the dose 
at the target site as well as to deliver anticancer drugs and radionuclides to increase the destruction 
of cancer cells that may have showed either resistance to chemotherapy or radiation [76]. 
 
2.2 Targeted Radionuclide Therapy 
In TRT, radionuclides are used for the specific targeting of cancer cells to reduce the toxicity 
and side effects associated with current treatment procedures [77], [78]. The rationale behind TRT 
is to use the radiation generated during the decay of radionuclides in-situ to destroy the nuclear 
DNA strands via either radiation-induced ionization, chemical transmutation, or generation of 
ROS [77]. The types of radiation that are of main interest for biological applications are α-particles, 
b–-particles, and Auger electrons because of their short range in tissue and high linear energy 
transfer [79]. The range is an essential parameter to identify the tumor size that can be treated with 
each type of radiation, where α- and b–-particles may be suitable for micrometastatic tumors and 
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solid tumors of large size, respectively [77], [79]. Radiopharmaceuticals such as Zevalin® (90Y-
ibritumomab tiuxetan), Bexxar® (131I-tositumomab), and Xofigo® (223RaCl2), based on both α- and 
b–-emitting radionuclides, have been approved by the United States Food and Drug Administration 
for medical treatment [44], [80]. 
The clinical efficacy of Xofigo® as well as the high linear energy transfer and relative 
biological effectiveness of α-particles has increased the interest in developing new 
radiopharmaceuticals based on α-emitting radionuclides [81], [82]. Using α-emitting radionuclides 
can lead to a large fraction of DNA double-strand breaks, which are hard to repair by the cells, 
thanks to the high linear energy transfer of α-particles and the similar distance between two 
ionizations events of α-particles in water to that of two strands of DNA [83]–[85]. Although there 
is not known resistance mechanism against the highly cytotoxic α-particles, their use in clinical 
settings has been limited by (i) the availability of radionuclides with proper physical and chemical 
characteristics, (ii) the production of radionuclides in clinical quantities, and (iii) the design of 
carriers to minimize the leakage of radionuclides in vivo [86], [87]. Among α-emitting 
radionuclides, the leakage of in vivo α-generators such as 223Ra, 225Ac, 227Th, and decay daughters 
from the tumor site represents a significant risk in biological settings since free radionuclides can 
deliver substantial dose to normal tissue and decrease the efficacy of the treatment [81]. To prevent 
the leakage of α-emitting radionuclides, various approaches have been proposed such as a local 
administration to the target site, a fast uptake by tumor cells by selecting a proper targeting agent, 
and/or the use of a carrier [81]. The development of carriers is not only the most promising 
alternative to minimize the side effects caused by the leakage of α-emitting radionuclides when 
using large activities, but it also allows the addition of multiple functionalities. The retention of α-
emitting radionuclides at the target site will be influenced by the highly energetic decay daughter 
nucleus as well as the in vivo stability and the resistance to radiation damage of the carrier [77]. 
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The simplest carriers that have been used for either α-emitting or other therapeutically 
relevant radionuclides are monoclonal antibodies (mAbs), chelating agents, and peptides [80], 
[83], [88], [89]. Monoclonal antibodies are characterized by their ability to be easily bound to the 
radionuclide, their high specificity towards predominant antigens in the tumor, and their superior 
diversity and affinity compared to peptides [90], [91]. The main disadvantage of either mAbs, 
peptides, or chelating agents is the fact that they cannot sustain the recoil energy of decay daughters 
resulting in their release [92]. More complex alternatives for the retention of in vivo α-generators 
have been proposed including liposomes, zeolites, polymersomes, lanthanide- and metal-based 
NPs [81]. Although these carriers may provide additional functionalities and the ability to deliver 
large activities, the α-particle recoil energy (100–200 keV) will always result in chemical bond 
breaking [92], [93]. The partial retention of α-emitting radionuclides and decay daughters in these 
structures has been associated to either (i) the conversion of a fraction of the recoil energy to 
translational energy of the structure, (ii) the intrinsic attenuation of the decay daughter by the 
structure, (iii) the implantation of the decay daughter in adjacent structures, or (iv) the 
reloading/adsorption of decay daughters by structure and/or surface groups [92], [94]–[96]. The 
structures that have been studied for the retention of in vivo α-generators such as 223Ra, 225Ac, 
227Th, and decay daughters will be described for each radionuclide in the following paragraphs.  
Although 223Ra is the first in vivo α-generator that has been approved for treatment of 
prostate cancer [44], the lack of suitable chelating agents and the rapid dissociation in biological 
media of radium isotopes have restricted their application for treatment of other cancers [97]. 
Various platforms have been proposed for the encapsulation and retention of radium isotopes and 
decay daughters (Table 2-2). Nanozeolites have been doped with radium isotopes via an exchange 
reaction with Na+ ions that are located within the channels and interstices of the NPs [98], [99]. 
These NPs have shown high retention of radium isotopes in multiple media and partial retention 
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of decay daughters (Table 2-2). The partial retention of decay daughters has been related to a 
translation of their recoil energy to the whole NP as well as to re-adsorption in the NPs because of 
their characteristics as ion exchanger [98], [99]. Despite the promising retention capabilities of 
nanozeolites, their large size (~100 nm), tendency to aggregate, and high hydrophilicity may limit 
their in vivo application [99]. Although liposomes have high retention of radium isotopes in 
multiple biological media, the retention of decay daughters is dependent on the liposome size 
[100], [101]. The application of liposomes in biological settings may be restricted by the 
difficulties associated to their synthesis and preparation, their large size (>100 nm), and 
polydispersity. Fe3O4 NPs are a promising multifunctional platform for theranostic applications 
where MRI and TRT are combined thanks to the sorption of 223Ra. However, low retention of 
decay daughters may be expected since the radionuclide is adsorbed on the NP surface [102]. Both 
hydroxyapatite and CaCO3 particles have shown high retention of radium isotopes (>90%) and 
have been used in a number of biomedical applications due to their biocompatibility, nonetheless, 
their main drawback is the lack of functionalities for molecular imaging and their affinity to bone 
tissue [103]–[105].  Lastly, the quantitative retention of 223Ra and decay daughter 211Pb in LaPO4 
core + 2 shells NPs is promising for TRT since it will reduce the dose deliver to healthy tissue and 
enhance the efficacy of the treatment [38]. Surface modification with targeting moieties of 
La(223Ra)PO4 NPs must be done to assess their biodistribution, biocompatibility, and in vivo 
response. 
Table 2-2 Nano-platform carriers that have been studied for the retention of Ra isotopes and 
decay daughters towards TRT. 
Platform Isotope Radiolabeling Parent/daughter retention Reference 
Nanozeolite 
(50–80 nm) 
223Ra Ion exchange   Na ⟷	Ra	 >99.5% for 223Ra 90–95 % for decay products [99] 
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Liposome 
(mean Ø 120 
nm) 
223Ra, 
224Ra, 
228Ac 
Ionophore 
mediated 
loading 
223Ra: 96 ± 1% in water 
93 ± 2% in serum 
No daughter retention reported 
[101] 
NaA 
nanozeolite 
(30–70 nm) 
224Ra, 
225Ra 
Ion exchange   
Na ⟷	Ra >99.5% for 223Ra in multiple media, Partial retention of decay products [98] 
Fe3O4 NPs 
(12–16 nm) 
223Ra 
Sorption or 
precipitation 
on surface 
Quantitative in PBS and PVP 
>95% in plasma, serum, albumin, 
Geloplasma® 
No daughter retention reported 
[102] 
LaPO4 core 
and core + 2 
shell NPs 
(3.8–7.1 nm) 
223Ra, 
225Ra 
Replacement 
of La for Ra in 
the crystal 
structure 
Core: ~88% of 223Ra 
211Pb in equilibrium with 223Ra 
Core + 2 shells: >99.6% of 223Ra 
quantitative retention of 211Pb 
>99.98% of 225Ra, 80% of 221Fr 
[38] 
Hydroxyapatite 
nano- and 
microparticles 
223Ra 
Sorption or 
incorporation 
into structure 
For NPs: >85% of 223Ra for 
incorporation while >90% for 
sorption, ~95% for incorporation and 
annealed 
No daughter retention reported 
 [103] 
Hydroxyapatite 
nanoparticles 
223Ra 
Surface and 
intrinsic 
labelling 
>95% of 223Ra after 24 hours in 
physiological saline. Depends on 
labeling yield 
[104] 
CaCO3 
microparticles 
(1–3 μm, 3–15 
μm) 
224Ra 
Precipitation 
on particle 
surface 
>95% for 224Ra and 212Pb [105] 
PBS: phosphate buffer saline, PVP: poly(vinylpyrrolidone) 
Contrary to radium, actinium isotopes can be readily attached to either chelating agents, 
complexes, or antibodies [87], [106], [107]. Biodistribution and toxicity studies using these 
carriers have shown rapid association of free 225Ac cations to serum proteins and significant 
accumulation of decay daughters, 221Fr and 213Bi, in the kidneys since no retention is expected at 
the target site [81]. Despite the anticipated toxicity of decay daughters when using chelating agents 
or mAbs, the interest in 225Ac for TRT has increased thanks to the remarkable therapeutic efficacy 
of 225Ac-PSMA-617 for large-stage metastatic castration-resistance prostate cancer [45], [108]. 
Liposomes, polymersomes, LnPO4 core-shell NPs, and TiO2 NPs have been studied as carriers of 
225Ac and decay daughters for application in TRT to minimize the leakage of radionuclides (Table 
2-3). The main challenge of using either liposomes or polymersomes as carriers is their size 
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dependent retention of decay daughters, which can be enhanced significantly when designing large 
liposomes (>1 µm) [101], [109], [110].  The large size of liposomes and polymersomes limits their 
stability, affects their intra- and inter-cellular uptake, and may result in the clogging of 
microcapillary vessels [94], [109]. Polymersomes loaded with 225Ac showed no uptake by the cell 
nucleus because of their large size [111]. Smaller carriers such as LnPO4 or TiO2 NPs have shown 
partial retention of radionuclides. The retention of radionuclides in LnPO4 NPs is dependent on 
the number of shells and their elemental composition [42]. Surface-modified LaPO4 core NPs with 
mAb 201B showed rapid accumulation in mouse lung and >80% in vivo retention of 213Bi [39]. 
Following a multi-step procedure to synthesize LnPO4 core-shell NPs, having four shells of GdPO4 
and a gold layer, an increase in the in vitro retention of 221Fr to 90% was achieved [42]. The high 
sorption affinity of TiO2 NPs was exploited to labeled 225Ac cations via a simple and fast procedure 
[94]. The high retention of decay daughters, >68.5% of 221Fr in PBS, physiological salt, and 
cerebrospinal fluid (CSF), was attributed to the reloading of decay daughters thanks to the cation 
exchange properties of TiO2 NPs [94]. Their relatively large size (~100 nm) after surface 
functionalization may impose limitations to their application in biological settings due to their slow 
clearance [81], [94]. 
Table 2-3 Nano-platform carriers that have been assessed for the retention of Ac isotopes and 
decay daughters towards TRT. 
Platform Isotope Radiolabeling Parent/daughter retention Ref. 
Zwitterionic 
and cationic 
liposomes 
(100–800 nm) 
225Ac Passive entrapment	 >88% of 225Ac in zwitterionic >54% of 225Ac in cationic <12% of 213Bi, retention was dependent 
on size and composition 
[100] 
Multivesicular 
liposomes 
(758 ± 287 nm) 
225Ac Passive entrapment 
>95% of 225Ac 
<20% of 213Bi [109] 
Liposomes 
(mean Ø 120 
nm) 
223Ra, 
224Ra, 
228Ac 
Ionophore 
mediated 
loading 
228Ac: 95 ± 2% 
No daughter retention reported [101] 
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PEGylated 
liposomes 
(121 ±6 nm) 
225Ac 
Ionophore 
mediated 
loading 
54–81% of 225Ac in PBS 
35–56% of 225Ac in serum media 
No daughter retention reported 
[112] 
Polymersomes 
(800 nm) 
225Ac 
Ionophore 
mediated 
loading 
~93% of 225Ac 
69 ± 1.5% of 221Fr 
53 ± 4.0% of 213Bi 
[113] 
InPO4 
containing 
polymersomes 
(100–800 nm) 
225Ac 
Co-
encapsulation 
with InPO4 
92 ± 3% of 225Ac 
<60% of 221Fr, <40% of 213Bi 
in 100 nm polymersomes 
[95] 
LaPO4 core 
NPs 
(<10 nm) 
225Ac 
Replacement 
of La for Ac 
in the crystal 
structure 
~99.9% for 225Ac 
~40% for 221Fr and 213Bi [39] 
La(1-x)GdxPO4 
core, core + 2, 
and core + 4 
shell NPs 
(<22 nm) 
225Ac 
Replacement 
of La for Ac 
in the crystal 
structure 
Core: 
~99% of 225Ac, 
60.2 ± 3.0% of 221Fr 
Core + 2 shells: 
99.42 ± 0.02% of 225Ac, 
69.2 ± 1.7% of 221Fr 
Core + 4 shells: 
>99.96% of 225Ac, 
>79.4% of 221Fr 
[42] 
TiO2 NPs 
(25 nm) 
225Ac 
Ion exchange 
reaction on 
OH groups 
>95% of 225Ac and 221Fr in PBS 
>9% of 225Ac, <70% of 221Fr in CSF [94] 
 
Differing from its first decay daughter, 227Th is able to form stable chelator complexes for 
its application in TRT [82], [86]. Several studies have shown the potential application of targeted 
thorium conjugates (TTC) for B-cell lymphomas, solid cancers, acute myeloid leukemia, among 
others [82], [114]–[116]. The half-life of 227Th (T1/2 = 18.7 days) is comparable to the blood half-
life of antibodies [115] and is suitable for radiopharmaceutical production, drug distribution, and 
patient treatment [117]. The long half-life of 227Th may also increase the dose delivered to the 
tumor while minimizing that to normal tissue [101]. The generation of 227Th from thermal neutron 
irradiation of a 226Ra target may allow its production in relevant quantities to promote the spread 
of TRT clinically [86]. Although TTCs have shown promising in vitro and in vivo results, these 
conjugates cannot retain decay daughters at the target site. It has been reported that TTCs can 
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induce myelosuppression because of the bone seeker characteristics of 223Ra, which can be 
reversible depending on the administered dose [82]. The leakage of decay daughters may also 
decrease the efficacy of the treatment and hence large activities will be required to achieve the 
desired dose. Therefore, the development and evaluation of nano-platforms doped with 227Th is of 
utmost importance to continue its spread as in vivo α-generator in TRT.  
Targeted radionuclide therapy using α- and b–-emitting radionuclides can reduce the 
collateral damage to healthy tissue compare to external beam radiation therapy [90]. Application 
of α-emitting radionuclides has the advantage that α-particles can overcome the resistance of cells 
to b–-radiation, g-radiation, chemotherapeutic drugs, and apoptosis [118]. Although the application 
of α-emitting radionuclides has been suggested for small tumors, metastasized cells, and cellular 
clusters because of the short range of α-particles, the treatment of solid tumors may also be possible 
[108]. A low amount of activity is required to deliver therapeutically relevant doses for cancer 
treatment when using in vivo α-generators [101]. However, the treatment efficacy depends on a 
reduction of the radionuclide leakage from the target site to maximize the dose deliver and 
minimize the toxicity to healthy organs. The design of nano-platforms aims to minimize the 
leakage of both parent and daughter radionuclides as well as to provide multiple functionalities to 
assess the evolution of the tumors and to develop personalized cancer treatments [119]. These 
nano-platforms can be modified with antibody fragments to achieve a specific and fast uptake by 
the tumor as well as to minimize their toxicity [87]. The partial retention of decay daughters and a 
fast uptake by the tumor of functionalized nano-platforms may be the solution to the collateral 
damage caused to healthy tissue [81]. 
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3 Experimental Procedure 
This chapter gives a general description of the chemical precursors and synthesis methods used 
for the preparation of nonradioactive LnPO4 and LnVO4 NPs.  More details regarding the 
concentration of reagents, temperature, heating time, among others, will be presented in Chapters 
4 and 5. The preparation of the radioisotopes of interest for the synthesis of radionuclide-doped 
NPs is also described in this section. Lastly, the techniques, equipment, and sample preparation 
used for the characterization of both nonradioactive and radionuclide-doped NPs are presented. 
3.1 Chemical Precursors, Radionuclides, and 
Materials 
3.1.1 Chemical Precursors 
The chemical precursors used for the synthesis of both LnPO4 and LnVO4 NPs are presented 
in Table 3-1. 
Table 3-1 Description, chemical formula, manufacturer, and purity of chemical precursors used 
for the synthesis of lanthanide-based NPs. 
Description Manufacturer Purity 
Lanthanum(III) chloride heptahydrate (LaCl3·7H2O) Sigma-Aldrich ACS reagent 
Cerium(III) chloride heptahydrate (CeCl3·7H2O) Sigma-Aldrich 99.9% 
Neodymium(III) chloride hydrate (NdCl3·xH2O) Alfa Aesar® 99.9% 
Europium(III) chloride hexahydrate (EuCl3·6H2O) Sigma-Aldrich 99.9% 
Gadolinium(III) chloride hexahydrate (GdCl3·6H2O) Alfa Aesar® 99.9% 
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Terbium(III) chloride hexahydrate (TbCl3·6H2O) Alfa Aesar® 99.9% 
Dysprosium(III) chloride hydrate (DyCl3·xH2O) Alfa Aesar® 99.9% 
Holmium(III) chloride hexahydrate (HoCl3·6H2O) Alfa Aesar® 99.9% 
Ytterbium(III) nitrate hydrate (Yb(NO3)3·xH2O) Alfa Aesar® 99.9% 
Lutetium(III) chloride hexahydrate (LuCl3·6H2O) Alfa Aesar® 99.9% 
Sodium tripolyphosphate pentabasic (Na5P3O10) Sigma-Aldrich ≥98% 
Sodium orthovanadate (Na3VO4) Acros Organics 99% 
Sodium citrate dihydrate (Na3C6H5O7·2H2O) Sigma-Aldrich Ultrapure reagent 
3.1.2 Radionuclides 
A brief description of the production and purification of radionuclides based on established 
routines at ORNL is given below:  
§ 156Eu 
A solution consisting mainly of 156Eu (T1/2 = 15.2 days) with negligible quantities of 154Eu 
and 155Eu in a 0.1 M HCl was obtained as a by-product of routine strontium-89 (T1/2 = 50.5 days) 
production at the High Flux Isotope Reactor at ORNL. The highly enriched 88Sr target contained 
<10 ppm of natural europium (151Eu and 153Eu), as impurities. During a 24-day irradiation of ~2 g 
of 88Sr target at a thermal neutron flux of 2 × 1015 n s–1 cm–1, ~20 µCi of 156Eu and <1 µCi of 154Eu 
and 155Eu, are co-produced with ~2 Ci of 89Sr. Various isotopes of europium such as 154Eu, 155Eu, 
and 156Eu as well as 89Sr were produced through neutron capture during the irradiation. Following 
irradiation, the target was processed in a hot cell facility, and the Eu isotopes were separated from 
Sr by ion exchange and extraction chromatography methods. 
§ 85, 89Sr and 156Eu cocktail 
A radioactive cocktail solution consisting of 85Sr (T1/2 = 64.8 days), 89Sr, and 156Eu in a 0.1 
M HCl was obtained from routine strontium-89 production at the High Flux Isotope Reactor at 
ORNL as described above. The radioactive solution had a high concentration of strontium ions (~ 
15 mg/mL). 
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§ 225Ac 
A carrier-free 225Ac (T1/2 = 9.9 days) stock was acquired from a mixture of 228Th, 229Th, 
and 232Th by anion and cation exchange chromatography at ORNL [120]. Briefly, thorium-229 
stock from either pre-existing waste material stored for over 30 years at ORNL or recovered from 
chemical separation of 233U is dissolved in 8 M HNO3. Ra and Ac are separated from the Th, U, 
and Fe cations using an anion exchange resin. Final purification and separation of 225Ac from Ra, 
Pb, and Bi cations is carried out using a cation exchange resin [120]. Production and separation of 
225Ac via spallation of Th targets has also been reported [121]–[123]. The separation process only 
comprises solid-support sorption, which implies a significant reduction of organic radioactive 
waste [121]. A two-step sequence involving cation exchange and extraction chromatography has 
also been proposed for purification of Ac from Th targets [123]. Overall, the separation and 
purification of Ac isotopes is dependent on their method of production [123]. The decay scheme 
of 225Ac is shown in Fig. 3-1. 
 
Fig. 3-1 Nuclear decay scheme of 225Ac. 
§ 227Th and 223Ra 
Production of 227Ac/227Th/223Ra generator may be carried out by several methods such as 
227Ac originating from natural sources of 235U, proton spallation of 232Th, or neutron irradiation of 
226Ra [226Ra(n,γ)227Ra → 227Ac] [121], [124]. The latter is the most feasible method for the 
production of 227Th and 223Ra in clinically relevant quantities. Purification and separation of either 
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227Th or 223Ra was carried out in a hot cell facility via ion exchange and extraction chromatography 
methods. The decay scheme of 227Th is shown in Fig. 3-2Fig. 3-1. 
 
Fig. 3-2 Nuclear decay scheme of 227Th. 
3.1.3 Materials 
Deionized (DI) water (18 MΩ) used for the preparation of aqueous solutions was obtained 
from a MilliQ® water purification system (Millipore Sigma, Burlington, MA). The purification of 
the NPs suspensions after synthesis was done by using dialysis against DI water. Biotech 
regenerated cellulose dialysis membranes with a molecular weight cutoff of 8–10 kDa were 
purchased from Spectrum Labs® (Repligen Corporation, Waltham, MA). The regenerated 
cellulose membrane was washed several times with DI water before being used to remove 
preservatives.  
3.2 Synthesis of LnPO4 core and core-shell NPs 
LnPO4 core NPs were synthesized by precipitation of Ln3+ and [PO4]3− ions from lanthanide 
salts (LnCl3·xH2O) and sodium tripolyphosphate (Na5P3O10, Na-TPP) [125]. Both LnCl3·xH2O 
and Na5P3O10 were prepared at 0.1 M in DI water. Lanthanide salts were mixed at specific volume 
ratios to achieve the desired molar concentrations of Ln3+ ions.  The Ln-solution was mixed with 
the solution containing Na-TPP at volume ratios of 1:1 and 1:2, depending on the Ln3+ ions used, 
to obtain a clear solution (Fig. 3-3 and Fig. 3-4). The mixture of LnCl3/Na-TPP was heated at 90 
°C for 3 hours to promote the hydrolysis of the tripolyphosphate ([P3O10]5−) ions into 
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pyrophosphate ([P2O7]4−) and orthophosphate ([PO4]3−) ions [125]. The interaction between the 
[PO4]3− and Ln3+ contributes to the nucleation and growth of the LnPO4 core NPs, while a fraction 
of the tripolyphosphate and pyrophosphate groups helps to restrict the growth and acts as stabilizer 
[125]. The formation and growth of LnPO4 core NPs resulted in a change of the solution 
appearance from clear to turbid (Fig. 3-5). The as-prepared LnPO4 core NPs suspensions were 
dialyzed against DI water to remove unreacted species. After dialysis, the NPs suspension changed 
appearance, becoming more translucent (Fig. 3-6). 
For the synthesis of LnPO4 core-shell NPs, a mixture of LnCl3 and Na-TPP was prepared at a 
1:2 volume ratio. The fresh LnCl3/Na-TPP mixture was added to the as-prepared or dialyzed core 
NPs suspensions in a 1:1 volume ratio and mixed using a vortex mixer. The resulting suspension 
was heated at 90 °C for 3 hours to synthesized LnPO4 core + 1 shell NPs. Deposition of additional 
shells was completed by repeating this procedure while keeping the 1:2 volume ratio between 
LnCl3 and Na-TPP and the 1:1 volume ratio between the fresh LnCl3/Na-TPP solution and core 
NPs suspension. The as-prepared LnPO4 core-shell NPs suspensions were also dialyzed against 
DI water to remove unreacted species. 
 
Fig. 3-3 Ln-TPP solution appearance at 1:1 Ln:Na-TPP volume ratio before synthesis. 
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Fig. 3-4 Ln-TPP solution appearance at 1:2 Ln:Na-TPP volume ratio before synthesis. 
 
Fig. 3-5 LnPO4 (Ln3+ = La, Ce, Gd, Tb, Yb, Lu) core NPs suspension appearance at 1:2 Ln:Na-
TPP volume ratio after synthesis at 90 °C for 3 hours. 
 
Fig. 3-6 Comparison between the appearance of as-prepared and dialyzed LaPO4 core NPs 
suspensions. 
 24 
3.3 Synthesis of LnVO4 core and core-shell NPs 
3.3.1 Citrate Route Synthesis  
LnVO4 core NPs were synthesized by an aqueous route from a mixture of lanthanide chloride 
salts, sodium citrate, and sodium orthovanadate [47]. The synthesis of LnVO4 core NPs started by 
mixing 0.1 M LnCl3·xH2O salts at specific volume ratios [Fig. 3-7(a)]. Next, a 0.75 volume 
equivalent of 0.1 M Na3C6H5O7·2H2O was added to a 1 volume equivalent of the lanthanide salts 
solution under constant stirring. The resulting mixture was homogenized using a vortex mixer until 
a white turbid solution, corresponding to Ln-cit complexes, was obtained [Fig. 3-7(b)]. Lastly, a 
0.75 volume equivalent of 0.1 M Na3VO4 (pH adjusted to 12.5 using NaOH) was added and the 
solution was stirred until it was clear and colorless [Fig. 3-7(c)]. The solution containing 
lanthanide-citrate-vanadate oligomeric species was heated at 60 °C for 30 minutes to synthesize 
LnVO4 core NPs. Afterwards, the suspension was cooled, transferred into the regenerated cellulose 
membrane, and dialyzed against DI water to remove unreacted species. 
 
Fig. 3-7 Solution appearance of (a) LnCl3, (b) Ln-cit, and (c) Ln-cit-VO4 used for the synthesis of 
LnVO4 NPs. 
LnVO4 core-shell NPs synthesis was carried out by preparing a solution containing lanthanide-
citrate-vanadate oligomeric species having the same molar concentration to that used for the 
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LnVO4 core NPs. This solution was then added in a volume ratio of 1.5:1 or 2:1 to the LnVO4 core 
NPs suspension and mixed thoroughly using a vortex mixer. The resulting clear and colorless 
suspension was heated at 60 °C for 30 minutes to synthesize LnVO4 core + 1 shell NPs. Deposition 
of additional shells was carried out by repeating this procedure while keeping the volume ratio of 
1.5:1 or 2:1 between the fresh lanthanide-citrate-vanadate oligomeric species solution and the 
LnVO4 core NPs suspension. 
3.3.2 Flow Synthesis 
LnVO4 core NPs were prepared in aqueous media by precipitation of Ln3+ and [VO4]3– ions at 
room temperature [126]. This synthesis method consists in the addition at a 1:1 volume ratio of an 
aqueous solution of 0.1 M LnCl3·xH2O salts into a 0.1 M Na3VO4 solution, which pH was adjusted 
to 12.5 using NaOH [126]. The addition of the lanthanide salt was done at ~1 mL min–1 using a 
peristaltic pump, while vigorously stirring the Na3VO4 solution. The pH of the mixture was 
monitored continuously during the addition of LnCl3 and stabilized ~11 using 1 M NaOH. After 
adding LnCl3, the turbid suspension was stirred for 30 minutes before the NPs suspension was 
precipitated by centrifugation and cleaned to remove the excess of unreacted species. The set-up 
used for the synthesis of LnVO4 core NPs before and after adding LnCl3 is shown in Fig. 3-8. 
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Fig. 3-8 Experimental setup for flow synthesis of LnVO4 NPs (a) before and (b) after preparation. 
3.4 Nanoparticles Characterization 
3.4.1 Crystal Structure and Crystallite Size 
The crystal structure of LnPO4 and LnVO4 core-shell NPs was characterized by powder x-ray 
diffraction (XRD) using a PANanalytical X’Pert Pro x-ray diffractometer (Malvern Panalytical, 
Malvern, United Kindom) operated at 45 kV and 40 mA with a Cu anode (Cu kα, λ = 1.504 Å).  
For the sample preparation, LnPO4 core-shell and LnVO4 core NPs suspensions prepared as 
described in sections 3.2 and 3.3.2, respectively, were precipitated by centrifugation and then dried 
in an oven at 60–90 °C overnight. LnVO4 core-shell NPs suspensions, prepared as described in 
section 3.3.1, were mixed with ethanol in a 3:2 volume ratio to facilitate their precipitation by 
centrifugation and then dried in an oven at 60–90 °C overnight. The dried samples were ground 
using a mortar and pestle until a fine powder was obtained.  
Room temperature diffraction patterns were collected using a reflection transmission spinner 
PW3064/60 stage while spun at 30 revolutions per minute. Analysis of the crystal structure was 
done using a HighScore Plus software equipped with an International Centre of Diffraction Data 
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database. The crystallite size of LnPO4 and LnVO4 NPs was calculated using the Scherrer equation 
[127]:  𝐷 =	 ()*	 +,- .      3-1 
where D is the crystallite size, λ is the wavelength of the Cu-Kα radiation, β is the full-width at 
half maximum (FWHM) of the selected reflection, θ is the Bragg angle, and K is a shape factor set 
as 0.9. 
3.4.2 Morphology 
Morphology of the LnPO4 and LnVO4 NPs was characterized transmission electron 
microscopy (TEM). TEM characterization was done using a Zeiss Libra 120 (Zeiss, Oberkochen, 
Germany) with a LaB6 filament operating at 120 kV and a FEI Titan operating at 300 kV. For 
sample preparation, the as-prepared or dialyzed LnPO4 NPs suspensions were diluted (×100 in DI 
water), followed by sonication for 30 minutes. The diluted sample was then drop-casted onto a 
carbon-coated copper grid (Mesh 300). LnVO4 NPs suspensions, prepared as described in section 
3.3.1, were diluted (×50–100 in DI water), dispersed by sonication, and drop-casted onto a carbon-
coated copper grid (Mesh 300). The dried LnVO4 NPs, prepared by both methods, were dispersed 
in acetone, sonicated for 10–30 minutes, and drop-casted onto a carbon-coated grid (300 mesh). 
The particle size of LnPO4 and LnVO4 NPs was measured manually using the software 
ImageJ v1.5i. 
3.4.3 Hydrodynamic Size and Zeta Potential 
The hydrodynamic size, particle size distribution, and ζ-potential of both as-prepared and 
dialyzed LnPO4 and LnVO4 NPs suspensions were obtained using a NanoPlus HD 
(Micromeritics®, Norcross, GA). This equipment uses a laser diode operated at 30 mW and 660 
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nm wavelength. Characterization of the hydrodynamic size and particle size distribution was done 
by dynamic light scattering (DLS) at room temperature using a quartz cuvette (1 cm path length). 
Both normalized intensity and number distributions were obtained for each sample. The intensity 
distribution is related to the intensity of light scattered by particles of different sizes and hence it 
is expected to highlight the contribution of larger particles based on Mie theory, whereas the 
number distribution provides a representation of the number of particles based on their size. Data 
collection for all samples was done using the same standard operating procedure. Briefly, the 
solvent was defined as water with a refractive index, viscosity, and dielectric constant of 1.3328, 
0.8878 cP, and 78.3, respectively. The regularization method, known as CONTIN, was used to 
obtain the size distribution of the NPs suspensions from the dynamic light scattering data. Three 
repetitions, each of them consisting of 25 accumulation times, were averaged to obtain the mean 
and standard deviation of the hydrodynamic size and particle size distributions.  
The mean ζ-potential of both as-prepared and dialyzed LnPO4 and LnVO4 NPs suspensions 
was obtained from 3 repetitions consisting of 5 accumulation times. Measurements were collected 
at a constant voltage and current of 60 V and 51 mA, respectively. The conversion equation used 
corresponds to the Smoluchowski equation, which relates the mobility of the NPs with the ζ-
potential at the interface [128]. 
3.4.4 Luminescence Properties 
The as-prepared and dialyzed LnPO4 and LnVO4 NPs suspensions were diluted (×20–50 in DI 
water) to characterize their absorption, emission, and excitation spectra. The absorption spectra 
were recorded on a GENESYS™ 10S UV-vis spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA). The excitation and emission spectra were acquired on a Cary Eclipse fluorescence 
spectrophotometer (Agilent, Santa Clara, CA). All suspensions were characterized using a UV 
Fused Quartz cuvette (ThorLabs, Newton, NJ) with four polished sides and 1 cm path length. A 
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detailed description of the program, optics, and conditions used to record the emission and 
excitation spectra of the NPs suspensions will be given in Chapters 4, 5, and 6 for each sample. 
Time-resolved luminescence lifetimes were recorded using a QuantMaster-3 spetrofluorometer 
with a Xenon Flash lamp excitation source and a photomultiplier tube (PMT) detector. 
3.4.5 Magnetic Susceptibility 
The magnetic susceptibilities of LnPO4 and LnVO4 NPs were characterized in a VersaLab™ 
3 Tesla (Quantum Design Inc., San Diego, CA) vibrating sample magnetometer. Each powder 
sample was massed into a polypropylene capsule, centered, and measured in a field from 0–3 T at 
300 K to record the magnetic moment. 
3.4.6 Elemental Composition 
The relative concentration of elements, particularly of lanthanide ions, was assessed by energy-
dispersive x-ray spectroscopy using a Hitachi SU-70 analytical field emission scanning electron 
microscope (Hitachi, Tokyo, Japan) and a Phenom ProX Desktop scanning electron microscope 
from Phenom-world (Thermo Fisher Scientific, Waltham, MA). For sample preparation, dried 
LnPO4 and LnVO4 NPs were mounted on a carbon tape in an aluminum sample holder. 
Inductively coupled plasma–optical emission spectroscopy (ICP–OES) was used to estimate 
the elemental content of LnPO4 and LnVO4 NPs suspensions. Characterization was done using an 
Agilent 5110 ICP-OES (Agilent, Santa Clara, CA), which detection limit for multiple elements is 
summarized in Table 3-2. ICP standards for Cs, Ba, La, Gd, Pb, and Bi were purchased from 
Inorganic Ventures™ (Christiansburg, VA). A 1000 ppm was diluted serially to standard solutions 
ranging in concentration from 0.1–150 ppm to construct a calibration curve for each element. 
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Table 3-2 Detection limit of various elements in Agilent 5110 ICP-OES. 
Element Detection limit (ppb) 
Cesium 3200 
Barium 0.07 
Lanthanum 0.02 
Gadolinium 2.5 
Lead 14 
Bismuth 12 
 
3.4.7 Radioactivity 
Radioactivity measurements were carried out using a high-purity germanium (HPGe) detector 
(Ortec, Oak Ridge, TN) with a crystal active volume ~100 cm3 and a beryllium window that was 
coupled to a PC-based multichannel analyzer (Canberra Industries, Meriden, CT). Energy and 
efficiency calibrations were determined by γ-ray sources traceable to the National Institute of 
Standards and Technology. The γ-energy and intensities used to determine the activity of multiple 
isotopes are summarized in Table 3-3. 
Table 3-3 Gamma energy and intensity of various isotopes. Data obtained from interactive charts 
of nuclides, National Nuclear Data Center, Brookhaven National Laboratory [129]. 
Isotope Gamma energy (keV) Intensity (%) 
85Sr 514.0 96.0 
89Sr 908.96 0.0095 
156Eu 
88.97 8.4 
811.77 9.7 
211Pb 404.85 3.78 
213Bi 440.4 25.94 
221Fr 218.1 11.4 
223Ra 154.2 5.7 
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269.46 13.9 
225Ac 150.1 0.6 
227Th 
235.96 12.9 
256.23 7.0 
 
Radiochemical yield and in vitro retention of radionuclides were evaluated using a similar set-
up as reported previously for LnPO4 NPs [38], [39], [41]–[43]. Briefly, the as-prepared 
radionuclide-doped LnPO4 and LnVO4 NPs were transferred into a dialysis membrane and 
dialyzed against DI water for 20 hours. The conical vial, spin vane, and pipette tip used during 
synthesis were assayed to determine the activity lost. A 5 mL aliquot from the dialysate was 
analyzed to quantify the activity associated with unreacted radionuclides from the first dialysis. 
The dialysate was changed with clean DI water to assess the retention of radionuclides in LnPO4 
and LnVO4 NPs over time. Subsequent 5 mL aliquots were taken periodically every 3–4 days and 
assayed in the HPGe detector. Aliquots from 225Ac-doped NPs were immediately counted after 
withdrawal in the HPGe detector to assess the activity of 221Fr due to its short half-life. Each aliquot 
was assayed for 20 consecutive 1-minute intervals that were used to build the decay curve of 221Fr. 
The same aliquot was assayed after a couple of hours to determine the activity of 225Ac based on 
the activity of 221Fr now in secular equilibrium with 225Ac. Dialysate aliquots from either 156Eu-, 
85, 89Sr-, 227Th-, or 223Ra-doped NPs were assayed for longer intervals (>10 minutes) based on their 
long half-lives. 
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4 LnPO4 core and core-shell NPs 
This chapter provides a description of the synthesis and characterization of LnPO4 core and 
core-shell NPs. The general synthesis route described in section 3.2 was used as a reference, 
however some modifications were made to study the influence of synthesis parameters such as 
temperature, heating time, lanthanide concentration, and reagents concentration, in both core and 
core-shell NPs. The crystal structure, morphology, luminescence and magnetic properties, as well 
as the physical stability of LnPO4 core and core-shell NPs were characterized. The results 
presented in this chapter were used as reference towards the development of radionuclide-doped 
LnPO4 NPs for applications in multimodal molecular imaging and TRT. 
4.1 Influence of Temperature and Heating Time 
In this section, the influence of temperature and heating time in the growth kinetics and 
formation of La0.4Ce0.45Tb0.15PO4 core and LaPO4 core-shell NPs was evaluated. The synthesis of 
LnPO4 NPs is based on the precipitation of Ln3+ and [PO4]3– using [P3O10]5– as orthophosphate 
source and complexing agent [125]. The hydrolysis of triphosphate upon heating results in 
pyrophosphate and orthophosphate species, hence variation of both temperature and heating time 
may provide the tools to control the yield and size of LnPO4 core-shell NPs. Buissette et al. 
reported that a significant fraction of the lanthanide phosphate phase was formed after 90 minutes 
at 90 ºC [125]. Having these conditions as reference, lower temperatures (75 ºC, 80 ºC, 85 ºC, and 
90 ºC) and shorter heating times (30–180 minutes) were studied to assess the formation of 
La0.4Ce0.45Tb0.15PO4 core NPs. LaPO4 core, core + 2 shells, and core + 4 shells NPs were 
synthesized at 80 ºC and 90 ºC after heating for either 2 or 3 hours. Overall, increasing the 
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temperature caused the formation of both La0.4Ce0.45Tb0.15PO4 core and LaPO4 core-shell NPs at 
shorter heating times (<3 hours). These results suggest that during radiochemical synthesis, the 
activity loss because of radioactive decay could be reduced by synthesizing LnPO4 core-shell NPs 
at high temperature (90 °C) and short heating time (<3 hours) without significantly affecting the 
formation of LnPO4 NPs. The results presented in this section have been adapted from [130]. 
4.1.1 Growth Kinetics of La0.4Ce0.45Tb0.15PO4 core NPs 
La0.4Ce0.45Tb0.15PO4 core NPs were synthesized using a 1:1 volume ratio of LnCl3 to Na-TPP. 
The synthesis was performed at either 75 ºC, 80 ºC, 85 ºC, or 90 ºC for 3 hours, while taking 
aliquots of the NPs suspensions every 30 minutes to study the growth kinetics of LnPO4 NPs. The 
absorption spectra of diluted solutions and NPs suspensions were used to evaluate the formation 
of LnPO4 NPs based on the evolution of the absorption bands of cerium-tripolyphosphate 
complexes (248 nm and 302 nm) and cerium in a crystalline lanthanide phosphate phase (272 nm) 
[125], [131]. Although the absorption band at 272 nm was seen at 75 ºC after 3 hours of heating, 
the presence of the absorption band at 302 nm suggests that a fraction of cerium-tripolyphosphate 
complexes did not result in NPs formation [Fig. 4-1(a)].  Increasing the temperature to 80 ºC 
resulted in the vanishing of the cerium-tripolyphosphate complexes bands after 2.5 hours of 
heating [Fig. 4-1(b)]. Additionally, the greater absorbance at 272 nm implies that a significant 
fraction of Ce3+ ions are in a lanthanide phosphate phase. A further increase in temperature to 85 
ºC or 90 ºC had as a consequence the disappearance of the cerium-tripolyphosphate bands after 
1.5 hours [Fig. 4-1(c)] and 1 hour [Fig. 4-1(d)] of heating, respectively. At these temperatures, the 
band at 272 nm reaches its maximum after 3 hours of heating, which implies a greater fraction of 
LnPO4 NPs in suspension with respect to shorter heating times (Fig. 4-1). In summary, the 
synthesis of LnPO4 NPs can be carried out at temperatures as low as 75 ºC with the disadvantage 
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that long heating times (>3 hours) are required to achieve a high yield of NPs. Increasing the 
temperature to >80 ºC allows for a reduction of the heating time to ~2 hours based on the 
disappearance of cerium-tripolyphosphate bands (Fig. 4-1). A reduction of the heating time may 
contribute to the development of LnPO4 NPs with small size and high physical stability since a 
lower fraction of polyphosphate species is hydrolyzed into orthophosphate groups, however this 
may also compromise the NPs yield [125]. 
 
Fig. 4-1 Absorption spectra evolution with heating time of La0.4Ce0.45Tb0.15PO4 core NPs 
synthesized at (a) 75 ºC, (b) 80 ºC, (c) 85 ºC, and (d) 90 ºC using 1:1 Ln:Na-TPP volume ratio. 
4.1.2 Crystal Structure of LaPO4 core-shell NPs 
The crystal structure and crystallite size of LaPO4 core, core + 2 shells, and core + 4 shells 
NPs synthesized as described in section 3.2 were evaluated at 80 ºC and 90 ºC after 2 hours and 3 
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hours of heating. A rhabdophane-type structure with a hexagonal crystal system and a space group 
P6222 (pdf: 01-075-1881) corresponding to LaPO4 was obtained for all the samples. The 
diffraction patterns of LaPO4 core NPs synthesized after 2 hours of heating at both temperatures 
showed broader and less intense Bragg reflections to that observed after 3 hours (Fig. 4-2). The 
broader Bragg reflections can be attributed to the small crystallite size of LaPO4 core NPs 
synthesized after 2 hours of heating.  
 
Fig. 4-2 Diffraction patterns of LaPO4 core NPs synthesized at 80 ºC and 90 ºC for either 2 or 3 
hours using a 1:1 La:Na-TPP volume ratio (section 3.2). 
The deposition of two LaPO4 shells, which will follow an epitaxial growth mechanism 
[131], resulted in a decrease of the FWHM and an increase of the Bragg reflection intensities for 
all synthesis conditions (Fig. 4-3). A similar trend, consisting in narrow and intense peaks, was 
observed after adding two more LaPO4 shells (Fig. 4-4).  
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Fig. 4-3 Diffraction patterns of LaPO4 core + 2 shells NPs synthesized by mixing a solution of 
La/Na-TPP (1:2 La:Na-TPP volume ratio) with LaPO4 core NPs suspension at a 1:1 volume ratio, 
while heating at 80 ºC and 90 ºC for either 2 or 3 hours (section 3.2). 
The epitaxial growth of two and four shells on LaPO4 core NPs was evidenced by a 
continuous increase of the crystallite size for both temperatures and heating times as shown in Fig. 
4-5. The crystallite size and error bars reported correspond to the average and standard deviation 
obtained from multiple Bragg reflections. LaPO4 core and core-shell NPs prepared at 80 ºC for 2 
hours had the broader Bragg reflection peaks and hence the smaller crystallite size among the 
synthesis conditions evaluated. Nonetheless, the obtained diffraction patterns demonstrated that 
short heating times (2 hours) and low temperatures (80 °C) can be used to prepare LnPO4 core and 
core-shell NPs with a small crystallite size (<4.5 nm). 
 37 
 
Fig. 4-4 Diffraction patterns of LaPO4 core + 4 shells NPs synthesized by mixing a solution of 
La/Na-TPP (1:2 La:Na-TPP volume ratio) with LaPO4 core NPs suspension at a 1:1 volume ratio, 
while heating at 80 ºC and 90 ºC for either 2 or 3 hours (section 3.2). 
For LaPO4 core-shell NPs synthesized at 80 ºC, the increase in crystallite size after the 
deposition of shells was not as significant as observed for the samples prepared at 90 ºC (Fig. 4-5). 
These results are consistent with the growth kinetics of LnPO4 core NPs, where an increase in 
temperature caused the vanishing of the cerium-tripolyphosphate complexes absorption bands in 
shorter (<2 hours) heating times (section 4.1.1). Furthermore, there is no significant difference 
between the mean crystallite size of LaPO4 core and core-shell NPs synthesized at 90 ºC for either 
2 or 3 hours (Fig. 4-5), which implies that shorter heating times (~2 hours) could be implemented 
for radiochemical synthesis. 
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Fig. 4-5 Mean crystallite size of LaPO4 core, core + 2 shells, and core + 4 shells synthesized 
following the procedure described in section 3.2, while heating at 80 ºC and 90 ºC for either 2 or 
3 hours. 
4.2 Influence of Reagents Concentration 
In this section, the role of sodium tripolyphosphate as complexing agent and source of 
orthophosphate species was studied. The concentration of tripolyphosphate species was varied at 
either 1:0.5, 1:1, 1:1.5, 1:2, or 1:3 Ln:Na-TPP volume ratio for the synthesis of La0.8Ce0.2PO4 core 
NPs, while temperature and heating time were kept at 90 ºC and 3 hours. The formation of 
La0.8Ce0.2PO4 core NPs was determined based on the absorption spectra of as-prepared NPs 
suspensions. The crystal structure, luminescence properties, particle size distribution, and ζ-
potential of La0.8Ce0.2PO4 core NPs suspensions were characterized for each Ln:Na-TPP. 
Increasing the concentration of Na-TPP caused the formation of smaller La0.8Ce0.2PO4 core NPs 
which displayed greater luminescence properties and physical stability compared to that of lower 
Na-TPP concentrations.  
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4.2.1 Absorption Spectra 
To study the influence of reagents concentration, the Ln:Na-TPP volume ratio was set at either 
1:0.5, 1:1, 1:1.5, 1:2, or 1:3 for the synthesis of La0.8Ce0.2PO4 core NPs at 90 ºC for 3 hours. 
Formation of La0.8Ce0.2PO4 core NPs was assessed as described in section 4.1.1. As shown in Fig. 
4-6, synthesis of La0.8Ce0.2PO4 core NPs using a 1:3 Ln:Na-TPP did not result in NP formation 
since only the bands of cerium-tripolyphosphate complexes were observed. Lower Ln:Na-TPP 
ratios (1:0.5–2) resulted in the formation of La0.8Ce0.2PO4 core NPs based on the absorption band 
at 272 nm. This behavior could be attributed to the role of the polyphosphate species as complexing 
agent and source of orthophosphate groups [125].  
 
Fig. 4-6 Normalized absorption spectra of La0.8Ce0.2PO4 core NPs synthesized at 90 ºC for 3 hours 
using different Ln:Na-TPP volume ratio. 
Higher concentrations of polyphosphate species, such as 1:3 Ln:Na-TPP, restricts 
significantly the formation of LnPO4 nuclei and hence the growth of LnPO4 NPs. Lower 
concentrations (1:0.5) may result in a large growth or aggregation of LnPO4 NPs since the fraction 
of polyphosphate species required to control the size and stabilize the NPs is relatively low. It is 
assumed that the shape of the absorption spectrum from La0.8Ce0.2PO4 (1:0.5) core NPs, where the 
 40 
absorption band at 272 nm is not well defined, is attributed to a lack of physical stability and hence 
aggregation of NPs that causes significant light scattering (Rayleigh scattering). Thus, a 
concentration of tripolyphosphate species lower than 3 times the concentration of Ln ions is 
desired for the synthesis of LnPO4 core and core-shell NPs. 
4.2.2 Crystal Structure 
La0.8Ce0.2PO4 core NPs synthesized using 1:0.5, 1:1, 1:1.5, and 1:2 Ln:Na-TPP have a 
rhabdophane-type structure with a hexagonal crystal system and a space group P6222 (pdf: 01-
075-1881, LaPO4). The diffraction pattern for the sample with the lowest concentration of 
tripolyphosphate species (1:0.5) evidenced sharper peaks with respect to the rest of the patterns 
(Fig. 4-7). Higher concentrations of tripolyphosphate species (>1:1 Ln:Na-TPP) lead to the 
formation of smaller crystallites and hence broader Bragg reflections of La0.8Ce0.2PO4 core NPs 
that resulted in significant overlapping of the peaks.  
 
Fig. 4-7 Diffraction patterns of La0.8Ce0.2PO4 core NPs synthesized at 90 ºC for 3 hours using 
different Ln:Na-TPP volume ratio. 
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Despite the overlapping of the Bragg reflections, the diffraction patterns obtained for 
La0.8Ce0.2PO4 core NPs are consistent with the hexagonal crystal structure of LaPO4. The 
crystallite size of La0.8Ce0.2PO4 core NPs decreased from 9.5 ± 3.1 nm to 4.0 ± 1.1 nm after 
increasing the concentration of tripolyphosphate species in solution by four times (Error! Not a 
valid bookmark self-reference.). 
Table 4-1 Crystallite size of La0.8Ce0.2PO4 core NPs synthesized at 90 ºC for 3 hours using 
different Ln:Na-TPP volume ratio. 
Ln:Na-TPP Crystallite size (nm) 
1:0.5 9.5 ± 3.1 
1:1 6.1 ± 0.6 
1:1.5 4.3 ± 1.1 
1:2 4.0 ± 1.1 
4.2.3 Excitation and Emission Spectra 
 The excitation and emission spectra of diluted La0.8Ce0.2PO4 core NPs suspensions are 
shown in Fig. 4-8. The excitation spectrum was recorded using an emission wavelength of 350 nm, 
an excitation filter at 250–395 nm, and a PMT voltage of 500 V. It can be observed the similarity 
between the absorption (Fig. 4-6) and the excitation (Fig. 4-8) spectra of La0.8Ce0.2PO4 core NPs, 
where the maximum intensity is at 272 nm. The highest excitation intensity corresponded to 
La0.8Ce0.2PO4 core NPs synthesized with 1:2 Ln:Na-TPP, whereas the lowest was observed for 
1:0.5 [Fig. 4-8(a)]. The emission spectrum of La0.8Ce0.2PO4 core NPs was acquired with a PMT 
voltage of 500 V, an emission filter at 295–1,100 nm, and an excitation wavelength of 272 nm 
[Fig. 4-8(b)]. The emission spectra is characterized by a broad and an intense band at ~350 nm 
related to transitions of Ce3+ ions from the lowest component of 2D state to the spin-orbit 
components 2F7/2 and 2F5/2 of the ground state, which luminescence is not completely quenched 
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[125], [132]–[135]. The lowest emission of La0.8Ce0.2PO4 core NPs (1:0.5) may be attributed to 
the lower excitation intensity as well as to a self-quenching effect caused by their aggregation 
[136]. 
 
Fig. 4-8 (a) Excitation and (b) emission spectra of La0.8Ce0.2PO4 core NPs synthesized at 90 ºC for 
3 hours using different Ln:Na-TPP volume ratio. 
4.2.4 Hydrodynamic Size and Zeta Potential 
DLS was used to determine the hydrodynamic size, particle size distribution, and ζ-
potential of the as-prepared La0.8Ce0.2PO4 core NPs. Table 4-2 shows the mean and standard 
deviation of the cumulant size, polydispersity index (PI), number size, and ζ-potential obtained for 
La0.8Ce0.2PO4 core NPs suspensions. An increase in tripolyphosphate concentration is 
accompanied by a decrease in the cumulant size, PI, and number size (Table 4-2). These results 
indicate significant aggregation of La0.8Ce0.2PO4 core NPs upon a decrease in the concentration of 
tripolyphosphate species, which is consistent with the discussion presented in section 4.2.1 
regarding the shape of the absorption spectra (Fig. 4-6) as well as with the lower intensity of the 
excitation and emission spectra (Fig. 4-8). The lower concentration of polyphosphate species 
available for complexation with Ln cations causes the aggregation of La0.8Ce0.2PO4 core NPs. 
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Although the mean PI, cumulant and number size were reported for La0.8Ce0.2PO4 core NPs 
synthesized using a 1:0.5 Ln:Na-TPP volume ratio, these values are not reliable since the NPs were 
not stable in suspension (precipitated at the bottom of the cuvette) during data acquisition. Based 
on the PI and particle size distribution, the optimum Ln:Na-TPP volume ratio to synthesize 
La0.8Ce0.2PO4 core NPs with homogenous particle size and high physical stability is 1:2. Almost 
all the as-prepared La0.8Ce0.2PO4 core NPs had a negative ζ-potential, which is consistent with the 
presence of polyphosphate species with negative charge at the NP surface, except for the sample 
synthesized with 1:0.5 Ln:Na-TPP that had a positive ζ-potential (Table 4-2). The difference in ζ-
potential for the latter is caused by the lower concentration of tripolyphosphate species, which may 
have transformed completely into orthophosphate groups and hence the fraction of polyphosphate 
species available for complexation is not enough to stabilize the NPs. The magnitude of the ζ-
potential indicates that La0.8Ce0.2PO4 core NPs prepared with 1:1 and 1:1.5 Ln:Na-TPP volume 
ratio are strongly anionic since their magnitude is greater than -30 mV [137]. The negative surface 
charge of the as-prepared La0.8Ce0.2PO4 core NPs may contribute to lower toxicity with respect to 
cationic NPs, where cell wall disruption is expected since most of the cell membranes are 
negatively charged [137]. 
Table 4-2 Cumulant size, PI, number size, and ζ-potential of La0.8Ce0.2PO4 core NPs synthesized 
at 90 ºC for 3 hours using different Ln:Na-TPP volume ratio. 
Ln:Na-TPP Cumulant size (nm) PI Number size (nm) ζ-potential (mV) 
1:0.5 (37.5 ± 4.1) × 102  1.04 ± 0.38 (3.9 ± 1.8) × 104 13.6 ± 0.6 
1:1 (33.1 ± 3.2) × 102 0.54 ± 0.09 (6.0 ± 4.4) × 102 -31.9 ± 0.9 
1:1.5 383.8 ± 0.7 0.29 ± 0.01 91.7 ± 16.5 -35.5 ± 0.2 
1:2 32.0 ± 0.4 0.19 ± 0.01 16.1 ± 0.3 -16.9 ± 0.7 
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4.3 Influence of Lanthanide Concentration 
In this section, LnPO4 (Ln3+ = GdCeTb and GdEu) core NPs possessing a wide concentration 
of lanthanide ions (Table 4-3) were synthesized using a 1:2 Ln:Na-TPP at 90 °C for 3 hours. The 
core NPs were characterized to assess their potential application as multimodal platforms for 
molecular imaging. The influence of lanthanide concentration in LnPO4 core NPs morphology, 
crystal structure, absorption, emission, excitation, and magnetic susceptibility (χ) was studied. The 
luminescence properties were assessed for the application of LnPO4 core NPs as contrasts agents 
for FI based on the emission of light from Ce3+, Eu3+, and Tb3+ ions. The magnetic susceptibility 
was characterized to evaluate the response of LnPO4 core NPs as MRI contrast agents. It is 
expected that LnPO4 core NPs will behave as positive-T1 contrast agents depending on the Gd3+ 
concentration because of its large spin magnetic moment (μs = S(S+1)ħ2) and its relation with the 
longitudinal relaxivity (r1 ∝ μs2) [25]. LnPO4 core NPs could also be used as negative-T2 contrast 
agents depending on the transversal relaxivity, which is related the magnetic moment associated 
to each Ln3+ (r2 ∝ μ2) [25]. Variations of χ are expected based on the Curie formula which relates 
χ with the concentration and magnitude of the magnetic moment associated to each Ln3+ (μCe = 2.4 
μB, μEu = 3.4 μB, μGd = 7.95 μB, and μTb = 9.5 μB) [138], [139]. The results presented in this section 
have been adapted from [140]. 
 
 
 
 
 
Table 4-3 Description, concentration, and sample abbreviation for LnPO4 core NPs. 
Description 30 at.% Gd3+ and Ce3+:Tb3+ molar ratio Abbreviation 
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GdCeTbPO4 
1:1 Gd0.3Ce0.35Tb0.35 
2:1 Gd0.3Ce0.467Tb0.233 
1:2 Gd0.3Ce0.233Tb0.467 
3:1 Gd0.3Ce0.525Tb0.175 
1:3 Gd0.3Ce0.175Tb0.525 
6:1 Gd0.3Ce0.6Tb0.1 
1:6 Gd0.3Ce0.1Tb0.6 
Description x at.% Gd3+ and 3:1 Ce3+:Tb3+ molar ratio Abbreviation 
GdCeTbPO4 
95 Gd0.95Ce0.0375Tb0.0125 
90 Gd0.9Ce0.075Tb0.025 
80 Gd0.8Ce0.15Tb0.05 
70 Gd0.7Ce0.225Tb0.075 
60 Gd0.6Ce0.3Tb0.1 
50 Gd0.5Ce0.375Tb0.125 
Description x at.% Eu3+ Abbreviation 
GdEuPO4 
10 Gd0.9Eu0.1 
20 Gd0.8Eu0.2 
30 Gd0.7Eu0.3 
40 Gd0.6Eu0.4 
50 Gd0.5Eu0.5 
4.3.1 Elemental Composition 
Energy-dispersive x-ray spectroscopy was used to confirm the concentration of lanthanide 
ions in the as-prepared LnPO4 core NPs with respect to the nominal concentrations (Table 4-3). 
The lanthanide concentration was calculated based on the weight percent of each lanthanide ion 
with respect to the total weight percent of lanthanide ions as reported by the EDAX system 
incorporated into the microscope. The results showed significant agreement between the nominal 
and experimental concentration of lanthanide ions for almost all the samples (Table 4-4). The 
discrepancies observed for Tb and Eu cations in a couple of samples were significant because of 
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the low concentrations used and the similarity in energy between the Lα and M lines of these 
lanthanides with respect to Gd. 
Table 4-4 Calculated relative molar concentration of lanthanide ions and error percent with 
respect to nominal concentrations. 
Abbreviation  Gd Ce Tb 
Gd0.3Ce0.35Tb0.35 
Calculated (%) 31.4 33.2 35.4 
Error (%) 4.6 5.2 1.2 
Gd0.3Ce0.525Tb0.175 
Calculated (%) 32.2 49.6 18.2 
Error (%) 7.8 5.5 4.0 
Gd0.3Ce0.6Tb0.1 
Calculated (%) 30.8 59.2 10.0 
Error (%) 2.8 1.4 0.2 
Gd0.3Ce0.1Tb0.6 
Calculated (%) 30.7 9.5 59.8 
Error (%) 2.3 4.8 0.4 
Gd0.95Ce0.0375Tb0.0125 
Calculated (%) 93.2 3.5 3.3 
Error (%) 1.9 6.5 162.4 
Gd0.8Ce0.15Tb0.05 
Calculated (%) 78.8 15.4 5.8 
Error (%) 1.4 2.4 15.9 
Gd0.6Ce0.3Tb0.1 
Calculated (%) 58.8 30.3 10.9 
Error (%) 2.0 1.0 8.7 
  Gd Eu  
Gd0.9Eu0.1 
Calculated (%) 88.1 11.9  
Error (%) 2.2 19.4  
Gd0.7Eu0.3 
Calculated (%) 70 30  
Error (%) 0.1 0.04  
Gd0.5Eu0.5 
Calculated (%) 50.5 49.5  
Error (%) 1.0 1.0  
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4.3.2 Crystal Structure  
The diffraction patterns of LnPO4 core NPs (Table 4-3) are shown in Fig. 4-9, Fig. 4-10, 
and Fig. 4-11. Significant peak broadening and hence overlapping of Bragg reflections, 
characteristic of nanoscale crystallites, were observed in all diffraction patterns.  
 
Fig. 4-9 Diffraction patterns of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-
TPP volume ratio, while having 30 at.% Gd3+ and different Ce3+:Tb3+ molar ratios.  
The Bragg reflections of LnPO4 core NPs are shifted with respect to the reference patterns 
of pure CePO4, EuPO4, GdPO4, and TbPO4 due to the presence of substitutional lanthanide atoms 
in their crystal structure. This shifting of the 2θ angles implies a change in the d-spacing due to 
elastic strains imposed by the difference in size between the ionic radius of the lanthanide ions 
used (i.e. Tb3+ ≈ 1.18 Å, Gd3+ ≈ 1.20 Å, Eu3+ ≈ 1.21 Å, Ce3+ ≈ 1.27 Å) [141]. The as-prepared 
LnPO4 core NPs matched with the crystal structure of cerium phosphate (pdf: 01-074-1889, 
CePO4) and hydrated gadolinium phosphate (pdf: 00-039-0232, GdPO4·xH2O) having a hexagonal 
crystal system and a space group P3121.  
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Fig. 4-10 Diffraction patterns of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio, while having a 3:1 Ce3+:Tb3+ molar ratio and different Gd3+ at.%. 
 
Fig. 4-11 Diffraction patterns of GdEuPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio, while having different Eu3+ at.%. 
The mean crystallite size and standard deviation of LnPO4 core NPs are presented in Table 
4-5. The small crystallite size (<5.1 nm) of LnPO4 core NPs is consistent with the higher 
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concentration of tripolyphosphate species used for synthesis (section 4.2.2). Moreover, the 
crystallite size was not influenced significantly by the concentration of lanthanide ions used. 
 
Table 4-5 Mean crystallite size for LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio. 
Abbreviation Crystallite size (nm) 
Gd0.3Ce0.35Tb0.35 3.3 ± 0.1 
Gd0.3Ce0.467Tb0.233 4.0 ± 0.8 
Gd0.3Ce0.233Tb0.467 2.8 ± 0.7 
Gd0.3Ce0.525Tb0.175 3.8 ± 0.9 
Gd0.3Ce0.175Tb0.525 2.9 ± 0.3 
Gd0.3Ce0.6Tb0.1 4.3 ± 0.5 
Gd0.3Ce0.1Tb0.6 2.9 ± 0.4 
Gd0.95Ce0.0375Tb0.0125 5.1 ± 0.8 
Gd0.9Ce0.075Tb0.025 3.1 ± 0.6 
Gd0.8Ce0.15Tb0.05 5.1 ± 1.9 
Gd0.7Ce0.225Tb0.075 2.5 ± 0.4 
Gd0.6Ce0.3Tb0.1 4.7 ± 1.2 
Gd0.5Ce0.375Tb0.125 3.7 ± 0.8 
Gd0.9Eu0.1 4.9 ± 1.2 
Gd0.8Eu0.2 2.9 ± 0.4 
Gd0.7Eu0.3 3.3 ± 0.9 
Gd0.6Eu0.4 3.2 ± 0.5 
Gd0.5Eu0.5 4.8 ± 1.2 
 
4.3.3 Morphology 
TEM micrographs of LnPO4 core NPs are shown in Fig. 4-12, Fig. 4-13, Fig. 4-14, and 
Fig. 4-15. Branched structures can be observed at low magnifications for all LnPO4 core NPs, 
while at higher magnifications these branched structures are formed by LnPO4 core NPs with 
spherical and ellipsoidal morphologies surrounded by a low-density matrix Fig. 4-13 and Fig. 
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4-14. The formation of these structures is assumed to be related to the polymerization of unreacted 
polyphosphate oligomers, [P3O10]5− and [P2O7]4−, that have a higher concentration in solution 
given by the initial volume ratio of Ln3+ to [P3O10]5− ions [125]. Thus, P3O10 and P2O7 anions 
promote the formation of a polymeric shell encompassing the LnPO4 core NPs as observed in the 
micrographs.  
 
Fig. 4-12 TEM micrographs of (a, b) Gd0.3Ce0.233Tb0.467PO4 and (c, d) Gd0.3Ce0.6Tb0.1PO4 NPs 
synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio. 
These unreacted phosphate oligomers were intended to be removed by dialysis, however, 
as seen from the images their removal was partially successful. Particle size distributions of 
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Gd0.95Ce0.0375Tb0.0125PO4 (Fig. 4-13) and Gd0.6Ce0.3Tb0.1PO4 (Fig. 4-14) NPs follow a lognormal 
distribution with mean sizes of 5.0 ± 1.3 nm (n = 112) and 3.5 ± 0.7 nm (n = 122), respectively.  
 
Fig. 4-13 TEM micrographs and particle size distribution of Gd0.95Ce0.0375Tb0.0125PO4 NPs 
[indicated by arrows] synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio. 
The remaining LnPO4 core NPs are expected to have comparable morphologies and 
particle size distributions with respect to Gd0.95Ce0.0375Tb0.0125PO4 and Gd0.6Ce0.3Tb0.1PO4. The 
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LnPO4 core NPs correspond to single crystals based on the similarity between the mean particle 
size and the mean crystallite size. 
 
Fig. 4-14 TEM micrographs and particle size distribution of Gd0.6Ce0.3Tb0.1PO4 NPs [indicated by 
arrows] synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio. 
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Fig. 4-15 TEM micrographs of (a, b) Gd0.7Eu0.3PO4 and (c, d) Gd0.5Eu0.5PO4 NPs synthesized at 
90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio. 
4.3.4 Absorption, Excitation, and Emission Spectra 
The absorption spectra of LnPO4 core NPs with concentrations outlined in Table 4-3 are 
presented in Fig. 4-16 and Fig. 4-17. The absorption spectra of LnPO4 (Ln3+ = Ce, Gd, and Tb) 
core NPs showed the characteristic peak at 272 nm attributed to the Ce3+ ions in the lanthanide 
phosphate phase (Fig. 4-16) [125]. The absorbance of the peak at 272 nm is directly related to the 
relative Ce3+ concentration within the NPs. For example, the highest absorbance corresponded to 
Gd0.3Ce0.6Tb0.1PO4, while Gd0.3Ce0.1Tb0.6PO4 had the lowest [Fig. 4-16(a)]. 
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Fig. 4-16 Absorption spectra of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-
TPP volume ratio, while having different (a) Ce3+:Tb3+ molar ratio and (b) Gd3+ concentration. 
 
Fig. 4-17 Absorption spectra of GdEuPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio, while having different Eu3+ at.%. 
The same trend was observed in Fig. 4-16(b), where decreasing the concentration of Gd3+ 
ions caused an increase in the absorbance at 272 nm. The additional absorption bands observed at 
214, 235, 255, and 272 nm correspond to the spin-orbit components of the excited 5d state of Ce3+ 
ions, 2D5/2 and 2D3/2, which are split by the crystal field [133]. The absorption spectra of GdxEu(1-
x)PO4 NPs is characterized by an absorption band below 300 nm that represents the charge-transfer 
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(CT) transition between Eu-O [142] and which absorbance increased with higher Eu3+ 
concentration (Fig. 4-17). 
The excitation spectra of LnPO4 (Ln3+ = Ce, Gd, and Tb) core NPs were recorded using an 
emission wavelength of 352 nm, an excitation filter at 250–395 nm, and a PMT voltage of 600 V. 
The similarity between the absorption (Fig. 4-16) and excitation (Fig. 4-18) spectra of LnPO4 
(Ln3+ = Ce, Gd, and Tb) core NPs is a validation of the energy transfer from Ce3+ to Tb3+ ions 
[133]. The excitation spectrum for LnPO4 (Ln3+ = Ce, Gd, and Tb) core NPs has its maximum 
intensity at 272 nm and the magnitude is particularly dependent on the concentration of Ce3+ ions 
for the samples prepared with different Ce3+:Tb3+ molar ratio [Fig. 4-18(a)].  
 
Fig. 4-18 Excitation spectra of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-
TPP volume ratio, while having different (a) Ce3+:Tb3+ molar ratio and (b) Gd3+ concentration. 
The excitation spectra of Gd(1−x)EuxPO4 core NPs were collected using an emission 
wavelength of 590 nm, an excitation filter at 250–395 nm, and a PMT voltage of 800 V. None of 
the spectra shown in Fig. 4-19 exhibited the characteristic CT from the O2− 2p orbital to the Eu3+ 
4f orbital represented by a broad band around 260 nm [143]. The lack of this band is assumed to 
be related to the high concentration of Eu3+ ions used for synthesis of Gd(1−x)EuxPO4 core NPs, 
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where it has been shown that europium-doped GdPO4 NPs having 10 at.% and 30 at.% of Eu3+ are 
missing this excitation band [142]. 
 
Fig. 4-19 Excitation spectra of GdEuPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio, while having different Eu3+ at.%. 
Emission filters at 295–1,100 nm and 550–1,100 nm were used to collect the emission 
spectra of GdCeTbPO4 and Gd(1−x)EuxPO4 core NPs to prevent secondary order transmissions 
[144]. The emission spectra of GdCeTbPO4 core NPs was acquired with a PMT voltage of 600 V 
and an excitation wavelength of 272 nm. The spectra is characterized by a broad and an intense 
emission band at ~350 nm (Fig. 4-20) related to transitions of Ce3+ ions from the lowest component 
of the 2D state to the spin-orbit components 2F7/2 and 2F5/2 of the ground state, which luminescence 
is not completely quenched [125], [132]–[135]. The high intensity of this emission band caused 
the appearance of a second harmonic in the visible range [600–800 nm] (Fig. 4-20). The emission 
intensity of both Ce3+ bands is dependent on the concentration of this lanthanide within LnPO4 
core NPs [Fig. 4-20(a)]. The characteristic 5D4-7FJ (J = 4, 5, and 6) Tb3+ transitions were also 
observed in the emission spectra of GdCeTbPO4 core NPs [145]. In Fig. 4-20(a), the intensity of 
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the 5D4-7FJ transitions increased with higher concentration of Tb3+ ions, where the highest intensity 
corresponded to Gd0.3Ce0.1Tb0.6PO4 core NPs. For GdCeTbPO4 core NPs synthesized with 
different Gd3+ at.%, the emission bands from Ce3+ ions are more intense than that of the 5D4-7FJ 
Tb3+ transitions [Fig. 4-20(b)], suggesting an inefficient energy transfer between Ce3+ to Tb3+ ions 
[146]. It has been shown that low concentrations of Ce3+ and Tb3+ ions, such as the ones used for 
GdCeTbPO4 core NPs, result in a higher emission from Ce3+ ions with respect to that from Tb3+ 
ions [147]. A continuous increase in the concentration of both Ce3+ and Tb3+ ions resulted in a 
significant increase in the intensity of the Tb3+ emission [Fig. 4-20(b)]. It is expected that by 
dropping the concentration of Ce3+ ions within LnPO4 core NPs, the emission of Tb3+ ions will 
increase at the expense of the Ce3+ emission [135], [147]. 
 
Fig. 4-20 Emission spectra of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-
TPP volume ratio, while having different (a) Ce3+:Tb3+ molar ratio and (b) Gd3+ concentration. 
The emission spectra of GdEuPO4 NPs was recorded using a PMT voltage of 800 V and 
an excitation wavelength of 225 nm. The spectra showed the characteristic 5D0−7FJ (J = 1–4) Eu3+ 
transitions (Fig. 4-21) [53], [148]. The most intense peak located at 594 nm is attributed to the 
magnetic-dipole (5D0–7F1) transition [149]. The relative intensity between the magnetic-dipole 
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(5D0–7F1) and electric-dipole (5D0–7F2) transitions is influenced by the local symmetry of Eu3+ ions 
within LnPO4 NPs [150]. Hence, the higher intensity of the magnetic-dipole transition in 
Gd(1−x)EuxPO4 NPs suggests the higher occupancy of Eu3+ ions with inversion symmetry in the 
GdPO4 hexagonal lattice [149].  
 
Fig. 4-21 Emission spectra of GdEuPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-
TPP volume ratio, while having different Eu3+ at.%. 
The fluorescence emission of LnPO4 core NPs doped with either Ce3+:Tb3+ or Eu3+ ions 
under UV light radiation is shown in Fig. 4-22. LnPO4 core NPs doped with Ce3+:Tb3+ are 
characterized by a bright green emission (~550 nm), while the Eu3+-doped NPs displayed a light 
red color (594 nm) (Fig. 4-22). It is well known that the fluorescence emission of LnPO4 core NPs 
is influenced by their nanocrystalline nature [151], the high concentration of Ln3+ ions [142], and 
the P/Ln ratio [152]. Particularly, the high [P/(Gd+Eu)] ratio used in GdEuPO4 core NPs may have 
caused a decrease of the luminescence emission due to the low intensity of the excitation band 
[152], [153]. 
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Fig. 4-22 Fluorescence of LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 Ln:Na-TPP 
volume ratio, while having different (a) Ce3+:Tb3+ molar ratio, (b) Gd3+ concentration, and (c) Eu3+ 
concentration. 
4.3.5 Magnetic Susceptibility 
The paramagnetic behavior of Ln3+ ions is characterized by a linear increase of the mass 
magnetization with the magnetic field (Fig. 4-23 and Fig. 4-24). The magnetic susceptibility (χ) 
was computed from the mass magnetization and magnetic field curves to compare the magnetic 
properties of the LnPO4 core NPs (GdEuPO4 core NPs synthesized at 90 ºC for 3 hours using 
1:2 Ln:Na-TPP volume ratio, while having different Eu3+ at.%. 
 
 
 
Table 4-6). It is important to mention the correction that must be done to determine the 
contribution of the diamagnetic susceptibility. Based on Pascal constants for the −PO4 group, it is 
expected that for all samples this group will have a diamagnetic susceptibility of −0.5 × 10−6 emu 
Oe−1 g−1 [154], which was subtracted from the paramagnetic susceptibility of the LnPO4 core NPs. 
Gd0.3Ce0.1Tb0.6PO4 core NPs displayed the highest susceptibility (94.50 × 10−6 emu Oe−1 g−1), 
whereas Gd0.3Ce0.6Tb0.1PO4 core NPs had the lowest (36.55 × 10−6 emu Oe−1 g−1). This trend is 
associated with the magnetic moment (µ) of each Ln3+ ion and its relationship to the magnetic 
susceptibility based on the Curie formula, where χ is directly proportional to the square of µ [138]: χ = 	 0123456  4-1 
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Fig. 4-23 Mass magnetization (emu/g) versus field (Oe) loop for LnPO4 core NPs synthesized at 
90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio, while having different (a) Ce3+:Tb3+ molar 
ratio and (b) Gd3+ concentration. 
 
Fig. 4-24 Mass magnetization (emu/g) versus field (Oe) loop for GdEuPO4 core NPs synthesized 
at 90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio, while having different Eu3+ at.%. 
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Table 4-6 Magnetic susceptibilities LnPO4 core NPs synthesized at 90 ºC for 3 hours using 1:2 
Ln:Na-TPP volume ratio. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4 Influence of Annealing Temperature 
 In this section, the influence of annealing temperature on the crystal structure, absorption, 
excitation, and emission of LaPO4, Gd0.3Ce0.6Tb0.1PO4, and Gd0.3Ce0.1Tb0.6PO4 core NPs was 
evaluated. Lanthanide phosphate compounds can be synthesized in hexagonal, monoclinic, or 
tetragonal crystal structures depending on the lanthanide concentration, the synthesis route, and 
the annealing treatment post-synthesis [155], [156]. The hexagonal crystal structure is associated 
with hydrated lanthanide phosphate (LnPO4·xH2O), whereas the anhydrous form crystallizes in 
monoclinic structure [155]. The tetragonal crystal structure is only expected for heavy lanthanide 
ions (Ln3+ = Tb, Dy, Ho, Er, Tm, Yb, Lu) [157]. Luminescence properties are improved after 
annealing because of an enhancement of the NPs crystallinity and a reduction of surface defects 
Abbreviation  Magnetic Susceptibility (× 10–6 emu Oe–1 g–1) 
Gd0.3Ce0.35Tb0.35 64.79 
Gd0.3Ce0.467Tb0.233 52.59 
Gd0.3Ce0.233Tb0.467 77.86 
Gd0.3Ce0.175Tb0.525 82.22 
Gd0.3Ce0.6Tb0.1 36.55 
Gd0.3Ce0.1Tb0.6 94.50 
Gd0.95Ce0.0375Tb0.0125 72.79 
Gd0.8Ce0.15Tb0.05 64.26 
Gd0.6Ce0.3Tb0.1 54.57 
Gd0.9Eu0.1 69.49 
Gd0.8Eu0.2 61.52 
Gd0.7Eu0.3 57.88 
Gd0.6Eu0.4 49.80 
Gd0.5Eu0.5 45.72 
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[158], [159]. Therefore, performing an annealing treatment to the as-prepared LnPO4 NPs may 
improve their response as FI contrast agents. Nonetheless, the application of annealed LnPO4 NPs 
for biomedical applications may be restricted because of the broad particle size distribution 
obtained after treatment [61]. Synthesis of LnPO4 core NPs was carried out using either 1:1 or 1:2 
Ln:Na-TPP, depending on the lanthanides used (section 3.2), at 90 °C for 3 hours. To study the 
influence of annealing, the as-prepared LnPO4 core NPs were dried initially at 100 ºC overnight 
and then annealed for 3 hours at either 400 or 800 ºC. The characterization of the absorption, 
emission, and excitation spectra was done by dispersing the powder material in DI water.  
4.4.1 Crystal Structure 
The diffraction patterns of as-prepared and annealed LaPO4, Gd0.3Ce0.6Tb0.1PO4, and 
Gd0.3Ce0.1Tb0.6PO4 core NPs are shown in Fig. 4-25, Fig. 4-26, and Fig. 4-27, respectively. A 
hexagonal crystal structure corresponding to LaPO4 with space group P6222 (pdf: 01-075-1881), 
CePO4 with space group P3121 (pdf: 01-074-1889), and GdPO4·xH2O with space group P3121 
(pdf: 00-039-0232) was obtained for LaPO4, Gd0.3Ce0.6Tb0.1PO4, and Gd0.3Ce0.1Tb0.6PO4 core 
NPs dried at 100 ºC overnight, respectively. These results are consistent with the hexagonal 
crystal structure reported for LnPO4 nanophosphors [160]. The sharp Bragg reflections observed 
at ~32º and 46º for Gd0.3Ce0.6Tb0.1PO4 and Gd0.3Ce0.1Tb0.6PO4 core NPs correspond to sodium 
chloride that precipitated from unreacted species after synthesis. After annealing at 400 ºC for 3 
hours, a phase transition from hexagonal to monoclinic was observed for LaPO4 and 
Gd0.3Ce0.6Tb0.1PO4 core NPs (Fig. 4-25 and Fig. 4-26), which can be indexed as LaPO4 (pdf: 00-
032-0493) and CePO4 (pdf: 00-026-0355) having a monoclinic structure with space group P21/n, 
respectively. Although the transition of LnPO4·xH2O from hexagonal to monoclinic has been 
reported to occur around 300 ºC [155], the crystal structure of Gd0.3Ce0.1Tb0.6PO4 core NPs 
remained hexagonal after annealing at 400 ºC for 3 hours (Fig. 4-27). It is assumed that the high 
concentration of Tb3+ ions contributed to a delay in the phase transformation. Overall, there was 
a slight decrease in the FWHM of the Bragg reflections after annealing at 400 ºC which was 
observed as an increase of the crystallite size for almost all the samples (synthesized at 90 ºC for 
3 hours using 1:2 Ln:Na-TPP volume ratio and annealed at different temperature for 3 hours. 
Lastly, Gd0.3Ce0.1Tb0.6PO4 core NPs have a tetragonal crystal structure with space group 
I41/amd (pdf: 00-032-1292) and few Bragg reflections peaks matched the monoclinic crystal 
structure of GdPO4 with space group of P21/n (pdf: 00-032-0386) (Fig. 4-27). These results 
indicate that the annealing of LnPO4 core NPs caused a refinement of the crystal structure, an 
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increase of the crystallite size, and a phase transition from hexagonal to either monoclinic or 
monoclinic/tetragonal depending on the lanthanide concentration. 
Table 4-7). The annealing of LnPO4 core NPs at 800 ºC for 3 hours caused a significant 
decrease of the FWHM of all Bragg reflections and a phase transition from hexagonal to either 
monoclinic or monoclinic/tetragonal crystal structures. The decrease of the FWHM is reflected 
by an increase in one order of magnitude of the crystallite size for all the samples (synthesized 
at 90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio and annealed at different temperature for 
3 hours. 
Lastly, Gd0.3Ce0.1Tb0.6PO4 core NPs have a tetragonal crystal structure with space group 
I41/amd (pdf: 00-032-1292) and few Bragg reflections peaks matched the monoclinic crystal 
structure of GdPO4 with space group of P21/n (pdf: 00-032-0386) (Fig. 4-27). These results 
indicate that the annealing of LnPO4 core NPs caused a refinement of the crystal structure, an 
increase of the crystallite size, and a phase transition from hexagonal to either monoclinic or 
monoclinic/tetragonal depending on the lanthanide concentration. 
Table 4-7).  
 
Fig. 4-25 Diffraction patterns of LaPO4 core NPs synthesized at 90 ºC for 3 hours using 1:1 La:Na-
TPP volume ratio and annealed at different temperature for 3 hours. 
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The crystal structure of LaPO4 core NPs corresponds to monoclinic with space group P21/n 
(pdf: 00-032-0493) (Fig. 4-25). For Gd0.3Ce0.6Tb0.1PO4 core NPs almost all the Bragg reflections 
matched with pure CePO4 having a monoclinic crystal structure and space group P21/n (pdf: 00-
026-0355). However, the Bragg reflections highlighted with * in Fig. 4-26 correspond to TbPO4 
with tetragonal structure and space group I41/amd (pdf: 00-032-1292).  
 
Fig. 4-26 Diffraction patterns of Gd0.3Ce0.6Tb0.1PO4 core NPs synthesized at 90 ºC for 3 hours 
using 1:2 Ln:Na-TPP volume ratio and annealed at different temperature for 3 hours. 
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Fig. 4-27 Diffraction patterns of Gd0.3Ce0.1Tb0.6PO4 core NPs synthesized at 90 ºC for 3 hours 
using 1:2 Ln:Na-TPP volume ratio and annealed at different temperature for 3 hours. 
Lastly, Gd0.3Ce0.1Tb0.6PO4 core NPs have a tetragonal crystal structure with space group 
I41/amd (pdf: 00-032-1292) and few Bragg reflections peaks matched the monoclinic crystal 
structure of GdPO4 with space group of P21/n (pdf: 00-032-0386) (Fig. 4-27). These results 
indicate that the annealing of LnPO4 core NPs caused a refinement of the crystal structure, an 
increase of the crystallite size, and a phase transition from hexagonal to either monoclinic or 
monoclinic/tetragonal depending on the lanthanide concentration. 
Table 4-7 Mean crystallite size of LnPO4 core NPs synthesized at 90 ºC for 3 hours and annealed 
at different temperature for 3 hours. 
 Crystallite size (nm) 
Temperature 
Sample 
100 ºC 400 ºC 800 ºC 
LaPO4 6.0 ± 0.4 6.6 ± 1.1 73.5 ± 12.9 
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Gd0.3Ce0.6Tb0.1PO4 4.8 ± 2.2 7.5 ± 1.4 63.8 ± 1.1 
Gd0.3Ce0.1Tb0.6PO4 5.5 ± 2.3 5.5 ± 0.8 76.8 ± 4.4 
 
4.4.2 Absorption, Excitation, and Emission Spectra 
The absorption spectra of Gd0.3Ce0.6Tb0.1PO4 core NPs is characterized by two absorption 
bands at 253 nm and 272 nm [Fig. 4-28(a)] corresponding to 4f → 5d electronic transitions of 
Ce3+ ions [161]. These bands are clearly observed for Gd0.3Ce0.6Tb0.1PO4 core NPs annealed at 
400 ºC for 3 hours, whereas the absorption spectra at 100 ºC and 800 ºC displayed two broad 
bands [Fig. 4-28(a)]. The higher normalized absorbance of Gd0.3Ce0.6Tb0.1PO4 core NPs 
annealed at 800 ºC may be related to a greater interaction of light with the NPs, Rayleigh 
scattering, due to a significant increase of the particle size and NP aggregation (synthesized at 
90 ºC for 3 hours using 1:2 Ln:Na-TPP volume ratio and annealed at different temperature for 3 
hours. 
Lastly, Gd0.3Ce0.1Tb0.6PO4 core NPs have a tetragonal crystal structure with space group 
I41/amd (pdf: 00-032-1292) and few Bragg reflections peaks matched the monoclinic crystal 
structure of GdPO4 with space group of P21/n (pdf: 00-032-0386) (Fig. 4-27). These results 
indicate that the annealing of LnPO4 core NPs caused a refinement of the crystal structure, an 
increase of the crystallite size, and a phase transition from hexagonal to either monoclinic or 
monoclinic/tetragonal depending on the lanthanide concentration. 
Table 4-7). A similar behavior was observed for Gd0.3Ce0.1Tb0.6PO4 core NPs, where the 
sample annealed at 800 ºC had a higher absorbance to that of the other samples because of light 
scattering [Fig. 4-28(b)]. For Gd0.3Ce0.1Tb0.6PO4 core NPs, the absorption spectra were 
characterized by an absorption band ~220 nm originating from the spin allowed f → d transitions 
of Tb3+, which relative intensity and shape was not affected by annealing. The excitation spectra 
of Gd0.3Ce0.6Tb0.1PO4 and Gd0.3Ce0.1Tb0.6PO4 core NPs were recorded using a PMT voltage of 600 
V and an emission wavelength of 352 nm. For Gd0.3Ce0.6Tb0.1PO4 core NPs, the excitation spectra 
showed resemblance with the absorption spectra since the 4f → 5d electronic transitions from Ce3+ 
ions can be observed, however, there was no significant difference in intensity between the 
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samples [Fig. 4-29(a)]. In Fig. 4-29(b), the excitation spectra of Gd0.3Ce0.1Tb0.6PO4 core NPs did 
not show the f → d transition band of Tb3+ (~218 nm) [162]. Although broad bands corresponding 
to Ce3+ ions were observed for Gd0.3Ce0.1Tb0.6PO4 core NPs annealed at 400 ºC, their intensity is 
relatively low because of the concentration of Ce cations in the sample. 
 
Fig. 4-28 Absorption spectra of (a) Gd0.3Ce0.6Tb0.1PO4 and (b) Gd0.3Ce0.1Tb0.6PO4 core NPs 
synthesized at 90 ºC for 3 hours using a 1:2 Ln:Na-TPP volume ratio and annealed at different 
temperature for 3 hours. 
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Fig. 4-29 Excitation spectra of (a) Gd0.3Ce0.6Tb0.1PO4 and (b) Gd0.3Ce0.1Tb0.6PO4 core NPs 
synthesized at 90 ºC for 3 hours using a 1:2 Ln:Na-TPP volume ratio and annealed at different 
temperature for 3 hours. 
The emission spectra of Gd0.3Ce0.6Tb0.1PO4 and Gd0.3Ce0.1Tb0.6PO4 core NPs were 
recorded using an emission filter at 295–1,100 nm, a PMT voltage of 600 V, and an excitation 
wavelength of 272 nm. For Gd0.3Ce0.6Tb0.1PO4 core NPs, there was not a significant difference 
between the emission spectra of the as-prepared NPs and the sample annealed at 400 ºC [Fig. 
4-30(a)]. Both spectra displayed a broad emission band ~350 nm related to the transition from the 
5d1 configuration to the 2F5/2 and 2F7/2 levels of Ce3+ ions [161]. The characteristic 5D4-7F6 (490 
nm), 5D4-7F5 (540 nm), and 5D4-7F4 (560 nm) Tb3+ transitions [62] were observed in all emission 
spectra [Fig. 4-30(a)]. At 800 ºC, the emission spectra displayed higher intensity bands for both 
Ce3+ and Tb3+ ions with respect to the other two samples. Moreover, the emission of Ce3+ ions is 
characterized by two bands at ~348 nm and 385 nm corresponding to the direct emission from the 
2D(5d1) state to the 2F5/2 and 2F7/2 caused by spin-orbit coupling, respectively [163]. The additional 
bands, between 400–450 nm, are associated to the emission of Tb3+ ions. A similar behavior was 
observed for Gd0.3Ce0.1Tb0.6PO4 core NPs, where the highest intensity was observed after 
annealing at 800 ºC for 3 hours [Fig. 4-30(b)]. The intensity of the 5D4-7FJ Tb3+ transitions is 
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comparable to the intensity of the Ce3+ band despite the difference in concentration between both 
Ln3+ ions. These results suggest that the emission of Tb3+ is significantly affected by concentration 
quenching. Additionally, the presence of two phases, monoclinic and tetragonal, in LnPO4 core 
NPs annealed at 800 ºC may result in segregation of Ln cations and hence lower energy transfer 
between Ce3+ to Tb3+ because of the large distance between ions [164]. 
 
Fig. 4-30 Emission spectra of (a) Gd0.3Ce0.6Tb0.1PO4 and (b) Gd0.3Ce0.1Tb0.6PO4 core NPs 
synthesized at 90 ºC for 3 hours using a 1:2 Ln:Na-TPP volume ratio and annealed at different 
temperature for 3 hours. 
4.5 Summary 
 LnPO4 core and core-shell NPs having characteristic luminescence and/or magnetic 
properties were synthesized in aqueous media by precipitation of Ln3+ and [PO4]3– ions. The 
proposed synthesis route, used for the precipitation of LnPO4 core and core-shell NPs from LnCl3 
and Na-TPP at 90 °C for 3 hours, has been tested in radiochemical synthesis because of its 
simplicity and the fact that nonspecialized equipment (i.e. hot plate-stirrer) is implemented. The 
influence of synthesis parameters on the crystal structure, morphology, physical stability, 
luminescence and magnetic properties of LnPO4 core, core + 2 shells, and core + 4 shells NPs was 
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assessed in this chapter.  Modification of synthesis parameters may allow the formation of LnPO4 
NPs in shorter synthesis times (<3 hours), whereas tailoring the composition and concentration of 
lanthanide ions will provide multifunctional properties. The main results obtained in this chapter 
regarding the synthesis and characterization of LnPO4 core and core-shell NPs towards the 
development of multifunctional platforms for TRT and molecular imaging are described below: 
§ No significant difference in the crystallite size of LaPO4 core and core-shell NPs was 
observed for samples synthesized at 90 °C for either 2 or 3 hours of heating. The time-
consuming multi-step procedure followed for the synthesis of radionuclide-doped LnPO4 
core-shell NPs can take advantage of shorter heating times (<3 hours) to minimize the 
activity loss without compromising the particle formation. The optimal synthesis 
parameters include a heating time greater than 2 hours at 90 °C, when using a 1:1 Ln:Na-
TPP volume ratio. 
§ Increasing the concentration of Na-TPP during synthesis resulted in the formation of 
smaller LnPO4 core NPs with good physical stability in water and enhanced luminescence 
properties. The optimum Ln:Na-TPP ratio will depend on the lanthanide(s) ions used 
during synthesis and their relative concentrations. Monodisperse and stable LnPO4 NPs are 
more attractive for biological applications than particles that have broad size distributions 
such as the ones observed in La0.8Ce0.2PO4 core NPs synthesized with a concentration of 
Na-TPP below 1.5 times the concentration of LnCl3. 
§ Luminescence and magnetic properties can be tailored by adjusting the composition and 
concentration of lanthanide ions in LnPO4 NPs. The characteristic green (554 nm) and red 
(594 nm) fluorescence of Tb3+ and Eu3+ ions was observed for LnPO4 NPs, respectively. 
An inefficient energy transfer between Eu cations and O anions may have caused the low 
fluorescence intensity observed for Eu3+ with respect to that of Tb3+ ions. 
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§ Post-annealing treatment of LnPO4 NPs caused a phase transition, an increase in the 
crystallite size, and a modification of the luminescence properties. Although high 
temperature annealing treatment is intended to enhance the crystallinity and luminescence 
properties of LnPO4 NPs, the resulting particle size distribution may not be suitable for 
biological applications.
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5 LnVO4 core and core-shell NPs 
This chapter summarizes the experiments and characterization carried out for LnVO4 core and 
core-shell NPs. The procedures described in section 3.3.1 and 3.3.2 were used as a reference for 
the synthesis of LnVO4 NPs using the citrate and flow route, respectively. Modifications to both 
synthesis routes were made to assess the influence of synthesis parameters and reagents 
concentration, among others, during the formation of LnVO4 core and core-shell NPs. The particle 
size, crystal structure, NPs yield, magnetic susceptibility, luminescence properties, and the ζ-
potential were characterized. Understanding the influence of each synthesis parameter on the 
formation of LnVO4 core and core-shell NPs contributed towards the development of 
multifunctional platforms for biomedical applications. 
 
5.1 Citrate Route Synthesis 
In this section, the influence of temperature, heating time, and reagents concentration in the 
synthesis of LnVO4 core and core-shell NPs was evaluated since additional studies are necessary 
for the development of multifunctional platforms for TRT and molecular imaging. Particularly, 
the development of core-shell structures is essential to increase the retention of decay daughters 
when using in vivo radionuclide generators [42]. Hence, a procedure for the synthesis of LnVO4 
core-shell NPs was proposed and tested in this section. The work of Huignard et al. consisted in 
the synthesis of europium-doped YVO4 core NPs at 60 ºC for 30 minutes using a specific 
concentration of reagents [47]. Additional lanthanide ions and their combination within LnVO4 
NPs may provide multifunctional capabilities for various applications. Having this in mind, the 
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evolution of the hydrodynamic size of LnVO4 (Ln3+ = Nd, Eu, Gd, Tb, Dy, Ho) core NPs, based 
on the intensity distribution, was followed over time using DLS after synthesis at either 60 ºC, 75 
ºC, or 90 ºC. Studying the particle size growth of LnVO4 core NPs at various temperatures and 
heating times will contribute to understand the role of these parameters during NPs formation when 
using different lanthanide ions. The crystal structure and magnetic susceptibility of LnVO4 core 
NPs, synthesized at either 60 ºC for 10 minutes or 90 ºC for 30 minutes, were characterized. These 
synthesis conditions represent two contrasting cases to assess the formation of LnVO4 core NPs at 
the lowest temperature (60 °C) and a short heating time (10 minutes). Moreover, the interest in 
LnVO4 core NPs synthesized at 90 °C for 30 minutes is related to the expected formation of larger 
particles, which can be used to enhance the retention of radionuclides. The yield and ζ-potential of 
GdVO4 core NPs synthesized at 60 °C and 90 °C for different heating times were compared to 
relate the growth kinetics with the fraction of NPs formed and their physical stability in suspension. 
The results showed that increasing the temperature and heating time causes the growth of larger 
particles as well as a greater fraction of them. There was no significant difference between the 
crystallite size and magnetic susceptibility of LnVO4 core NPs synthesized at either 60 ºC for 10 
minutes or 90 ºC for 30 minutes, which suggests aggregation of NPs for the latter synthesis 
conditions. Finally, the variability of the ζ-potential for GdVO4 core NPs synthesized at 60 °C and 
90 °C could be associated with the fraction of NPs in suspension. 
GdVO4 was used as reference compound to test the proposed procedure for the synthesis of 
core-shell NPs.  During synthesis, various reagents concentrations were used while the heating 
time and temperature were kept at 30 minutes and 60 °C. The concentrations of sodium citrate and 
sodium orthovanadate were varied to assess their influence on the particle size, formation of core-
shell structures, and NPs yield. Reducing the concentration of sodium citrate contributed to the 
formation of large particles and/or aggregation of NPs because of its role as complexing agent 
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[47]. In contrast, a significant increase in the particle size was observed when using high 
concentrations of sodium orthovanadate because of NPs aggregation. There was no significant 
difference on the particle size growth of core-shell structures when using a 1:1, 1:1.5, and 1:2 
volume ratio between LnVO4 core NPs suspension and lanthanide-citrate-vanadate solution. An 
increase in LnVO4 NPs yield was obtained after decreasing the concentration of sodium citrate 
during synthesis. 
5.1.1 Influence of Temperature and Heating Time 
LnVO4 core NPs were synthesized as described in section 3.3.1, the volume ratio between 
reagents was kept at 1:0.75:0.75 for LnCl3, sodium citrate, and Na3VO4, while the heating time 
and temperature were varied. The particle size growth was followed for LnVO4 (Ln3+ = Nd, Eu, 
Gd, Tb, Dy, Ho) core NPs synthesized at either 60 ºC, 75 ºC, or 90 ºC for heating times ranging 
between 5 to 60 minutes. The hydrodynamic size of the LnVO4 core NPs was obtained from the 
normalized intensity distribution using DLS. The crystal structure, crystallite size, and magnetic 
susceptibility of LnVO4 core NPs synthesized at either 60 ºC for 10 minutes or 90 ºC for 30 minutes 
were also reported. 
5.1.1.1 Hydrodynamic Size  
The mean hydrodynamic size of LnVO4 core NPs synthesized at 60 ºC, 75 ºC, and 90 ºC 
for multiple heating times is shown in Fig. 5-1, Fig. 5-2, and Fig. 5-3, respectively. The 
hydrodynamic size increased at each temperature after synthesizing LnVO4 core NPs for longer 
heating times. This increase in particle size with time is associated with the progressive 
consumption of free molecular species that contribute to LnVO4 NPs formation [47]. A similar 
behavior was obtained after increasing the temperature for the same heating time. The largest 
particle size for each LnVO4 core NPs was obtained after heating at 90 ºC. At this temperature, the 
 75 
rate at which the oligomeric species are consumed is expected to be higher with respect to lower 
temperatures (60 °C or 75 °C). This trend suggests that NPs formation can be achieved at shorter 
heating times (<30 minutes) by increasing the temperature, which could be of interest for the 
synthesis of radionuclide-doped LnVO4 core NPs, particularly when using short-lived 
radionuclides.  
 
Fig. 5-1 Mean hydrodynamic size (intensity distribution) of LnVO4 NPs synthesized at 60 °C for 
different heating times using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Although all samples were synthesized at the same conditions, the rate of particle growth 
was higher for NdVO4 core NPs, while there was not significant difference between the remaining 
samples based on the reported standard deviations. In summary, the increase of temperature and 
heating time resulted in larger particle size and also broader size distributions, which could be 
associated with particle growth, NP aggregation, or both. 
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Fig. 5-2 Mean hydrodynamic size (intensity distribution) of LnVO4 NPs synthesized at 75 °C for 
different heating times using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
 
Fig. 5-3 Mean hydrodynamic size (intensity distribution) of LnVO4 NPs synthesized at 90 °C for 
different heating times using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
5.1.1.2 Crystal Structure 
The diffraction patterns of LnVO4 core NPs synthesized at either 60 °C for 10 minutes or 
90 °C for 30 minutes are shown in Fig. 5-4. The crystal structure of LnVO4 core NPs matches with 
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a tetragonal system with space group I41/amd. The Bragg reflections highlighted with * correspond 
to sodium chloride that was precipitated after synthesis [Fig. 5-4(a)]. In Table 5-1, the reference 
pattern and crystallite size for each LnVO4 core NPs are presented. As expected from the 
diffraction patterns, where broad Bragg reflections were observed, LnVO4 core NPs have a 
crystallite size below 10 nm. Although two contrasting conditions were used for the synthesis of 
LnVO4 core NPs, no significant difference was observed between their crystallite sizes. These 
results suggest that LnVO4 core NPs are formed by crystallites, which size is independent of the 
temperature and heating time used during synthesis, but that may be affected by the reagents 
concentration (LnCl3, sodium citrate, and Na3VO4). Therefore, the increase in particle size 
evidenced from DLS upon an increase in heating time and temperature may correspond to NP 
aggregation rather than growth. This hypothesis is consistent with the influence of heating time 
and temperature on the consumption of oligomeric species. 
 
Fig. 5-4 Diffraction patterns of LnVO4 core NPs synthesized at (a) 60 °C for 10 minutes and (b) 
90 °C for 30 minutes using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
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Table 5-1 Crystallite size and reference pattern of LnVO4 core NPs synthesized at different 
conditions using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Sample 60 °C – 10 minutes 90 °C – 30 minutes Reference 
NdVO4 7.4 7.7 pdf: 01-072-0859 
EuVO4 5.8 5.9 pdf: 01-072-0278 
GdVO4 5.7 5.7 pdf: 00-017-0260 
TbVO4 5.7 5.9 pdf: 01-072-0276 
DyVO4 5.9 6.7 pdf: 01-072-0275 
HoVO4 5.8 6.5 pdf: 00-015-0764 
 
5.1.1.3 Magnetic Susceptibility 
In Fig. 5-5, the mass magnetization versus magnetic field loops of LnVO4 core NPs synthesized 
at 60 °C for 10 minutes and 90 °C for 30 minutes are shown. The trend observed for the mass 
magnetization of LnVO4 core NPs agrees with the Curie formula [equationχ=	 0123456 4-1χ = 	 0123456  
4-1], which relates the magnetic susceptibility to magnetic moment of each Ln3+ ion. The 
magnetic susceptibility was calculated from the slope of each curve (The highest magnitude was 
obtained for DyVO4, whereas the lowest corresponds to EuVO4. No significant difference 
between the magnetic susceptibility of LnVO4 core NPs synthesized at both set of conditions 
was observed. The high magnetic moment of Tb3+, Dy3+, and Ho3+ ions and hence large 
magnetic susceptibility may be exploited for the development of negative-T2 contrast agents for 
application in high magnetic fields [25], [165]. 
Table 5-2).  
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Fig. 5-5 Mass magnetization (emu/g) versus field (Oe) loop for LnVO4 core NPs synthesized at 
(a) 60 °C for 10 minutes and (b) 90 °C for 30 minutes using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
The highest magnitude was obtained for DyVO4, whereas the lowest corresponds to 
EuVO4. No significant difference between the magnetic susceptibility of LnVO4 core NPs 
synthesized at both set of conditions was observed. The high magnetic moment of Tb3+, Dy3+, and 
Ho3+ ions and hence large magnetic susceptibility may be exploited for the development of 
negative-T2 contrast agents for application in high magnetic fields [25], [165]. 
Table 5-2 Magnetic susceptibility of LnVO4 core NPs synthesized at different conditions using a 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
 Magnetic Susceptibility (× 10–6 emu Oe–1 g–1) 
Sample 60 °C – 10 minutes 90 °C – 30 minutes 
NdVO4 11.0 9.92 
EuVO4 9.79 7.74 
GdVO4 68.8 71.7 
TbVO4 112.2 110.1 
DyVO4 125.6 129.1 
HoVO4 118.5 116.9 
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5.1.1.4 Nanoparticle Yield 
The yield of GdVO4 core NPs synthesized at 60 ºC and 90 ºC for various heating times was 
calculated based on the concentration of Gd cations measured using ICP-OES. The as-prepared 
GdVO4 core NPs suspensions were dialyzed against DI water for 20 hours and the Gd 
concentration of both dialysate and dialyzed NPs suspension was compared to the nominal 
concentration of Gd cations. In Table 5-3, the mean yield and standard deviation for GdVO4 core 
NPs synthesized at various heating times and temperatures are presented. Although no significant 
difference was observed between the yield of GdVO4 synthesized for 10 minutes and 30 minutes 
at 60 ºC, a higher yield was observed upon increase in heating time at a specific temperature. An 
increase in temperature to 90 ºC caused a higher GdVO4 core NPs yield with respect to those 
obtained at 60 ºC (Table 5-3). The fact that a greater fraction of LnVO4 core NPs could be 
synthesized at higher temperatures (90 °C) and shorter heating times (<30 minutes) is appealing 
for radiochemical settings, particularly when using short-lived radionuclides. 
Table 5-3 Yield of GdVO4 core NPs synthesized at different conditions using a 1:0.75:0.75 
Ln:cit:VO4 volume ratio. 
Temperature (°C) Heating time (min) Yield (%) 
60 
10 68.8 ± 5.7 
30 65.8 ± 5.8 
60 73.0 ± 8.4 
90 
5 74.2 ± 9.7 
15 80.1 ± 6.6 
30 85.0 ± 8.2 
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5.1.1.5 Zeta Potential 
The physical stability of as-prepared GdVO4 core NPs synthesized at 60 °C and 90 °C was 
assessed based on the ζ-potential. In Table 5-4, the mean ζ-potential and standard deviation of 
GdVO4 core NPs synthesized at various conditions are summarized. The magnitude of the zeta 
potential was below -10 mV for GdVO4 core NPs synthesized at 60 °C for heating times shorter 
than 40 minutes. The sudden increase in the absolute magnitude of the zeta potential at heating 
times equal or longer than 50 minutes could be related to a larger fraction of NPs in suspension. It 
is assumed that the variability and low ζ-potential of GdVO4 NPs synthesized at heating times 
between 10 to 40 minutes is caused by a low fraction of NPs and a high concentration of unreacted 
species. This behavior was not observed at 90 °C, where the absolute magnitude of the mean ζ-
potential was greater than 25 mV for almost all the samples. The consistent ζ-potential of GdVO4 
core NPs synthesized at 90 °C is assumed to be related to a higher yield of NPs (Table 5-3). The 
negative magnitude of the ζ-potential obtained for all samples is consistent with the presence of 
citrate groups that are complexed to Ln3+ ions on the NP surface [47]. 
Table 5-4 Mean ζ-potential of GdVO4 core NPs synthesized at different conditions using a 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
ζ-potential (mV) 
Time (m)  
Temp. 10 20 30 40 50 60 
60 °C -4.7 ± 6.6 -0.1 ± 0.5 -8.9 ± 2.3 -5.1 ± 4.4 -12.5 ± 0.4 -35.7 ± 0.6 
90 °C -28.4 ± 7.5 -18.7 ± 2.1 -30.3 ± 3.6 -27.4 ± 6.8 -33.4 ± 3.2 -27.2 ± 4.8 
 
5.1.2 Influence of Reagents Concentration 
The concentration of sodium citrate and sodium orthovanadate was varied to assess their 
influence on particle growth for GdVO4 core and core-shell NPs. Synthesis of GdVO4 core NPs 
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was carried out at 60 °C for 30 minutes, while the volume ratio between sodium citrate and sodium 
orthovanadate was adjusted at 0.55–0.75 and 0.75–0.95 with respect to GdCl3, respectively. The 
hydrodynamic size from the intensity and number distributions was reported at each concentration 
as well as the PI. The crystallite size and yield of GdVO4 core NPs obtained for multiple citrate 
concentrations were also compared. The synthesis procedure proposed for the development of 
GdVO4 core-shell NPs was tested at various reagents concentrations and volume ratios between 
the core NPs suspension and the fresh oligomeric species solution. The hydrodynamic size, particle 
size distribution, and crystallite size were used to assess the formation of core-shell structures.  
5.1.2.1 Hydrodynamic Size  
In Table 5-5, the mean hydrodynamic size and standard deviation are reported for different 
volume ratios of sodium citrate and Na3VO4 with respect to that of GdCl3. The hydrodynamic size 
of GdVO4 core NPs synthesized with 0.55, 0.65, and 0.75 volume equivalent of sodium citrate for 
a fixed 0.75 volume equivalent of Na3VO4 did not show significant difference (Table 5-5). Larger 
hydrodynamic size and size distributions were observed upon an increase in concentration of 
Na3VO4 for the same concentrations of sodium citrate. This trend is related to a decrease in the 
fraction of surface Gd cations available for complexation with citrate groups as well as a reduction 
of citrate groups to stabilize the GdVO4 core NPs. It is expected that decreasing the concentration 
of sodium citrate while increasing the concentration of Na3VO4 will result in significant NP 
aggregation rather than NP growth. 
Table 5-5 Mean intensity and number particle size of GdVO4 core NPs synthesized 60 °C for 30 
minutes using different chemical volume ratios. 
Ln Cit VO4 PI Size [intensity] (nm)  Size [number] (nm) 
1 0.75 
0.75 0.112 15.1 ± 8.4 8.8 ± 2.0 
0.85 0.202 34.5 ± 14.4 14.6 ± 3.9 
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0.95 0.280 258.0 ± 122.3 38.7 ± 19.0 
0.65 
0.75 0.159 15.8 ± 5.8 8.8 ± 2.2 
0.85 0.181 56.6 ± 27.6 21.9 ± 6.2 
0.95 0.311 326.4 ± 230.3 40.4 ± 14.7 
0.55 
0.75 0.072 16.8 ± 6.6 8.8 ± 2.2 
0.85 0.231 69.7 ± 40.6 22.7 ± 6.4 
0.95 0.322 497.4 ± 342.5 122.2 ± 62.8 
A procedure for the synthesis of GdVO4 core-shell NPs based on mixing the core NPs 
suspension with a solution containing Ln-cit-VO4 oligomeric species was proposed. The volume 
ratio between the core NPs suspension and the oligomeric species solution was varied at either 1:1, 
1:1.5, or 1:2. To study the influence of the concentration of fresh oligomeric species in the particle 
growth of GdVO4 core-shell NPs, the volume ratio between Ln:cit:VO4 was kept at 1:0.75:0.75 
while the synthesis was carried out at 60 °C for 30 minutes. In Fig. 5-6, the particle size of GdVO4 
core, core + 1 shell, and core + 2 shells NPs is compared with respect to the volume ratio between 
the core NPs suspension and the oligomeric species solution. These results showed that there is no 
significant difference between the particle size of core and core-shell structures based on the 
volume ratios used. However, it is observed that the mean core-shell particle size is larger when 
synthesized using volume ratios of 1:1.5 and 1:2 with respect to 1:1 of core NPs suspension to 
oligomeric species solution. The deposition of shells for all the volume ratios studied was 
accompanied by an increase in the mean particle size and standard deviation (Fig. 5-6).  
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Fig. 5-6 Mean particle size (number distribution) of GdVO4 core-shell NPs synthesized at 60 °C 
for 30 minutes using a 1:0.75:0.75 Ln:cit:VO4 volume ratio, while increasing the volume ratio of 
oligomeric species solution to core NPs suspension. 
The evolution of the intensity and number distribution of GdVO4 core-shell NPs is shown 
in Fig. 5-7. The deposition of shells caused broader particle size distributions suggesting that the 
mechanism behind core-shell structure formation may be Ostwald ripening, where the smaller 
nuclei dissolve while the larger nuclei and/or core NPs coarsen [166]. Hence, the synthesis of core-
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shell structures could result in the formation of new core NPs depending on the concentration of 
oligomeric species and the synthesis parameters used. 
 
Fig. 5-7 Normalized (a) intensity and (b) number particle size distributions of GdVO4 core-shell 
NPs synthesized at 60 °C for 30 minutes using a 1:0.75:0.75 Ln:cit:VO4 volume ratio, while 
keeping a 1:1.5 volume ratio of core NPs suspension to oligomeric species solution. 
The formation of GdVO4 core-shell NPs was also studied using lower concentration of 
sodium citrate to promote the deposition of thicker shells, while keeping a constant concentration 
of Na3VO4. The mean hydrodynamic size and standard deviation of GdVO4 core, core + 1 shell, 
and core + 2 shells for 1:1.5 and 1:2 volume ratio of core NPs suspension to fresh oligomeric 
solution are shown in Table 5-6 and Table 5-7, respectively. The fresh oligomeric solution was 
prepared using the same concentration of chemical reagents proposed for the core NPs. Despite 
the assumption that decreasing the concentration of sodium citrate would result in a thicker shell 
deposition, the results showed that there is no significant difference in particle size between the 
proposed chemical concentrations. 
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Table 5-6 Mean intensity and number particle size of GdVO4 core and core-shell NPs synthesized 
at 60 °C for 30 minutes using at various chemical ratios, while keeping the volume ratio of core 
NPs suspension to fresh oligomeric solution 1:1.5. 
Ln Cit VO4 Structure PI Size [intensity] (nm) Size [number] (nm) 
1 0.75 0.75 
Core 0.156 13.9 ± 17.5 6.6 ± 1.2 
Core + 1 shell 0.209 15.5 ± 3.7 9.3 ± 2.0 
Core + 2 shells 0.236 17.5 ± 3.8 13.6 ± 2.3 
1 0.65 0.75 
Core 0.097 12.8 ± 4.3 7.8 ± 1.8 
Core + 1 shell 0.132 16.5 ± 4.8 9.3 ± 2.1 
Core + 2 shells 0.152 18.3 ± 5.1 12.8 ± 2.4 
1 0.55 0.75 
Core 0.036 13.4 ± 4.5 8.1 ± 1.9 
Core + 1 shell 0.092 17.3 ± 5.7 10.5 ± 2.5 
Core + 2 shells 0.110 19.8 ± 6.8 11.6 ± 2.8 
Table 5-7 Mean intensity and number particle size of GdVO4 core and core-shell NPs synthesized 
at 60 °C for 30 minutes using at various chemical ratios, while keeping the volume ratio of core 
NPs suspension to fresh oligomeric solution 1:2. 
Ln Cit VO4 Structure PI Size [intensity] (nm)  Size [number] (nm) 
1 0.75 0.75 
Core 0.095 12.8 ± 20.2 8.1 ± 1.5 
Core + 1 shell 0.146 14.6 ± 2.7 12.2 ± 1.8 
Core + 2 shells 0.132 16.7 ± 3.0 14.0 ± 1.8 
1 0.65 0.75 
Core 0.058 12.2 ± 4.0 6.3 ± 1.4 
Core + 1 shell 0.064 16.0 ± 4.4 11.0 ± 2.1 
Core + 2 shells 0.076 19.1 ± 6.4 11.4 ± 2.7 
1 0.55 0.75 
Core 0.054 13.2 ± 4.4 8.1 ± 1.8 
Core + 1 shell 0.075 17.6 ± 5.9 10.6 ± 2.5 
Core + 2 shells 0.132 19.8 ± 6.7 11.8 ± 2.8 
It is expected that a larger fraction of citrate groups on the NPs surface may hinder the 
deposition and growth of shells. Additionally, an increase in the concentration of oligomeric 
species did not promote the formation of thicker shells. This behavior could be attributed to the 
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fact that a high concentration of oligomeric species may promote the formation of new core NPs 
rather than the deposition of shells under the temperature and heating time used. 
5.1.2.2 Crystal Structure 
The diffraction patterns of GdVO4 core and core + 2 shells NPs synthesized at 60 °C for 
30 minutes while using either 0.75, 0.65, or 0.55 volume equivalent of sodium citrate are shown 
in Fig. 5-8. The crystal structure of both core and core + 2 shells NPs corresponds to a tetragonal 
system with space group I41/amd (pdf: 00-017-0260). A decrease in the concentration of sodium 
citrate did not result in a significant difference in the crystallite size of GdVO4 core NPs, which 
magnitude was between 4.8 to 5.2 nm. Although the citrate groups control the size of the GdVO4 
core NPs, the similarity in crystallite size may be attributed to the citrate concentrations studied. 
A further decrease of citrate concentration was not explored because significant aggregation of 
NPs has been reported [47]. The deposition of two shells of GdVO4 was carried out using a 1:1.5 
volume ratio of core NPs suspension to fresh oligomeric solution. The deposition of two GdVO4 
shells caused an increase in the crystallite size to 5.8–6.4 nm. As observed from the GdVO4 core 
NPs, the difference in crystallite size for core + 2 shells NPs synthesized using various citrate 
concentrations is not significant. It is expected that the formation of core-shells structures and 
hence increase in crystallite size are related to an epitaxial grow mechanism of GdVO4 shells on 
the core NPs surface. An additional set of experiments to test the deposition of shells at different 
heating time and temperature was performed. In this case, GdVO4 core-shell NPs were synthesized 
at 90 °C for 10 minutes while keeping the volume ratio of chemicals at 1:0.75:0.75 and a 1:1.5 
volume ratio of core NPs suspension to fresh oligomeric solution. The deposition of shells 
decreased the FWHM of the Bragg reflections and therefore resulted in an increase of the 
crystallite size (Fig. 5-9).  The crystallite size was 6.6 nm, 8.6 nm, and 9.5 nm for GdVO4 core, 
core + 1 shell, and core + 2 shells, respectively. The crystallite size of GdVO4 core + 2 shells (9.5 
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nm), synthesized at 90 °C for 10 minutes, is larger than the one obtained for GdVO4 core NPs (5.7 
nm), synthesized at 90 ºC for 30 minutes. This difference of 3.8 nm in crystallite size between two 
NPs suspensions that were synthesized at the same temperature (90 °C) and equivalent heating 
time (30 minutes) supports the hypothesis that the addition of fresh oligomeric solutions 
contributed to the deposition of shells on the core surface. In summary, the development of core-
shell structures is dependent on the heating time, temperature, and reagents concentration. The 
continuous increase in crystallite size validates the successful growth of GdVO4 shells by using 
the proposed method under various synthesis conditions.   
 
Fig. 5-8 Diffraction patterns of GdVO4 (a) core and (b) core + 2 shells NPs synthesized at 60 °C 
for 30 minutes using different citrate concentrations (Ln:cit = 1:0.75, 1:0.65, 1:0.55), while 
keeping a 1:1.5 volume ratio of core NPs suspension to oligomeric species solution. 
 89 
 
Fig. 5-9 Diffraction patterns of GdVO4 core, core + 1 shell, and core + 2 shells NPs synthesized 
at 90 °C for 10 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. 
5.1.2.3 Nanoparticle Yield 
The fraction of GdVO4 core NPs synthesized at 60 °C for 30 minutes was assessed based 
on the concentration of Gd cations. GdVO4 core NPs suspensions synthesized with either 0.75, 
0.65, or 0.55 volume equivalent of sodium citrate were dialyzed against DI water for 20 hours. 
The Gd concentration of both dialysate and dialyzed NPs suspension was measured by ICP-OES 
and compared to the nominal concentration of Gd cations. A decrease in sodium citrate 
concentration did not result in a significant difference in the NPs yield (Table 5-8). However, it 
can be observed that the mean value increases ~10% for lower concentrations of sodium citrate 
(0.65 and 0.55). The higher yield obtained when using lower concentrations of sodium citrate (0.65 
and 0.55) could be explained by its role as complexing agent, where it may also hinder the 
formation of NPs since a fraction of lanthanide ions can remain as Ln-cit complexes in solution. 
 90 
Therefore, a decrease in sodium citrate concentration will contribute to the formation of a larger 
fraction of NPs with negligible influence on the particle size distribution and crystallite size.  
Table 5-8 GdVO4 core NPs yield synthesized at 60 °C for 30 minutes using different citrate 
concentrations, while keeping a 1:0.75 Ln:VO4 volume ratio. 
Reagents concentration [Ln:cit:VO4] Yield (%) 
1:0.75:0.75 65.8 ± 5.8 
1:0.65:0.75 78.6 ± 9.9 
1:0.55:0.75 76.9 ± 1.2 
 
5.1.2.4 Magnetic Susceptibility 
The mass magnetization versus magnetic field loops of GdVO4 core, core + 1 shell, and 
core + 2 shells NPs synthesized at 90 °C for 10 minutes while keeping the volume ratio of 
chemicals at 1:0.75:0.75 and a 1:1.5 volume ratio of core NPs suspension to fresh oligomeric 
solution are shown in Fig. 5-10.  
 
Fig. 5-10 Mass magnetization (emu/g) versus field (Oe) loop for GdVO4 core, core + 1 shell, and 
core + 2 shells NPs synthesized at 90 °C for 10 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 
core NPs suspension to fresh oligomeric solution volume ratios. 
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The deposition of shells resulted in an increase of magnetic susceptibility with respect to 
the GdVO4 core NPs. Although the increase in magnetic susceptibility is not significant, the larger 
magnitude could be related to a higher yield of GdVO4 core-shell NPs with respect to core. This 
assumption is based on the dependence of the magnetic susceptibility on the number of ions (N) 
as shown in equation χ=	 0123456  4-1, where temperature and the magnetic moment were kept 
constant. In core-shell structures, a lower fraction of unreacted species that are diamagnetic will 
contribute toward a higher magnetic susceptibility. 
5.1.3 Synthesis of Gd(1-x)EuxVO4 core NPs 
Europium-doped gadolinium vanadate (Gd(1-x)EuxVO4) core NPs were synthesized by 
mixing 0.1 M GdCl3 and 0.1 M EuCl3 at specific volume ratios [Eu/(Gd+Eu) = 0.05, 0.1, 0.2, and 
0.4] while using the concentration of reagents, temperature, and heating time described in section 
3.3.1. The diffraction patterns, time-resolved luminescence decay lifetimes, absorption, excitation, 
and emission spectra were collected for the different samples to assess the influence of Eu3+ 
concentration. Particular interest was placed on the minimum Eu3+ concentration that will provide 
the highest emission intensity with negligible concentration quenching for the development of 
multimodal contrast agents for FI and MRI. The absorption, excitation, and emission spectra as 
well as the luminescence decay lifetimes were influenced by the Eu3+ concentration, whereas no 
significant difference was observed in the crystal structure and crystallite size of Gd(1-x)EuxVO4 
core NPs. The results presented in this section have been adapted from a manuscript accepted at 
Journal of Materials Chemistry B. 
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5.1.3.1 Crystal Structure 
Diffraction patterns of Gd(1-x)EuxVO4 core NPs matched with a tetragonal system having a 
zircon-type structure and space group I41/amd (pdf: 00-017-0260, GdVO4). The increase in Eu3+ 
concentration results in a slight shifting of 2θ, which implies a change in the d-spacing due to 
elastic strains imposed by the difference in size between the ionic radii of Gd3+ and Eu3+ ions (Fig. 
5-11) [141]. The crystallite size of Gd(1-x)EuxVO4 core NPs seems to be independent of the Eu3+ 
concentration since no significant differences were observed between samples (Error! Reference s
ource not found.). 
 
Fig. 5-11 Diffraction patterns of Gd(1-x)EuxVO4 core NPs synthesized at 60 °C for 30 minutes using 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Table 5-9 Crystallite size of Gd(1–x)EuxVO4 core NPs synthesized at 60 °C for 30 minutes using 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Sample Crystallite size (nm) 
Gd0.95Eu0.05VO4 4.5 
Gd0.9Eu0.1VO4 4.4 
Gd0.8Eu0.2VO4 4.7 
Gd0.6Eu0.4VO4 4.7 
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5.1.3.2 Luminescence Properties 
The absorption, excitation, and emission spectra of Gd(1-x)EuxVO4 core NPs having Eu3+ 
concentration from 5–40 at.% are shown in Fig. 5-12, Fig. 5-13, and Fig. 5-14, respectively. The 
concentration of lanthanide ions in Gd(1-x)EuxVO4 core NPs is consistent with the nominal Eu3+ 
concentrations (Table 5-10).The absorption spectrum is characterized by an absorption band 
around 280 nm, which corresponds to the O2−-V5+ CT band [167]. An increase in Eu3+ 
concentration resulted in a slight rise in the absorbance, which may be related to the O2−-Eu3+ CT 
(250–260 nm), which could not be observed due to overlapping with O2−-V5+ CT band (Fig. 5-12). 
The excitation spectrum was recorded using an emission wavelength of 618 nm, an excitation filter 
between 250–395 nm, and a PMT voltage of 600 V. As shown in Fig. 5-13, the excitation spectrum 
is characterized by two CT bands corresponding to O2−-Eu3+ (~280 nm) and O2−-V5+ (~305 nm), 
where the latter is related to the symmetry-allowed absorption 1A1→1T2 of the [VO4]3− unit [168]–
[170]. An increase of Eu3+ concentration was accompanied by a higher intensity of the O2−-Eu3+ 
band, while the O2−-V5+ band becomes unnoticeable due to overlapping (Fig. 5-13).  
 
Fig. 5-12 Absorption spectra of Gd(1–x)EuxVO4 core NPs synthesized at 60 °C for 30 minutes using 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
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Fig. 5-13 Excitation spectra of Gd(1–x)EuxVO4 core NPs synthesized at 60 °C for 30 minutes using 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
The emission spectrum of each sample was recorded using an excitation wavelength of 280 
nm, a PMT voltage of 600 V, and an emission filter from 295–1,100 nm. All emission spectra 
displayed the characteristic 5D0 → 7FJ (J = 1–4) Eu3+ transitions originating from low energy 
transfer (Fig. 5-14) [171]. It has been evidenced that the dopant concentration has to be optimized 
for each Ln3+ ion based on the properties of the host lattice [8]. Although increasing the Eu3+ 
concentration to 40 at.% caused the highest emission intensity at 5D0 → 7F2 transition, the 
difference with 20 at.% was not significant evidencing concentration quenching. Time-resolved 
luminescence decay curves of Gd(1–x)EuxVO4 core NPs displayed a better fit (higher R2) when 
using a biexponential function with respect to that obtained with an exponential (Fig. 5-15). An 
increase of Eu3+ concentration from 5% to 40% caused a decrease in the average luminescence 
decay lifetime from 1.33 μs to 0.89 μs, respectively. Increasing the concentration of Eu3+ ions 
caused a decrease in the distance between dopant ions, which promoted Eu-Eu interactions 
resulting in cross relaxation processes [59], [126], [172]. The higher the concentration of dopant 
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ions, the greater is the probability of non-radiative de-excitation, which is observed as a decrease 
in the average luminescence decay lifetime [8]. Additionally, the nonexponential behavior of the 
time-resolved luminescence decay curves may suggest the energy transfer of Eu3+ to impurities 
[169]. Although the average luminescence decay life time of Gd0.8Eu0.2VO4 core NPs was 17.9% 
lower with respect to that of Gd0.95Eu0.05VO4, an increase of 89% in emission intensity encouraged 
the use of 20% Eu3+ as an optimal concentration for fluoresence applications. 
 
Fig. 5-14 Emission spectra of Gd(1–x)EuxVO4 core NPs synthesized at 60 °C for 30 minutes using 
1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Table 5-10 Lanthanide weight percentage results for Gd(1–x)EuxVO4 core NPs synthesized at 60 
°C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
 Weight percentage (%) 
Sample Eu Gd 
Gd0.95Eu0.05VO4 5.6 94.4 
Gd0.9Eu0.1VO4 10.6 89.4 
Gd0.8Eu0.2VO4 20.9 79.1 
Gd0.6Eu0.4VO4 40.4 59.6 
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Fig. 5-15 Time-resolved luminescence decay curves of Gd(1–x)EuxVO4 core NPs synthesized at 60 
°C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
5.2 Flow Synthesis 
In this section, the formation of LnVO4 NPs by precipitation at room temperature was 
studied because of its attractiveness for radiochemical synthesis and the promising application of 
these NPs as MRI contrast agents. A detailed study of the influence of pH, reagents (LnCl3 and 
Na3VO4) concentration, and lanthanide composition is presented for LnVO4 NPs prepared using 
flow synthesis. Huignard et al. reported that the pH of the solution must not be either too alkaline 
(pH > 13) to prevent the irreversible precipitation of Ln(OH)3 species or too acidic (pH < 8) since 
polyvanadate species will be formed [126]. Based on these results, it was concluded that additional 
studies were necessary for the development of multifunctional platforms for biomedical 
applications. The synthesis of LnVO4 NPs was completed as reported in section 3.3.2. The pH was 
monitored continuously during the addition of LnCl3 solutions and adjusted at either 8, 10, 11, or 
12 using NaOH (1 M). The reagents concentration, LnCl3 and Na3VO4, was set at either 0.01 M, 
0.05 M, 0.1 M, or 0.2 M while the pH was kept at 12. Pure LnVO4 (Ln3+ = La, Gd, Tb, Dy, and 
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Ho) and Dy-doped LnVO4 (Ln3+ = La, Gd, and Lu) NPs were prepared using 0.1 M solutions of 
both LnCl3 and Na3VO4, while keeping the pH at ~11 to assess their potential application as 
radionuclides carriers and molecular imaging contrast agents. It was observed that the pH, reagents 
concentration, and crystal structure influenced the morphology of LnVO4 NPs. The results 
presented in this section have been adapted from a manuscript that is under preparation. 
5.2.1 Influence of Synthesis Parameters 
GdVO4 NPs were synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4 by adding GdCl3 at 
~1 mL min–1 and adjusting the pH at either 8, 10, 11, or 12 using 1 M NaOH. Synthesis parameters 
such as flow rate, stirring speed, and stirring time were also studied, however, the results are not 
shown since no significant influence on the morphology and crystallite size of GdVO4 NPs was 
observed. The concentration of both GdCl3 and Na3VO4 was also varied at either 0.01, 0.05, 0.1, 
or 0.2 M while keeping the flow rate and pH at ~1 mL min–1 and 12, respectively. The crystallite 
size and morphology of the as-prepared GdVO4 NPs were characterized. 
5.2.1.1 Crystal Structure 
The crystal structure of GdVO4 NPs synthesized at various pH corresponds to a tetragonal 
system with zircon-type structure having a space group of I41/amd (pdf: 00-017-0260). As shown 
in Fig. 5-16, no second phases were observed in the diffraction patterns suggesting that gadolinium 
hydroxide and polyvanadate species were not precipitated under the synthesis conditions and pH 
range used throughout the experiments. The Bragg reflections become broader with a decrease in 
the pH indicating a reduction of the crystallite size (Table 5-11). The crystallite size was almost 
three times larger for GdVO4 NPs when the pH was adjusted from 12 to 8, 23.4 nm versus 8.3 nm, 
respectively. It is assumed that a decrease of the pH may contribute to a slower formation and 
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precipitation of NPs because of the simultaneous and competing process where orthovanadate 
groups change into polyvanadate species.  
 
Fig. 5-16 Diffraction patterns of GdVO4 NPs synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, 
a flow rate ~1 mL min-1, while adjusting the pH at different values. 
Table 5-11 Crystallite size of GdVO4 NPs synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a 
flow rate ~1 mL min-1, while adjusting the pH at different values. 
pH Crystallite size (nm) 
12 23.2 
11 17.2 
10 13 
8 8.4 
In Fig. 5-17, GdVO4 NPs synthesized using both GdCl3 and Na3VO4 at concentrations 
from 0.01 M to 0.2 M in a 1:1 volume ratio have diffraction patterns that match with a tetragonal 
structure with space group of I41/amd of pure GdVO4 (pdf: 00-017-0260). The crystallite size of 
GdVO4 NPs synthesized using both GdCl3 and Na3VO4 at either 0.01 M or 0.05 M is ~44 nm, 
while for higher concentrations (≥0.1 M) the crystallite size is almost half this magnitude (Table 
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5-12). The difference in crystallite size may be associated to the concentration of Gd3+ and [VO4]3– 
species available for nuclei formation. At lower GdCl3 and Na3VO4 concentrations, either 0.01 M 
or 0.05 M, the fraction of stable nuclei formed after mixing both chemicals may be lower with 
respect to high reagents concentrations. Therefore, a lower fraction of stable nuclei will promote 
the formation and growth of large particles. Another hypothesis is related to the precipitation of 
Gd(OH)3, which interaction with Na3VO4 is slow causing the formation of few particles of large 
size [126]. Particularly, at lower reagents concentration (<0.1 M), the pH of the solution remained 
~12.5 for a significant fraction of time, which may have prompted the precipitation of gadolinium 
hydroxide species. 
 
Fig. 5-17 Diffraction patterns of GdVO4 NPs synthesized using different GdCl3 and Na3VO4 
concentrations, a flow rate ~1 mL min-1, and keeping the pH ~12. 
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Table 5-12 Crystallite size of GdVO4 NPs synthesized using different GdCl3 and Na3VO4 
concentrations, a flow rate ~1 mL min-1, and keeping the pH ~12. 
Reagents concentration (mol/L) Crystallite size (nm) 
0.01 43.0 
0.05 44.5 
0.1 23.2 
0.2 18.9 
 
5.2.1.2 Morphology and Particle Size Distribution 
 
Fig. 5-18 TEM micrographs, SAED pattern, and particle size distribution of GdVO4 NPs 
synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the 
pH at 8. 
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TEM micrographs, selected area electron diffraction (SAED) patterns, and particle size 
distributions of GdVO4 NPs prepared at a pH of 8, 10, 11, and 12 are shown in Fig. 5-18, Fig. 
5-19, Fig. 5-20, and Fig. 5-21, respectively. The particle size distribution of each sample is 
represented by two characteristic dimensions, width and length, with mean sizes and distributions 
reported in Table 5-13. Anisotropic GdVO4 NPs of various sizes were observed after keeping the 
pH ~8 (Fig. 5-18).  
 
Fig. 5-19 TEM micrographs, SAED pattern, and particle size distribution of GdVO4 NPs 
synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the 
pH at 10. 
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In Fig. 5-18, it is observed a contrast change through the particles that could be associated 
to either aggregation of small crystallites, defects on the NPs surface, or porosity. The assumption 
that the contrast change is related to aggregation of crystallites is consistent with the difference 
between the crystallite (Table 5-11) and particle size (Table 5-13). Keeping the pH ~10 resulted 
in NPs with ellipsoidal shape in which the contrast change through the particle was observed (Fig. 
5-19). As discussed above, small crystallites could aggregate resulting in larger particles based on 
the difference between the crystallite size (Table 5-11) and the mean particle size (Table 5-13).  
 
Fig. 5-20 TEM micrographs, SAED pattern, and particle size distribution of GdVO4 NPs 
synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the 
pH at 11. 
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Increasing the pH to ~11 caused the formation of GdVO4 NPs with ellipsoidal and 
trapezoidal shape (Fig. 5-20). The contrast difference within each NP was not as noticeable as 
observed for GdVO4 NPs synthesized at pH of 8 and 10, which may be related to the larger 
crystallite size obtained at a pH of 11 (Table 5-11). However, polycrystalline particles are expected 
based on the disparity between the crystallite size and the measured width and length, having mean 
values of 26.8 ± 6.7 nm and 42.4 ± 12.9 nm, respectively.  
 
Fig. 5-21 TEM micrographs, SAED pattern, and particle size distribution of GdVO4 NPs 
synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the 
pH at 12. 
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Lastly, two distinct features were observed for GdVO4 NPs synthesized at a pH ~12, the 
presence of large ellipsoidal and trapezoidal particles and aggregates of small crystallites (Fig. 
5-21). The formation of large particles is consistent with the magnitude of the crystallite size 
(Table 5-11). The homogeneous contrast observed within each particle may imply the formation 
of single crystals or a reduction of surface defects. The formation of aggregates and dispersion of 
small particles could be caused by the rapid precipitation of Gd(OH)3 which interacts slowly with 
[VO4] anions due to the high pH used during synthesis (Fig. 5-21). This hypothesis is consistent 
with the diffraction results, where the intensity of the Bragg reflections of GdVO4 NPs synthesized 
at a pH of 12 was lower to that of samples prepared at a pH of 10 and 11 (Fig. 5-16). The lower 
intensity may be related to a low fraction of crystalline GdVO4 NPs. The SAED patterns of all 
GdVO4 matched with the Bragg reflections of a tetragonal crystal structure. A decrease in the pH 
caused the appearance of rings rather than brighter dots because of the precipitation of 
polycrystalline GdVO4 NPs with small crystallite size (Table 5-11). In summary, polycrystalline 
particles with anisotropic morphology, which may have a significant concentration of defects or 
porosity, were obtained after decreasing the pH towards acidic conditions during synthesis. The 
presence of surface defects may affect the retention of radionuclides and the response as contrast 
agents. The pH of the solution should not be kept above 12 since a larger fraction small crystallites 
and aggregates of lanthanide hydroxide species may be precipitated. 
 
 
Table 5-13 Mean particle size, standard deviation, and distribution of GdVO4 NPs synthesized 
synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the 
pH at different values. 
pH Length (nm) Width (nm) Distributions (length, width) 
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12 48.2 ± 12.7 32.7 ± 5.7 Lognormal, lognormal 
11 42.4 ± 12.9 26.8 ± 6.7 Weibull, normal 
10 46.4 ± 14.2 28.7 ± 8.7 Weibull, lognormal 
8 23.2 ± 11.2 16.1 ± 7.2 Lognormal, lognormal 
 
TEM micrographs of GdVO4 NPs synthesized using both GdCl3 and Na3VO4 at 0.2 M, 0.1 
M, 0.05 M, and 0.01 M are shown in Fig. 5-22, Fig. 5-23, Fig. 5-24, and Fig. 5-25, respectively. 
GdVO4 NPs synthesized using both GdCl3 and Na3VO4 at 0.1 M correspond to the reference 
conditions (section 3.3.2). At 0.1 M reagents concentration and a pH of 12, the TEM micrographs 
are characterized by large GdVO4 NPs surrounded by aggregates of small crystallites (Fig. 5-23).  
Increasing the reagents concentration to 0.2 M caused the formation large aggregates 
corresponding to particles ~20 nm in size with trapezoidal shape (Fig. 5-22). Although the pH was 
kept at 12, the formation of aggregates of small crystallites was not observed. GdVO4 NPs prepared 
using both GdCl3 and Na3VO4 at 0.05 M are characterized by large particles accompanied by a 
low fraction of small crystallites at their surface (Fig. 5-24). The presence of these crystallites 
could be related to the irreversible precipitation of gadolinium hydroxide species or to the 
mechanism of formation of GdVO4 NPs. The latter may involve the coarsening of small 
crystallites, which resulted in large GdVO4 NPs. Similar results were obtained using both GdCl3 
and Na3VO4 at 0.01 M, however, a larger fraction of small crystallites with respect to higher 
reagents concentrations (0.05 or 0.1 M) was observed near the GdVO4 NP surface (Fig. 5-25). As 
discussed previously, the lower concentration of reagents caused the formation of a smaller 
fraction of stable nuclei and hence the growth of large particles because of the rapid precipitation 
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of Gd(OH)3. Overall, the as-prepared GdVO4 NPs correspond to single crystals based on the 
similarity between their particle size and crystallite size (Table 5-12). 
 
Fig. 5-22 TEM micrographs of GdVO4 NPs synthesized using 0.2 M GdCl3 and 0.2 M Na3VO4, a 
flow rate ~1 mL min-1, while adjusting the pH at 12. 
 
Fig. 5-23 TEM micrographs of GdVO4 NPs synthesized using 0.1 M GdCl3 and 0.1 M Na3VO4, a 
flow rate ~1 mL min-1, while adjusting the pH at 12. 
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Fig. 5-24 TEM micrographs of GdVO4 NPs synthesized using 0.05 M GdCl3 and 0.05 M Na3VO4, 
a flow rate ~1 mL min-1, while adjusting the pH at 12. 
 
Fig. 5-25 TEM micrographs of GdVO4 NPs synthesized using 0.01 M GdCl3 and 0.01 M 
Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 12. 
5.2.2 Synthesis of LnVO4 (Ln3+ = La, Gd, Tb, Dy, and Ho) NPs 
LnVO4 (Ln3+ = La, Gd, Tb, Dy, and Ho) were synthesized by adding 0.1 M LnCl3 into 0.1 
M Na3VO4 at a flow rate ~1 mL min–1 while keeping the pH ~11. The crystal structure, 
morphology, and magnetic susceptibility of LnVO4 NPs were characterized. The crystal structure 
was influenced by the tendency of each Ln3+ ion to crystallize in either monoclinic or tetragonal 
structure [173]. The particle shape seems to be related to the crystal structure of LnVO4 NPs since 
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no significant difference was observed between GdVO4, TbVO4, DyVO4, and HoVO4. The 
magnetic susceptibilities were consistent with the magnetic moment of each Ln3+ ion. 
5.2.2.1 Crystal Structure 
The diffraction patterns of LnVO4 NPs are shown in Fig. 5-26. A tetragonal system with a 
space group of I41/amd was obtained for GdVO4 (pdf: 00-017-0260), TbVO4 (pdf: 01-072-0276), 
DyVO4 (pdf: 01-072-0275), and HoVO4 (pdf: 00-015-0764) NPs. A shifting of the Bragg 
reflections towards higher 2θ in tetragonal structures is caused by a decrease in the d-spacing and 
hence cell volume related to a reduction of the ionic radii of Ln3+ [174]. LaVO4 NPs have a 
monoclinic structure with space group of P21/n (pdf: 00-023-0324). The crystal structure of LaVO4 
NPs is consistent with that of bulk LaVO4 [175]. 
 
 
Fig. 5-26 Diffraction patterns of LnVO4 NPs synthesized using 0.1 M LnCl3 and 0.1 M Na3VO4, 
a flow rate ~1 mL min-1, while adjusting the pH at 11. 
The crystallite size of LaVO4, GdVO4, TbVO4, DyVO4, and HoVO4 was 18.9 nm, 20.2 
nm, 11.4 nm, 13.6 nm, and 15.7 nm, respectively. The increase in crystallite size with the decrease 
of the ionic radii of Ln3+ (Tb, Dy, and Ho) ions is consistent with the results presented in [176]. 
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5.2.2.2 Morphology and Particle Size Distribution 
TEM micrographs showed that LaVO4 NPs corresponds to particles with anisotropic 
morphology (Fig. 5-27), whereas GdVO4 (Fig. 5-28), TbVO4 (Fig. 5-29), DyVO4 (Fig. 5-30), and 
HoVO4 (Fig. 5-31) NPs are characterized by particles with trapezoidal shape.  
 
Fig. 5-27 TEM micrographs and particle size distribution of LaVO4 NPs synthesized using 0.1 M 
LaCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
 
Fig. 5-28 TEM micrographs and particle size distribution of GdVO4 NPs synthesized using 0.1 M 
GdCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
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Fig. 5-29 TEM micrographs and particle size distribution of TbVO4 NPs synthesized using 0.1 M 
TbCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
 
Fig. 5-30 TEM micrographs and particle size distribution of DyVO4 NPs synthesized using 0.1 M 
DyCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
This difference in morphology between LaVO4 and the rest of the samples seems to be 
related to its crystal structure (monoclinic). The mean values for the width and length of all LnVO4 
NPs as well as their respective distributions are summarized in Table 5-14. It is assumed that the 
LnVO4 NPs may correspond to polycrystalline particles based on the difference observed between 
the crystallite and particle size (Table 5-14). 
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Fig. 5-31 TEM micrographs and particle size distribution of HoVO4 NPs synthesized using 0.1 M 
HoCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
Table 5-14 Mean particle size and standard deviation of LnVO4 NPs synthesized using 0.1 M 
LnCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
Sample Length (nm) Width (nm) Distribution (length, width) 
LaVO4 32.4 ± 11.0 25.2 ± 8.9 
Normal, normal 
GdVO4 28.7 ± 6.1 22.1 ± 4.2 
TbVO4 21.3 ± 7.5 14.1 ± 4.8 
Lognormal, lognormal DyVO4 21.5 ± 7.6 19.5 ± 7.7 
HoVO4 29.4 ± 7.7 18.4 ± 3.3 
 
5.2.2.3 Magnetic Susceptibility 
The mass magnetization versus magnetic field loops of GdVO4, TbVO4, DyVO4, and 
HoVO4 NPs (Fig. 5-32) are consistent with the Curie formula [equationχ=	 0123456  4-1] and the 
results presented in section 5.1.1.3. Despite the similar magnetic behavior between LnVO4 NPs 
synthesized using the citrate and flow routes, LnVO4 NPs prepared using flow have a higher 
magnetic susceptibility. The magnetic susceptibility of GdVO4, TbVO4, DyVO4, and HoVO4 NPs 
is 78.1, 133.3, 157.5, and 156.4 × 10–6 emu Oe–1 g–1, respectively. These values correspond to a 
13.5%, 18.8%, 25.4%, and 32.0% increase in magnitude with respect to the magnetic susceptibility 
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of LnVO4 NPs prepared by the citrate route. This increase may be related to either a lower fraction 
of unreacted species which have a diamagnetic susceptibility, a higher yield of NPs, or to the fact 
that larger particles have a higher magnetization [165]. TbVO4, DyVO4, and HoVO4 NPs may 
have potential application as negative-T2 contrast agents since large particles have proven to have 
higher transversal relaxivities (r2) to that of small particles [25], [165]. 
 
Fig. 5-32 Mass magnetization (emu/g) versus field (Oe) loop for LnVO4 NPs synthesized using 
0.1 M LnCl3 and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
5.2.3 Synthesis of Dy-doped LnVO4 (Ln3+ = La, Gd, and Lu) NPs 
To assess the potential application of LnVO4 NPs as FI contrast agents, LaVO4, GdVO4, 
and LuVO4 NPs were doped with Dy3+ ions. The concentration of Dy3+ was set to 2 at.% to prevent 
concentration quenching. LnVO4 NPs were prepared with 0.1 M LnCl3 and 0.1 M Na3VO4 while 
keeping the pH of the solution at ~11. The influence of the crystal structure in the emission 
properties of Dy3+ was also studied by synthesizing LnVO4 NPs with either monoclinic or 
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tetragonal structure. Differences in both excitation and emission spectra of LnVO4 NPs are 
attributed to their crystal structure. 
5.2.3.1 Crystal Structure 
GdVO4 and LuVO4 NPs have a tetragonal system with a space group of I41/amd (pdf: 00-
017-0260 and 00-017-0260, respectively), while LaVO4 NPs have a monoclinic structure with 
space group of P21/n (pdf: 00-023-0324, LaVO4) (Fig. 5-33). Doping LnVO4 NPs with 2 at.% did 
not cause a shifting in the position of the Bragg reflections with respect to the reference patterns 
of pure LnVO4.  The crystallite size was 16.4 nm, 21.1 nm, and 21.1 nm for Dy-doped LaVO4, 
GdVO4, and LuVO4 NPs, respectively.  
 
Fig. 5-33 Diffraction patterns of LnVO4 NPs doped with 2 at.% Dy synthesized using 0.1 M LnCl3 
and 0.1 M Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
5.2.3.2 Excitation and Emission Spectra 
The excitation spectra of Dy-doped LnVO4 NPs were recorded using an excitation filter at 
250–395 nm, a PMT voltage of 600 V, and an emission wavelength of 574 nm. Although all 
spectra were recorded at the same concentration of LnVO4 NPs (~0.5 mg/mL), the excitation 
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intensity of LuVO4 NPs was higher to that of LaVO4 and GdVO4, respectively [Fig. 5-34(a)]. The 
difference in excitation intensity between LnVO4 NPs may be related to a more efficient and 
favorable energy transfer between O2– and V5+ ions [176]. The excitation spectrum is characterized 
by a broad band in the range of 220–340 nm which maxima is ~280 nm for GdVO4 and LuVO4, 
while for LaVO4 the highest intensity is shifted to higher wavelengths (290–300 nm) [Fig. 
5-34(a)]. The broad excitation band is related to (i) the O2–-Dy3+ CT from the oxygen 2p excited 
state to the 4f state of dysprosium (~280 nm) and (ii) the O2–-V5+ CT from the oxygen 2p excited 
state to the empty d states of the central vanadium atom in the [VO4]3– group (~310 nm) [177]. 
The wavelength at which the excitation band has its maxima may be influenced by the coordination 
number (CN) of V5+ and Ln3+ ions in tetragonal (CN = 8) and monoclinic (CN = 9) structures [14]. 
The emission spectra of Dy-doped LnVO4 was recorded at excitation wavelengths of 280 nm, 310 
nm, and 321 nm based on the differences observed in the excitation spectra, while using an 
emission filter at 295–1,100 nm and a PMT voltage of 600 V. Dy-doped LnVO4 NPs exhibited 
blue (483 nm) and yellow (572 nm) emissions corresponding to 4F9/2 → 6H15/2 and 4F9/2 → 6H13/2 
transitions, respectively [167], [177]–[179]. The intensity of the 4F9/2 → 6H15/2 and 4F9/2 → 6H13/2 
transitions was higher for all LnVO4 NPs when using an excitation wavelength of 280 nm (Fig. 
5-34). Increasing the excitation wavelength to either 310 nm or 321 nm caused a reduction of the 
emission intensity for all the samples. The decrease in emission intensity was significant for Dy-
doped GdVO4 NPs [Fig. 5-34(c)], whereas for Dy-doped LaVO4 [Fig. 5-34(b)] and LuVO4 [Fig. 
5-34(d)] the drop in intensity was lower due to their characteristic excitation spectrum [Fig. 
5-34(a)]. Moreover, variation of the excitation wavelength influenced the intensity ratio of 4F9/2 
→ 6H13/2 to 4F9/2 → 6H15/2 transitions [Fig. 5-35]. The ratio between both transitions will determine 
the chromaticity of LnVO4 NPs after excitation at various wavelengths [177]. At λexc = 280 nm, 
the emission of Dy-doped LnVO4 NPs will be predominantly yellow, while increasing the 
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excitation wavelength may result in green emission because of the similar intensity between both 
transitions [Fig. 5-35].  
 
Fig. 5-34 LnVO4 NPs doped with 2 at.% Dy (a) excitation spectra (λem = 574 nm) and emission 
spectra of (b) LaVO4, (c) GdVO4, and (d) LuVO4 synthesized using 0.1 M LnCl3 and 0.1 M 
Na3VO4, a flow rate ~1 mL min-1, while adjusting the pH at 11. 
 116 
 
Fig. 5-35 Dependence of the 4F9/2 → 6H13/2 (blue) to 4F9/2 → 6H15/2 (yellow) ratio on the excitation 
wavelength of Dy-doped LnVO4 NPs synthesized using 0.1 M LnCl3 and 0.1 M Na3VO4, a flow 
rate ~1 mL min-1, while adjusting the pH at 11. 
5.3 Summary 
  In this chapter, LnVO4 core and core-shell NPs were prepared by two synthesis routes 
in aqueous media that require only a fraction of the time need it for LnPO4 NPs (30 minutes versus 
3 hours). LnVO4 NPs with characteristic morphology, stability, and surface chemistry can be 
obtained with each synthesis route. The short synthesis time required for each route and their 
simplicity could be exploited for radiochemical settings involving short-lived radionuclides. A 
procedure for the synthesis of LnVO4 core-shell structures was proposed for the citrate route, while 
the deposition of shells was tested based on the increase in crystallite size and particle size 
distribution. Synthesis parameters such as temperature, heating time, reagents concentration, 
among others were varied and their influence on the particle size distribution, physical stability, 
luminescence and magnetic properties of LnVO4 core-shell NPs was studied. The key outcomes 
from this chapter are summarized below: 
Citrate route 
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§ Heating time and temperature have a significant influence in the growth of LnVO4 NPs 
based on the consumption of oligomeric species. Although short heating times resulted in 
LnVO4 NPs formation, the NPs yield and physical stability are lower with respect to longer 
heating times (>10 minutes). A balance between heating time and temperature must be 
evaluated in each case based on the desired particle size distribution, NPs yield, and 
physical stability. Despite the fact that increasing the temperature to 90 °C resulted in 
higher NPs yield, the formation of aggregates could affect their application in biological 
settings. Considering the potential application of LnVO4 NPs for biomedical applications, 
a moderate temperature (60 °C) and heating times ~30 minutes would give the optimum 
balance between NPs yield, particle size distribution, and physical stability.     
§ Synthesis of LnVO4 core-shell NPs was confirmed by an increase in the crystallite size and 
particle size distribution. The reagents concentrations and concentration of oligomeric 
species solution added to the core NPs suspension can be adjusted to achieve the desired 
shell thickness. Although the development of LnVO4 core-shell NPs is a multi-step 
synthesis procedure, it requires significantly less time (~1.5 hours for core + 2 shells) 
compared to that of LnPO4 core + 2 shells NPs (~9 hours). The decrease in heating time 
could be exploited for the development of LnVO4 core and core-shell NPs doped with 
short-lived radionuclides. 
§ Europium-doped GdVO4 core NPs displayed more intense fluorescence or emission 
intensity upon excitation with UV light (λ = 254 nm) compared to that of Gd(1-x)EuxPO4 
core NPs. This suggests that LnVO4 NPs are suitable contrast agents for FI as well as MRI 
contrast agents. Additional advantages of LnVO4 NPs involved their uniform size 
distribution and physical stability, which could be valuable for their application in 
biological settings. 
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Flow synthesis 
§ The formation of LnVO4 NPs using flow synthesis is a single step and fast synthesis 
procedure that has potential for radiochemical settings toward the development of 
radionuclide carriers for TRT and nuclear waste forms. 
§ The morphology and crystallite size of GdVO4 NPs is mainly affected by the pH and 
reagents concentration (LnCl3 and Na3VO4). Particles with uniform shape can be obtained 
when the pH is kept between 10.5 and 11.5, whereas polycrystalline GdVO4 NPs with 
either ellipsoidal or anisotropic shape were precipitated at lower pH. 
§ The morphology of LnVO4 (Ln3+ = La, Gd, Tb, Dy, Ho) NPs seems to be related to their 
crystal structure, since tetragonal-like and anisotropic particles were obtained for tetragonal 
and monoclinic systems, respectively.  LnVO4 (Ln3+ = Tb, Dy, Ho) NPs may have 
application as negative-T2 MRI contrast agents based on their high magnetic susceptibility 
and uniform particle size distribution. 
§ Luminescence properties of dysprosium-doped LnVO4 (Ln3+ = La, Gd, Lu) NPs were 
influenced by the crystal structure and lanthanide ion used as a host. The chromaticity of 
dysprosium-doped LnVO4, defined by the ratio of 4F9/2 → 6H13/2 to 4F9/2 → 6H15/2 
transitions, was dependent on the host ion (Ln3+ = La, Gd, Lu) as well as the excitation 
wavelength used. 
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6 Radionuclide-doped LnPO4 and LnVO4 
NPs 
This chapter reviews the synthesis and characterization of radionuclide-doped lanthanide-
based core and core-shell NPs. LnPO4 NPs were doped with 85, 89Sr, 156Eu, and 227Th, whereas 
only in vivo α-generators 223Ra, 225Ac, and 227Th were used for LnVO4 NPs. The synthesis 
conditions such as temperature, heating time, and reagents concentration were chosen based on the 
results obtained for nonradioactive LnPO4 and LnVO4 NPs in Chapters 4 and 5, respectively. 
Additional details regarding the synthesis conditions used and complementary characterization of 
nonradioactive NPs are also presented in this chapter. Focus has been placed on assessing the in 
vitro retention of radionuclides in both LnPO4 and LnVO4 NPs as described in section 3.4.7. The 
partial retention of radionuclides within both LnPO4 and LnVO4 core-shell NPs has proven to be 
suitable for biomedical and engineering applications.   
6.1 Retention of 85, 89Sr, and 156Eu 
In this section, LnPO4 core NPs doped with either 156Eu or a cocktail of 85, 89Sr and 156Eu are 
proposed as platforms where the luminescence and magnetic properties of Ln3+ ions are combined 
with radioisotopes. Although the high energy γ-rays emitted by 156Eu (>1000 keV) restricts its use 
for biomedical applications [36], its successful incorporation and retention in LnPO4 NPs 
evidences the potential implementation of lanthanide radioisotopes with lower energy γ-rays such 
as 141Ce, 153Gd, 177Lu, and 166Ho, among others, for diagnostic and therapeutic applications [180], 
[181]. The ability to host other radionuclides used for medical applications within the LnPO4 
crystal structure was evidenced by the partial retention of strontium radionuclides (85, 89Sr), which 
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are used for the detection and treatment of bone diseases [182], [183]. The results presented in this 
section add to the current trend where LnPO4 nanomaterials are contributing to the development 
of noninvasive techniques for the identification, visualization, and treatment of tumors by 
combining imaging and therapeutic functionalities within a single platform [50], [51].  
6.1.1 GdPO4 and GdPO4:Ln3+ core NPs doped with 156Eu 
 
Synthesis of 156Eu-doped GdPO4, Gd0.7Eu0.3PO4, and Gd0.6Ce0.3Tb0.1PO4 core NPs began by 
drying a 0.1 M HCl solution containing ~2 µCi of 156Eu in a conical vial at 80 °C. Then, lanthanide 
chloride solutions were added and stirred for 20 minutes to ensure a complete dispersion of 156Eu3+ 
ions. Sodium tripolyphosphate was added to the Ln solution under constant stirring in a 2:1 volume 
ratio to obtain a translucent solution (section 3.2). The final solution containing Ln3+-156Eu3+-TPP 
complexes was heated to 90 °C for 3 hours to synthesize Ln(156Eu)PO4 core NPs. The turbid 
suspensions containing the 156Eu-doped LnPO4 core NPs were transferred into a dialysis 
membrane and dialyzed overnight in DI water. The first dialysate was changed after 20 hours and 
an aliquot was taken to quantify the activity associated with 156Eu3+ ions that were not incorporated 
within the NPs. Afterward, aliquots from the dialysate were taken periodically (every 3−4 days) 
to assess the retention of 156Eu over a 3-week period. The crystal structure, morphology, 
luminescence and magnetic properties of Gd0.7Eu0.3PO4 and Gd0.6Ce0.3Tb0.1PO4 core NPs were 
presented in section 4.3. The particle size distribution and ζ-potential of as-prepared and dialyzed 
LnPO4 core NPs were evaluated and the results are shown in section 6.1.1.1. In addition, the release 
of Gd3+ ions during dialysis was determined to estimate the potential in vivo toxicity of using bare 
LnPO4 core NPs. The results presented in this section have been adapted from [140]. 
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6.1.1.1 Particle Size Distribution, Physical Stability, and Release of Gd3+ ions 
GdPO4, Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4 core NPs suspensions were dialyzed against 
DI water for 48 hours to remove unreacted species. The particle size distribution and ζ-potential 
of as-prepared and dialyzed suspensions were compared to assess the physical stability of LnPO4 
NPs. LnPO4 core NPs suspensions at a concentration of 0.033 M showed broad normalized 
intensity distributions, suggesting significant aggregation of NPs (Fig. 6-1). After dialysis, the 
particle size distribution and mean hydrodynamic size decrease for almost all the NPs suspensions 
with respect to the as-prepared suspensions (Fig. 6-1). The decrease in hydrodynamic size may be 
associated to the removal of unreacted species which cause aggregation of NPs.  
 
Fig. 6-1 Normalized intensity distribution of as prepared (left) and dialyzed (right) LnPO4 (0.033 
M) core NPs suspensions synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
In Fig. 6-2, the mean hydrodynamic size of the dialyzed NPs suspensions is 1–2 orders of 
magnitude lower than that of the as-prepared suspensions based on the normalized number 
distributions. The number particle size distribution is consistent with the branched structures 
observed in the TEM micrographs with sizes between 20–100 nm (Fig. 4-14 and Fig. 4-15). 
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Fig. 6-2 Normalized number distribution of as prepared (left) and dialyzed (right) LnPO4 (0.033 
M) core NPs suspensions synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
The as-prepared and dialyzed NPs suspensions were diluted to 1.33 mM to also assess their 
particle size at this condition. The dilution of both suspensions caused a significant decrease of the 
mean hydrodynamic size and particle size distribution as shown in Fig. 6-3 and Fig. 6-4.  
 
Fig. 6-3 Normalized intensity distribution of as prepared (left) and dialyzed (right) LnPO4 (1.33 
mM) core NPs suspensions synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
The normalized intensity distribution shows that both as-prepared and dialyzed 
suspensions have a broad hydrodynamic size in the range of few tens to hundreds of nanometers 
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(Fig. 6-3), which may be related to the branched structures observed in the TEM micrographs. As 
shown in Fig. 6-4, there is no significant difference between the normalized number distributions 
of both suspensions suggesting that the branched structures formed during synthesis are not 
affected by dialysis. 
 
Fig. 6-4 Normalized number distribution of as prepared (left) and dialyzed (right) LnPO4 (1.33 
mM) core NPs suspensions synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
Both as-prepared and dialyzed NPs suspensions had a negative ζ-potential (Table 6-1), 
which is attributed to the polymeric shell formed by polyphosphate species [125]. After dialysis, 
the absolute zeta potential of dialyzed LnPO4 core NPs suspensions decreased relative to as-
prepared suspensions (Table 6-1). The decrease of ~10 mV in the absolute zeta potential may be 
related to the removal of the polyphosphate species from the NP’s surface. 
 
 
Table 6-1 Mean ζ-potential and standard deviation of LnPO4 (0.033 M) core NPs suspensions 
synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
 
Mean ζ-potential (mV) 
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To assess the release of Gd cations over time, the as-prepared GdPO4, Gd0.6Ce0.3Tb0.1PO4, 
and Gd0.7Eu0.3PO4 core NPs suspensions were dialyzed for 4 days and a 10 mL aliquot was taken 
daily from each dialysate and analyzed for Gd using ICP-OES. As shown in Fig. 6-5, the maximum 
concentration of Gd cations in the dialysate is ~1.2 ppm, 1 ppm, and 0.1 ppm for GdPO4, 
Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4 NPs, respectively. The presence of Gd cations in the 
dialysate may be related to the fraction of lanthanide ions that did not result in NPs formation but 
was retained within the polymeric shell formed around the NP’s surface [125].  
 
Fig. 6-5 Concentration (left) and leakage percentage (right) of Gd3+ in the dialysate over time from 
bare LnPO4 core NPs synthesized at 90 °C for 3 hours using a 1:2 Ln:Na-TPP volume ratio. 
The concentration of Gd cations measured in the dialysate is equivalent to a leakage of 
~5.5 at.%, 8.5 at.%, and 0.9 at.% for GdPO4, Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4 core NPs, 
respectively. As shown in Fig. 6-5, the leakage of Gd cations to the dialysate remains constant 
over time, which suggests that the NPs are chemically stable in DI water at the set conditions. 
 
As prepared Dialyzed 
GdPO4 -23.88 ± 1.92 -13.03 ± 0.08 
Gd0.6Ce0.3Tb0.1PO4 -23.36 ± 1.57 -13.59 ± 0.27 
Gd0.7Eu0.3PO4 -28.52 ± 7.78 -18.50 ± 1.15 
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6.1.1.2 Radiochemical Yield and Retention of 156Eu 
The initial activity of the as-prepared Ln(156Eu)PO4 core NPs determined by γ-ray analysis 
was ~1.8, 2.4, and 2.2 µCi for GdPO4, Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4, respectively. The 
activity lost in the vial, spin vane, and pipette tip used during the synthesis and transfer of the NPs 
suspensions into the dialysis membrane was <2% of the initial activity. After 20 hours in dialysis, 
an aliquot from the dialysate was taken to assess the percentage of activity associated to unreacted 
156Eu3+ ions. Unreacted species are expected to pass through the membrane and stay in the dialysate 
based on a concentration gradient. The fraction of activity measured in the dialysate was 5.2%, 
5.6%, and 16.0% for GdPO4, Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4, respectively. It is assumed 
that the activity found in the dialysate was due to 156Eu3+ ions that were not incorporated within 
the NPs but adsorbed on their surface by polyphosphate species. However, in the case of 
Gd0.7Eu0.3PO4 NPs the activity found in the 1st dialysate was about three times higher than that 
observed for the other two samples. In this case, it is hypothesized that a competing process 
between Eu3+ and 156Eu3+ ions may contribute to a larger fraction of unreacted species from the 
latter, which resulted in a lower retention of 156Eu3+ within Gd0.7Eu0.3PO4 core NPs. A similar 
behavior was observed with Lu0.5Gd0.5PO4 core NPs doped with 177Lu, where an excess of LuCl3 
solution added during synthesis caused an activity loss of 21% after 24 hours [43]. The authors 
suggested that the increase in activity loss was due to surface bound 177Lu and an exchange 
between stable and radioactive isotopes [43]. Nevertheless, subsequent aliquots were taken 
periodically and demonstrated the successful retention of 156Eu in GdPO4 over 3 weeks, where the 
activity measured was less than 0.2% of the initial activity. Similarly, Gd0.6Ce0.3Tb0.1PO4 NPs had 
a maximum leakage of 0.3% over the same period of time. The leakage of 156Eu from both GdPO4 
and Gd0.6Ce0.3Tb0.1PO4 is comparable to that of 225Ac from La(225Ac)PO4 and La0.5Gd0.5(225Ac)PO4 
core NPs, ~0.1% and ~0.9%, respectively [42]. Instead, the maximum leakage observed for 
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Gd0.7Eu0.3PO4 was ~3.5% the initial activity. The higher leakage observed for Gd0.7Eu0.3PO4 with 
respect to GdPO4 and Gd0.6Ce0.3Tb0.1PO4 may be related to the competing processes previously 
discussed and a higher fraction of surface bound 156Eu cations that were not removed in the first 
or initial dialysate. The radiochemical yield of 156Eu was 93.5%, 92.8%, and 79.6% for GdPO4, 
Gd0.6Ce0.3Tb0.1PO4, and Gd0.7Eu0.3PO4 core NPs, respectively. The reported yield considers the 
activity loss during synthesis and the initial dialysate as well as corrections for radioactive decay 
and volume change in dialysate due to the aliquots withdrawn. These results demonstrate the 
successful incorporation of 156Eu3+ within the LnPO4 crystal structure. Moreover, the values 
obtained for the radiochemical yields of GdPO4 and Gd0.6Ce0.3Tb0.1PO4 are comparable to the 
yields reported for LaPO4 core NPs doped with 223Ra (~91%), 225Ra (94%), and 225Ac (95%) [38] 
as well as the yield of intrinsically radiolabeled cerium oxide NPs using 141Ce (97%) [33]. 
Consequently, the synthesized LnPO4 core NPs have the potential to retain radioactive lanthanide 
ions such as 141Ce, 153Gd, 177Lu, 166Ho, in addition to 225Ac and 223Ra, within their crystal structure. 
6.1.2 La(1-x)EuxPO4 and LnPO4 core NPs doped with 85, 89Sr and 
156Eu 
La(1-x)EuxPO4 and LnPO4 (Ln3+ = La, Ce, Eu, Gd, Tb, Yb, and Lu) core NPs were doped 
with a cocktail of 85, 89Sr and 156Eu to assess the influence of lanthanide concentration in the 
retention of these radionuclides. The results presented in 6.1.1 implied that the retention of 156Eu 
and hence other radionuclides may be dependent on the lanthanide concentration of LnPO4 core 
NPs. A 0.1 M HCl solution containing ~0.188 µCi, 187.1 µCi, and 0.322 µCi of 85Sr, 89Sr, and 
156Eu, respectively, was dried in a conical glass vial at 80 °C for the synthesis of La(1-x)EuxPO4 
core NPs, whereas for LnPO4 core NPs ~0.197 µCi, 226.7 µCi, and 0.218 µCi of 85Sr, 89Sr, and 
156Eu were used. Lanthanide chloride solutions were added and stirred for 10 minutes to ensure a 
complete dispersion of radionuclides. Then, sodium tripolyphosphate was added to the lanthanide 
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solution in a 2:1 volume ratio under constant stirring to obtain a clear solution. Synthesis of La(1-
x)EuxPO4 and LnPO4 core NPs was carried out at 90 °C for 3 hours, after which the radionuclide-
doped core NPs suspensions were transferred into a dialysis membrane and dialyzed against DI 
water for 5 days. The activity of 85Sr and 156Eu was quantified daily by measuring the whole 
radionuclide-doped LnPO4 core NPs suspension inside the membrane. Additionally, a 5 mL 
dialysate aliquot was taken at the fourth and third day in dialysis for La(1-x)EuxPO4 and LnPO4 core 
NPs, respectively. The crystal structure of La(1-x)EuxPO4 and LnPO4 core NPs was characterized 
as a reference to compare the retention properties. It is expected that both La(1-x)EuxPO4 and LnPO4 
core NPs will have potential application as multifunctional platforms for molecular imaging based 
on the discussion presented in Chapter 4. 
6.1.2.1 Crystal Structure 
The diffraction patterns of La(1-x)EuxPO4 core NPs can be indexed as a hexagonal crystal 
system [Fig. 6-6(a)]. Narrow and intense Bragg reflections at ~32º and 45º suggest the presence 
of impurities, which in this case corresponds to sodium chloride that was precipitated because of 
the high Ln:Na-TPP volume ratio. A shifting of the Bragg reflections towards higher 2θ angles is 
consistent with a decrease of the d-spacing due to the difference in size between the ionic radius 
of La3+ (1.29 Å) and Eu3+ (1.21 Å) ions [141]. Higher Eu3+ concentrations caused an increase in 
crystallite size where the largest magnitude was obtained for EuPO4 with 9.0 ± 2.0 nm, whereas 
LaPO4 had the smallest with 4.1 ± 0.8 nm. In Fig. 6-6(b), the diffraction patterns of LaPO4, CePO4, 
GdPO4, and TbPO4 core NPs matched with the crystal structure of hydrated LnPO4 having a 
hexagonal crystal system and a space group P3121 [184], [185]. The presence of NaCl is clearly 
observed for LaPO4, GdPO4, and TbPO4 [Fig. 6-6(b)]. In Fig. 6-6(b), the diffraction patterns of 
YbPO4 and LuPO4 core NPs are characterized by broad Bragg reflections indicating either the 
formation of small crystallites or the precipitation of poorly crystalline NPs [186]. It is assumed 
 128 
that YbPO4 and LuPO4 core NPs may have a hexagonal crystal system based on the position of the 
Bragg reflections since the substantial peak broadening difficult the phase identification. 
 
Fig. 6-6 Diffraction patterns of (a) La(1-x)EuxPO4 and (b) LnPO4 core NPs synthesized at 90 °C for 
3 hours using a 1:2 Ln:Na-TPP volume ratio. 
6.1.2.2 Retention of 85, 89Sr, and 156Eu 
The leakage of 85Sr and 156Eu from La(1-x)EuxPO4 and LnPO4 core NPs was determined by 
measuring the activity in (i) the whole radionuclide-doped core NPs suspension inside the 
membrane daily for a 5-day period and (ii) in a dialysate aliquot. Both approaches to quantify the 
leakage of radionuclides gave similar results. Although the leakage of 89Sr was not explicitly 
reported, it is expected to follow the same behavior observed for 85Sr. As shown in Fig. 6-7, the 
leakage of 85Sr was relatively constant among La(1-x)EuxPO4 core NPs, where the fraction of 85Sr 
in the dialysate was between 12.9 ± 1.3% and 18.1 ± 2.1% for La0.4Eu0.6PO4 and La0.6Eu0.4PO4, 
respectively. These results imply that the incorporation of 85Sr and 89Sr within La(1-x)EuxPO4 core 
NPs is not influenced significantly by the lanthanide concentration. The contrary effect was 
observed for 156Eu where the leakage of either La0.8Eu0.2PO4 or La0.6Eu0.4PO4 was ~5 times larger 
than that of EuPO4 (Fig. 6-7).  
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Fig. 6-7 Leakage of 85Sr and 156Eu from La(1-x)EuxPO4 core NPs synthesized at 90 °C for 3 hours 
using a 1:2 Ln:Na-TPP volume ratio. 
The substantial difference in 156Eu leakage among La(1-x)EuxPO4 core NPs supports the 
hypothesis that the lanthanide concentration influences the retention of lanthanide radionuclides. 
As discussed in section 6.1.1.2, the higher leakage observed for Gd0.7Eu0.3PO4 core NPs to that of 
GdPO4 and Gd0.6Ce0.3Tb0.1PO4 is assumed to be related to a competing process between Eu and 
156Eu cations. This hypothesis seems to be relevant only when the concentration of Eu3+ ions is 
lower (<50%) with respect to the remaining lanthanide ions. A continuous rise in 156Eu leakage 
was observed when the concentration of Eu3+ ions increased from 0 at.% to 40 at.% in La(1-
x)EuxPO4 core NPs, whereas at higher Eu3+ concentrations (>50%) there was a significant decrease 
in leakage (Fig. 6-7). Both Eu and 156Eu are incorporated as substitutional atoms in the La3+ site in 
LaPO4 causing a contraction in the unit cell as the Eu concentration increases [186]. It is assumed 
that LaPO4 matrix will accommodate up to certain fraction of substitutional atoms before 
significant changes in the unit cell occur causing a higher leakage of 156Eu. At higher Eu3+ 
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concentrations (>50%) in La(1-x)EuxPO4, 156Eu can be easily accommodated in the EuPO4 crystal 
structure and hence its leakage decreased. 
The leakage of both 85Sr and 156Eu from pure LnPO4 (Ln3+ = La, Ce, Eu, Gd, Tb, Yb, and 
Lu) core NPs is shown in Fig. 6-8. Almost all LnPO4 core NPs had a similar leakage of 85Sr (12.1–
16.9%), except for GdPO4 which had a 28.2 ± 2.3% (Fig. 6-8). Three distinctive behaviors 
regarding the leakage of 156Eu were observed in LnPO4 core NPs. The fraction of 156Eu that leaked 
from CePO4, EuPO4, and TbPO4 core NPs was below 7%. An increase to 23.2 ± 2.0% and 19 ± 
4.1% was observed for LaPO4 and GdPO4 core NPs, while the 156Eu leakage from YbPO4 and 
LuPO4 was greater than 40%. It is expected that the difference in ionic radii between 156Eu, Yb3+, 
and Lu3+ is the main cause behind the lower incorporation of radioactive ions in the crystal 
structure. The poor crystallinity of YbPO4 and LuPO4 core NPs could also increase the leakage of 
radionuclides [Fig. 6-6(b)]. The abrupt increase in leakage for both 85Sr and 156Eu between EuPO4 
and TbPO4 could be attributed to the electronic peculiarities of Gd3+ ions commonly known as 
gadolinium break [187]. Although the leakage of 156Eu from La(1-x)EuxPO4 and LnPO4 core NPs 
was similar to the results presented in section 6.1.1.2, the high concentration of Sr cations (~15 
mg/mL) in solution may have affected the retention of both 85Sr and 156Eu. High radionuclide 
purity is essential in radiochemical synthesis to increase the specific activity within each platform. 
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Fig. 6-8 Leakage of 85Sr and 156Eu from LnPO4 core NPs synthesized at 90 °C for 3 hours using a 
1:2 Ln:Na-TPP volume ratio. 
6.2 Retention of in vivo α-generators 223Ra, 225Ac, and 
227Th 
In this section, the retention of in vivo α-generators such as 223Ra, 225Ac, and 227Th in LnVO4 
and LnPO4 core and core-shell NPs is assessed. Adding to the proven retention capabilities of 
LnPO4 NPs, LaPO4 core and core + 2 shells NPs were tested as carriers of 227Th. GdVO4 and 
Gd0.8Eu0.2VO4 core and core-shell NPs have been proposed as alternative carriers of 225Ac, 223Ra, 
227Th, and decay daughters, while providing multifunctional properties for multimodal molecular 
imaging. The results and characterization of nonradioactive NPs presented in Chapters 4 and 5 
were used as a reference to develop radionuclide-doped LnPO4 and LnVO4 core-shell NPs, 
respectively. The in vitro retention of radionuclides was evaluated as described in section 3.4.7.  
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6.2.1 GdVO4 and Gd0.8Eu0.2VO4 core-shell NPs doped with 225Ac 
GdVO4 and Gd0.8Eu0.2VO4 core and core + 2 shells NPs were synthesized using the 
concentration of reagents, temperature, and heating time described in section 3.3.1. A 1:1.5 volume 
ratio between the core NPs suspension and the oligomeric species solution was used for core-shell 
synthesis (section 5.1.2). The proposed concentration of Gd and Eu cations is based on the results 
presented in section 5.1.3. Gd(225Ac)VO4 and Gd0.8Eu0.2(225Ac)VO4 core and core-shell NPs were 
synthesized by adding 225Ac during core NPs synthesis. An aliquot containing ~50 µCi of 225Ac 
diluted in 0.1 M HNO3 was initially evaporated to dryness on a glass conical vial at 80 ºC. GdCl3 
and EuCl3 were added at specific volume ratios into the vial and stirred for 5 minutes to ensure a 
homogeneous dispersion of 225Ac cations and decay daughters. Sodium citrate and sodium 
orthovanadate were added under constant stirring at 0.75 volume equivalent to that of LnCl3. The 
synthesis of core and the deposition of shells were completed as described for nonradioactive NPs 
(sections 3.3.1 and 5.1.2). Both Gd(225Ac)VO4 and Gd0.8Eu0.2(225Ac)VO4 core and core + 2 shells 
NPs suspensions were transferred into dialysis membranes and dialyzed against DI water to 
evaluate the radiochemical yield and in vitro retention of radionuclides over time. The crystal 
structure, morphology, and NPs yield were characterized for both GdVO4 and Gd0.8Eu0.2VO4 NPs. 
The potential application as contrast agents of Gd0.8Eu0.2VO4 core and core-shell NPs was assessed 
based on their luminescence and magnetic properties, whereas GdVO4 core NPs were evaluated 
as positive MRI contrast agents based on their longitudinal relaxivity (r1). The results presented in 
this section been adapted from two manuscripts under review.  
6.2.1.1 Crystal Structure 
The diffraction patterns of Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs are shown 
in Fig. 6-9. Both Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs correspond to a zircon-type 
structure having a tetragonal system with space group I41/amd of GdVO4 (pdf: 00-017-0260). The 
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characteristic peak broadening caused by the nanometric size of the crystallites was observed for 
all diffraction patterns (Fig. 6-9). A slight decrease of the FWHM of the Bragg reflections was 
observed upon deposition of shells suggesting an increase of the crystallite size as described in 
section 0. The peak located at 25°, which corresponds to the (200) plane in the tetragonal structure, 
was used to calculate the crystallite size of Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs 
(Table 6-2). As expected, the deposition of two shells resulted in an increase of the crystallite size 
of 0.9 nm and 0.7 nm for Gd0.8Eu0.2VO4 and GdVO4, respectively. 
 
Fig. 6-9 Diffraction patterns of (a) Gd0.8Eu0.2VO4 and (b) GdVO4 core and core-shell NPs 
synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension 
to oligomeric species solution volume ratios. 
Table 6-2 Crystallite size of Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs synthesized at 60 
°C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. 
Crystallite size (nm) 
Sample Gd0.8Eu0.2VO4 GdVO4 
Core 4.7 4.0 
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Core + 1 shell 5.1  
Core + 2 shells 5.6 4.7 
6.2.1.2 Morphology and Particle Size Distribution 
Spherical Gd0.8Eu0.2VO4 and GdVO4 core NPs are observed in the TEM micrographs (Fig. 
6-10). The Gd0.8Eu0.2VO4 core NPs range from 2.0–5.1 nm with a mean particle size of 3.4 ± 
0.7 nm [Fig. 6-10(a)], whereas a mean particle size of 3.6 ± 0.9 nm was obtained for GdVO4 core 
NPs [Fig. 6-10(b)].  
 
Fig. 6-10 TEM micrographs of (a) Gd0.8Eu0.2VO4 and (b) GdVO4 core NPs [indicated by arrows] 
synthesized at 60 °C for 30 minutes using a 1:0.75:0.75 Ln:cit:VO4 volume ratio. 
Both Gd0.8Eu0.2VO4 and GdVO4 core NPs have a narrow particle size distribution and 
correspond to single crystals based on the similarities between the particle size and the crystallite 
size (Table 6-2). For GdVO4 core + 2 shells NPs, TEM micrographs were characterized by small 
aggregates of spherical and ellipsoidal NPs having a mean particle size of 4.4 ± 1.0 nm (Fig. 6-11). 
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Fig. 6-11 TEM micrograph of GdVO4 core + 2 shells NPs [showed in circle regions] synthesized 
at 60 °C for 30 minutes using 1:0.75:0.75 Gd:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. 
Hydrodynamic size and particle size distributions of Gd0.8Eu0.2VO4 and GdVO4 core and 
core-shells NPs were characterized using as-prepared suspensions. In Table 6-3, the PI and mean 
hydrodynamic size of Gd0.8Eu0.2VO4 core and core-shell NPs are summarized. The deposition of 
shells was accompanied by an increase in the PI and mean hydrodynamic size based on both 
particle size distributions as reported in section 5.1.2. The low PI values of both core and core + 1 
shell suspensions suggest the presence of highly monodisperse NPs. In Fig. 6-12, narrow intensity 
and number distributions were obtained for GdVO4 core NPs. An increase in the mean 
hydrodynamic size and particle size distribution was evidenced upon deposition of shells (Fig. 
6-12). Particularly, the number particle size distribution of GdVO4 core + 2 shells NPs revealed 
that either new core NPs were created or some of them were not covered with GdVO4 shells [Fig. 
6-12(b)].  
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Table 6-3 Statistics obtained from DLS of Gd0.8Eu0.2VO4 core and core-shell NPs synthesized at 
60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. 
Sample PI Mean size [intensity] (nm) Mean size [number] (nm) 
Core 0.028 10.5 ± 3.6 6.2 ± 1.4 
Core + 1 shell 0.053 14.5 ± 4.6 9.1 ± 2.1 
Core + 2 shells 0.148 15.2 ± 3.1 12.1 ± 2.0 
 
Fig. 6-12 Normalized (a) intensity and (b) number distribution of GdVO4 core and core + 2 shells 
NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs 
suspension to oligomeric species solution volume ratios. 
This could be a consequence of a combined effect between the mechanism of shell growth 
(Ostwald ripening), the volume ratio of chemicals, and the lack of oligomeric species added during 
synthesis. Overall, the mean hydrodynamic size obtained from both intensity and number 
distributions seems to overestimate the size of Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs 
based on the magnitude of crystallite size and mean particle size measured by XRD and TEM, 
respectively. The presence of citrate molecules on the surface or a counter ion layer in charged 
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surfaces will contribute to an overestimation of the particle size from both size distributions. 
However, the large hydrodynamic size and broad particle size distributions could also suggest the 
aggregation of NPs upon the deposition of shells because of a lack of complexing agents. 
6.2.1.3 Nanoparticle Yield 
The NPs yield is an essential parameter to assess the fraction of radioactivity lost during 
synthesis, while it also provides information to evaluate the proton relaxivities of MRI contrast 
agents and potential toxicity of using bare LnVO4 NPs in biomedical applications. The as-prepared 
Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs suspensions were dialyzed against DI water 
for 20 hours. Analysis of both dialyzed NPs suspension and dialysate was carried out. In Table 
6-4, it is observed that the NPs yield increased upon deposition of shells for both Gd0.8Eu0.2VO4 
and GdVO4 NPs. This increase is related to a higher consumption of oligomeric species caused by 
the continuous heating of the NPs suspension to promote the formation of core-shell structures 
since no intermediate cleaning was performed. 
Table 6-4 Average yield of Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs synthesized at 60 
°C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. 
NPs yield (%) 
Sample Gd0.8Eu0.2VO4 GdVO4 
Core 41.1 ± 16.5 61.4 ± 1.6 
Core + 1 shell 55.4 ± 8.0 63.4 ± 1.5 
Core + 2 shells 54.8 ± 11.2 58.6 ± 3.8 
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6.2.1.4 Absorption, Excitation, and Emission Spectra of Gd0.8Eu0.2VO4 core-shell 
NPs 
The absorption spectrum of Gd0.8Eu0.2VO4 core and core-shell NPs is represented by a 
broad band corresponding to the O2−-V5+ CT band [167]. The increase in absorbance upon 
deposition of shells for Gd0.8Eu0.2VO4 may be related to a higher concentration of NPs [Fig. 
6-13(a)], which is consistent with the increase in NPs yield reported in section 6.2.1.3. An emission 
wavelength of 618 nm, an excitation filter between 250–395 nm, and a PMT voltage of 600 V 
were used to record the excitation spectra. A broad excitation band with maximum intensity ~280 
nm was observed for Gd0.8Eu0.2VO4 core NPs, whereas the excitation spectra of Gd0.8Eu0.2VO4 
core-shell NPs is characterized by two excitation bands corresponding to O2−-Eu3+ (~280 nm) and 
O2−-V5+ (~305 nm) CT [Fig. 6-13(b)] [168]–[170]. In addition, a red shift in the excitation spectra 
and an increase in the intensity of the O2−-V5+ CT band were observed after the deposition of shells 
to the core NPs [Fig. 6-13(b)].  
 
Fig. 6-13  (a) Absorption and (b) excitation (λem = 618 nm) spectra of Gd0.8Eu0.2VO4 core and 
core-shell NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core 
NPs suspension to oligomeric species solution volume ratios. 
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The red shift implies that the core-shell structures could be excited with lower energy 
photons with respect to the core NPs. The increase in the O2−-V5+ CT band suggests that the 
excitation of Eu3+ ions is more efficient through the [VO4]3− units due to changes in the Eu3+-O2− 
bond elongation and/or crystal cell volume for the core-shell NPs [169], [188]. Finally, the 
emission spectrum was recorded using an excitation wavelength of 280 nm, an emission filter from 
295–1,100 nm, and a PMT voltage of 600 V. The emission spectra of Gd0.8Eu0.2VO4 core and core-
shell NPs displayed the characteristic 5D0 → 7FJ (J = 1–4) Eu3+ transitions (Fig. 6-14) [171]. The 
deposition of shells caused a decrease in the emission intensity, which may be related to the use 
of an excitation wavelength that does not correspond to the maxima intensity [Fig. 6-13(b)]. The 
changes in the excitation spectra were not considered when recording the emission spectrum since 
the excitation wavelength was kept at 280 nm.  
 
Fig. 6-14 Emission (λexc = 280 nm) spectra of Gd0.8Eu0.2VO4 core and core-shell NPs synthesized 
at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension to oligomeric 
species solution volume ratios. Inset corresponds to Gd0.8Eu0.2VO4 core and core-shell suspensions 
NPs under UV light (λ = 254 nm). 
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Additionally, aggregation of NPs in both core-shell structures may have caused a decrease 
in the emission intensity taking into account their broader particle size distributions [188]. The 
inset in Fig. 6-14 corresponds to photographs taken of aliquots from Gd0.8Eu0.2VO4 core and core-
shell NPs suspensions under UV light (λ = 254 nm). 
6.2.1.5 Magnetic Susceptibilities and Relaxation Time Studies  
The mass magnetization as a function of the magnetic field of Gd0.8Eu0.2VO4 core and core-
shell NPs is shown in Fig. 6-15. The magnetic susceptibility of Gd0.8Eu0.2VO4 core and core-shell 
NPs was 56 × 10−6 emu Oe−1 g−1, which is consistent with the constant lanthanide concentration 
(Table 6-5) and the Curie formula [equation χ=	 0123456  4-1].  
 
Fig. 6-15 Mass magnetization versus magnetic field of Gd0.8Eu0.2VO4 core and core-shell NPs 
synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs suspension 
to oligomeric species solution volume ratios. 
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Table 6-5 Gadolinium and europium weight and atomic percentage in Gd0.8Eu0.2VO4 core and 
core-shell NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core 
NPs suspension to oligomeric species solution volume ratios. 
 Weight percentage (%) Atomic percentage (%) 
Sample Eu  Gd  Eu  Gd  
Core 78.0 22.0 77.3 22.7 
Core + 1 shell 78.0 22.0 77.3 22.7 
Core + 2 shells 77.9 22.1 77.3 22.7 
 
The response of GdVO4 core NPs as positive-T1 MRI contrast agents was tested using a 
dialyzed suspension in order to remove unreacted species, particularly Gd3+ ions. The phantoms 
used for characterization were prepared by diluting the dialyzed core NPs suspension at various 
concentrations (0.016-0.5 mM). Each solution was loaded into a 2 mL plastic syringe avoiding air 
bubbles. The phantoms were imaged in a 7T BioSpec 70/30 small animal MRI scanner (Bruker, 
Billerica, MA). T1 values and T1-weighted images were obtained using the same multi-slice and 
multi-echo sequence. Longitudinal relaxivity (r1) was obtained from the slopes of the curves 1/T1 
versus the concentration of Gd3+ expressed in millimoles. An increase in concentration of GdVO4 
core NPs resulted in an enhancement of the signal intensity, observed as brighter images [Fig. 
6-16(a)], which is characteristic of positive (T1) MRI contrast agents. The T1-1 relaxation rate of 
water protons increased with higher concentration of Gd3+ ions as shown in Fig. 6-16(b). The 
calculated longitudinal proton relaxivity (r1) has a magnitude of 0.805 s–1 mM–1, which is 
comparable to the longitudinal relaxivity reported for surface functionalized Gd0.9Eu0.1VO4 
nanocrystals, r1 = 0.776 s–1 mM–1 [59]. However, Abdesselem et al. reported a longitudinal 
relaxivity for GdVO4 NPs, synthesized using the same procedure, which is ~5 times higher to that 
obtained for the dialyzed GdVO4 core NPs suspension [5].  
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Fig. 6-16 (a) T1-weighted images (DI water was used as a reference) and (b) longitudinal proton 
relaxivity (r1) measured for different concentrations of GdVO4 core NPs synthesized at 60 °C for 
30 minutes using a 1:0.75:0.75 Gd:cit:VO4 volume ratio.  
 
Fig. 6-17 Normalized (a) intensity and (b) number distributions of as-prepared and dialyzed 
GdVO4 core NPs suspensions synthesized at 60 °C for 30 minutes using a 1:0.75:0.75 Gd:cit:VO4 
volume ratio. 
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This difference could be related to an increase in the particle size after dialysis, attributed 
to NPs aggregation, since significant broadening of the normalized intensity distribution was 
observed [Fig. 6-17(a)]. A reduction of the concentration of citrate groups and counter ions during 
dialysis could be the main reason behind the NPs aggregation based on the decrease in mean 
particle size observed from the normalized number distribution [Fig. 6-17(b)]. Overall, an increase 
of the particle size [22] and/or the aggregation of NPs [65] have as a consequence a decrease of 
the longitudinal (r1) proton relaxivity due to lower concentration of surface Gd3+ ions. 
6.2.1.6 In vitro Retention of 225Ac and Decay Daughters  
In vitro retention of 225Ac and decay daughters was studied in Gd0.8Eu0.2VO4 and GdVO4 
core and core + 2 shells NPs. In Fig. 6-18, the fraction of radioactivity (leakage) found in the 
dialysate from 225Ac as a function of time for both Gd0.8Eu0.2VO4 and GdVO4 core and core + 2 
shells NPs is presented. The activity of 225Ac in the dialysate continuously increased until it 
reached a plateau, at which point the dialysate was replaced with fresh DI water to continue 
monitoring the release of 225Ac (Fig. 6-18). After changing the dialysate, the fraction of 
radioactivity of 225Ac built up again and reached a maximum of 25.8 ± 1.6% and 3.3 ± 0.3% after 
4 weeks for Gd0.8Eu0.2VO4 core and core + 2 shells NPs, respectively [Fig. 6-18(a)]. The leakage 
of 225Ac from GdVO4 core NPs reached a maximum 15.0 ± 0.9%, while the activity of 225Ac 
increased over time for GdVO4 core + 2 shells up to 2.4 ± 0.2% [Fig. 6-18(b)]. These results 
suggest that the lanthanide concentration may have an influence on the retention of 225Ac within 
core NPs that could be related to their yield (Table 6-4). The activity observed in the dialysate 
may be related to unreacted 225Ac cations that were not retained within the NPs and that remained 
as 225Ac-cit species after synthesis. This hypothesis is supported by the continuous increase in 
leakage of 225Ac observed for both Gd0.8Eu0.2VO4 and GdVO4 core NPs when the dialysate was 
replaced with fresh DI water. The continuous increase of activity could only mean that 225Ac is not 
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a free ion but instead is in the form of a low-molecular-weight metal-citrate complex in solution 
or adsorbed onto the NPs surface (Fig. 6-18). It has been demonstrated that 225Ac cations can easily 
form complexes with citrate ions [189], which might hinder their retention within the core NPs.  
 
Fig. 6-18 Leakage of 225Ac from (a) Gd0.8Eu0.2(225Ac)VO4 and (b) Gd(225Ac)VO4 core and core + 
2 shells NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs 
suspension to oligomeric species solution volume ratios. 
A simple experiment using La cations as surrogates of 225Ac was carried out to assess the 
difference between the leakage in dialysis of La as free ion and as a La-citrate complex. Briefly, 
LaCl3, LaCl3-cit, and GdCl3-LaCl3-cit solutions were dialyzed against DI water for 72 hours. 
Aliquots were taken after 1, 6, 24, 48, and 72 hours in dialysis and analyzed using ICP-OES to 
determine the La concentration. A stable concentration of La cations in the dialysate was reached 
between 1 to 6 hours in dialysis for LaCl3, whereas La-cit and La-Gd-cit complexes required at 
least 48 and 24 hours, respectively [Fig. 6-19(a)]. The fraction of La in the dialysate was consistent 
with a 100% leakage for all the solutions analyzed [Fig. 6-19(b)]. These results endorse the fact 
that 225Ac was in the form of a metal-citrate complex that caused a continuous increase in activity 
over time for core NPs. The overall enhancement in the retention of 225Ac within Gd0.8Eu0.2VO4 
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and GdVO4 core + 2 shells NPs may be related to the reaction and consumption of the 225Ac-cit 
complexes during the deposition of nonradioactive shells since no intermediate cleaning step was 
carried out after core synthesis. Therefore, a significant fraction of 225Ac-cit complexes may result 
in the formation of new core NPs and/or retain within shells. 
 
Fig. 6-19 (a) La concentration and (b) fraction of La in dialysate as a free La cation and as a La-
citrate complex. 
The radiochemical yield of 225Ac was calculated considering the initial activity in the NPs 
suspensions, the activity lost in the conical vials and pipettes, and the total activity lost during 
dialysis. The radiochemical yield of 225Ac was 43.8% and 75% for Gd0.8Eu0.2VO4 and GdVO4 core 
NPs, whereas an enhancement to 93.7% and 95% was obtained upon the deposition of 2 
nonradioactive shells, respectively. The yield for both Gd0.8Eu0.2VO4 and GdVO4 core NPs is 
consistent with their NPs yield (Table 6-4). The 225Ac radiochemical yield of Gd0.8Eu0.2VO4 core 
NPs is similar to the 47 ± 5% reported for LaPO4 NPs of 3–5 nm after surface modification and 
purification [39]. The measured yield represents a significant enhancement with respect to 
procedures for radiolabeling mAbs with 225Ac, which have shown ~10% of radiochemical yield 
[190], [191]. Similarly, GdVO4 core NPs had a higher radiochemical yield with respect to the 
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loading efficiency of polymer vesicles (67%) [113] and 225Ac-DOTA-IgG (<10%) [109], whereas 
its magnitude is comparable to that obtained for gold-coated LnPO4 core-shell NPs (76%) [42]. As 
discussed previously, the higher 225Ac radiochemical yield of core + 2 shells NPs implies that a 
significant fraction of activity is retained within the two nonradioactive shells and/or in newly 
formed core NPs.  
The leakage of 221Fr was determined after subtracting the activity of 221Fr being produced 
from 225Ac in the dialysate. For Gd0.8Eu0.2VO4 core NPs, the leakage of 221Fr was 58.7 ± 3.8% 
within 12 days and increased to 70.9 ± 4.4% after 28 days in dialysis [Fig. 6-20(a)]. A similar 
behavior was observed for GdVO4 core NPs, where the maximum leakage was 69.5 ± 4.9% [Fig. 
6-20(b)]. Both Gd0.8Eu0.2VO4 and GdVO4 core NPs had a higher leakage of 221Fr with respect to 
the 60% and 40% reported for LaPO4 and La0.5Gd0.5PO4 core NPs, respectively [39], [42]. The 
deposition of two nonradioactive shells decreased the leakage of 221Fr to a maximum of 43.5 ± 
3.6% and 49.2 ± 4.7% for Gd0.8Eu0.2VO4 and GdVO4, respectively (Fig. 6-20). This enhancement 
is related to the presence of a dense lattice structure which acts as a physical barrier against the 
leakage of radionuclides and is consistent with the 70% and 80% retention of 221Fr in La0.5Gd0.5PO4 
and LaPO4 core + 2 shells NPs, respectively [38], [42]. The leakage of 213Bi was found to be lower 
to that of 221Fr (Fig. 6-21). In addition, both Gd0.8Eu0.2VO4 and GdVO4 core NPs seem to have 
higher retention of 213Bi with respect to core + 2 shells NPs (Fig. 6-21). This difference is more 
significant for Gd0.8Eu0.2VO4 core-shell NPs, where the leakage of 213Bi from core + 2 shells is 
~10% higher with respect to core NPs [Fig. 6-21(a)].  
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Fig. 6-20 Leakage of 221Fr from (a) Gd0.8Eu0.2(225Ac)VO4 and (b) Gd(225Ac)VO4 core and core + 
2 shells NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs 
suspension to oligomeric species solution volume ratios. 
 
Fig. 6-21 Leakage of 213Bi from (a) Gd0.8Eu0.2(225Ac)VO4 and (b) Gd(225Ac)VO4 core and core + 
2 shells NPs synthesized at 60 °C for 30 minutes using 1:0.75:0.75 Ln:cit:VO4 and 1:1.5 core NPs 
suspension to oligomeric species solution volume ratios. 
The partial retention of both 221Fr and 213Bi in Gd0.8Eu0.2VO4 and GdVO4 core-shell NPs 
will cause toxicity to normal organs, particularly kidney, during in vivo applications [192]. It is 
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expected that the fraction of decay daughters leaking from the LnVO4 NPs will increase because 
of the 225Ac activity retained within the nonradioactive shells. Variation of synthesis parameters 
to deposit thicker shells and/or intermediate cleaning steps are expected to enhance the retention 
of decay daughters. A simple experiment where the Gd(225Ac)VO4 core NPs suspension was 
dialyzed before the deposition of two nonradioactive shells showed that the leakage of 221Fr 
reached a maximum ~32% after 2 weeks, which is comparable to the results obtained with LnPO4 
core + 2 shells NPs [39], [42]. Overall, the partial retention of both 221Fr and 213Bi may be attributed 
to a combination of the following effects: (i) the conversion of a fraction of the recoil energy to 
translational energy of the NP, (ii) the intrinsic attenuation of decay daughters by the NP, or (iii) 
the reloading of decay daughters by adjacent NPs and/or surface groups [81], [92], [94]–[96]. The 
fact that inorganic LnVO4 NPs are very rigid and dense suggests the possibility that a faction of 
the recoil energy is transferred to the translational energy of NPs. It is expected that the recoil 
energy will be reduced by [mDD/(mDD+mNP)], where mDD is atomic mass of the decay daughter and 
mNP is the average molecular mass of NP, which is ~1000. The intrinsic attenuation of decay 
daughters by the NP seems unlikely due to the difference between the particle size of both core 
and core-shell NPs with the range of 221Fr (E = 105.5 keV, ~26 nm) and 213Bi (E = 132.8 keV, ~30 
nm) in GdVO4 (ρ = 5.47 g/cm3) [81], [193]. Based on the large range of decay daughters in GdVO4, 
a complete leakage of decay daughters would be expected in both Gd0.8Eu0.2VO4 and GdVO4 core 
and core + 2 shells NPs. Hence, the reloading of both decay daughters by adjacent NPs could 
contribute significantly to the partial retention observed in both Gd0.8Eu0.2VO4 and GdVO4 core 
and core-shell NPs. As observed from the DLS results, the width of the particle size distribution 
increased after deposition of shells because of NP aggregation (section 6.2.1.2). To illustrate, 
Gd0.8Eu0.2VO4 core + 2 shells NPs displayed a particle size from 6 nm to 38 nm, while either 
particles or aggregates of less than ~21 nm were obtained for core NPs. In addition, it has been 
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observed that the width of the particle size distribution increases after dialyzing the NPs 
suspensions because of a reduction in the concentration of sodium citrate (Fig. 6-17). These results 
are consistent with the higher retention of 221Fr in both Gd0.8Eu0.2VO4 and GdVO4 core + 2 shells 
NPs with respect to that in the core NPs. Therefore, it is expected that the free decay daughter will 
be implanted in adjacent NPs. Reloading of decay daughters by the adjacent NPs and/or surface 
groups, is also associated to the ion exchange characteristics of some compounds [98], [99] and 
the ability of surface groups to interact with free ions [94]. This effect could be responsible for the 
higher retention of 213Bi by the core NPs with respect to that of core + 2 shells. The recoiled 213Bi 
ions out of the NPs are thermalized quickly (within ~30 nm) and may form a complex with the 
citrate groups on the NPs surface. Particularly, it is expected that 213Bi may be captured by the 
hydroxyl group, which have shown high affinity for Bi cations [94], of the citrate species that are 
complexed to the lanthanide ions on the NPs surface. The fact that a greater fraction of citrate 
species is consumed during core-shell synthesis may be responsible for the higher leakage of 213Bi 
observed for core + 2 shells NPs with respect to that of core (Fig. 6-21). In summary, the partial 
retention of both 221Fr and 213Bi is due to the transfer of the recoil energy to the translation of the 
NP, their reloading by adjacent NPs facilitated by the formation of aggregates with sizes ~30 nm, 
and the interaction with hydroxyl and carboxylic groups present at the NPs surface. 
6.2.2 GdVO4 and LaPO4 core-shell NPs Doped with 227Th 
Gd(227Th)VO4 core and core + 2 shells NPs were synthesized using a 1:0.65:0.9 volume 
ratio between Gd3+:cit:[VO4]3–. This modification was done with the purpose to (i) enhance the 
NPs yield and (ii) increase the shell thickness based on the results obtained in section 5.1.2. An 
acidic solution with an initial activity of ~32 µCi of 227Th was evaporated to dryness in a conical 
vial at 80 ºC. A 0.1 M GdCl3 solution was added to the vial and stirred for 10–15 minutes for a 
complete dispersion of 227Th and decay daughters. Sodium citrate and sodium orthovanadate 
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solutions were added drop-by-drop under constant stirring at the established volume ratios. This 
radioactive solution was heated at 60 ºC for 30 minutes to obtain Gd(227Th)VO4 core NPs. The 
core NPs suspension was dialyzed overnight to remove unreacted 227Th ions. The deposition of 
nonradioactive GdVO4 shells was carried out using the dialyzed Gd(227Th)VO4 core NPs 
suspension to prevent precipitation of unreacted 227Th and decay daughters. After dialysis, the core 
solution was divided into two equal parts, one for retention studies and the other for core-shell 
synthesis. The deposition of nonradioactive shells was done by mixing the dialyzed core 
suspension with a solution containing oligomeric species prepared at the same volume ratio of 
reagents as described for the core NPs. This oligomeric species solution was added under constant 
stirring to the core NPs suspension in a 2:1 volume ratio (section 5.1.2). The mixture was heated 
at 60 ºC for 30 minutes to deposit the first shell. The process was repeated once more to synthesize 
Gd(227Th)VO4 core + 2 shells NPs, while keeping a 1:2 volume ratio of core NPs suspension to 
oligomeric species solution. The Gd(227Th)VO4 core + 2 shells NPs suspension was dialyzed 
against DI water to assess in vitro retention of 227Th and decay daughter 223Ra over time.  
An initial activity of 12–45 µCi of 227Th in 0.1 M HCl was evaporated to dryness in a 
conical vial at 80 ºC. LaCl3 was added and stirred for 15–20 minutes before adding Na-TPP in a 
1:1 volume ratio (section 3.2 and 4.2). La(227Th)PO4 core NPs were synthesized at 90 ºC for 3 
hours and dialyzed overnight. The core NPs suspension was divided into two equal parts, one for 
retention analysis of core NPs and the other for core-shell synthesis, as carried out for 
Gd(227Th)VO4. Deposition of nonradioactive LaPO4 shells was done as described in section 3.2, 
while keeping the temperature and heating time at 90 ºC and 3 hours, respectively. The 
radionuclide-doped core + 2 shells NPs suspensions were dialyzed against DI water to assess the 
retention of radionuclides over time. The crystal structure of both GdVO4 and LaPO4 core and core 
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+ 2 shells NPs was characterized as well as the morphology of LaPO4 NPs. The results presented 
in this section have been adapted from two manuscripts under preparation. 
6.2.2.1 Crystal structure 
GdVO4 core and core + 2 shells NPs have a tetragonal crystal system with space group 
I41/amd (pdf: 00-017-0260), whereas a hexagonal crystal system with space group P6222 (pdf: 01-
075-1881) was obtained for LaPO4 core and core + 2 shells NPs. Both GdVO4 and LaPO4 NPs 
showed an increase in the crystallite size upon deposition of two shells. An increase from 5.5 nm 
to 7.5 nm was observed for GdVO4 NPs, while for LaPO4 NPs it was from 4.2 nm to 5.2 nm. As 
expected from section 5.1.2, the adjustment of the volume ratio between reagents and volume of 
oligomeric species solution resulted in a larger increase of crystallite size for Gd(227Th)VO4 with 
respect to the results obtained for Gd(225Ac)VO4 in section 6.2.1.1. The increase in size between 
core and core + 2 shells NPs was 0.7 nm and 2.0 nm for Gd(225Ac)VO4 and Gd(227Th)VO4, 
respectively. 
6.2.2.2 Morphology of LaPO4 core and core + 2 shells NPs 
LaPO4 core and core + 2 shells NPs have spherical and ellipsoidal shape based on the TEM 
micrographs (Fig. 6-22). The mean particle size for core and core + 2 shells was 4.5 ± 1.2 nm and 
5.4 ± 0.9 nm, respectively. The similarity between the mean particle size and crystallite size of 
both core and core + 2 shells suggests that the as-prepared LaPO4 NPs correspond to single 
crystals. 
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Fig. 6-22 TEM micrographs of LaPO4 core (left) and core + 2 shells (right) NPs synthesized at 90 
°C for 3 hours by mixing a solution of La/Na-TPP (1:2 La:Na-TPP volume ratio) with LaPO4 core 
NPs suspension at a 1:1 volume ratio (section 3.2). 
6.2.2.3 In vitro Retention of 227Th and Decay Daughters  
Previous studies have only involved the development of 227Th radioimmunoconjugates, 
which cannot retain decay daughters at the target site [81], [114], [115], [194]–[197]. The synthesis 
of Gd(227Th)VO4 and La(227Th)PO4 core and core + 2 shells NPs may provide a partial retention 
of radionuclides contributing to a reduction of the radiotoxicity generated by decay daughters 
[195]. The leakage of 227Th and 223Ra from Gd(227Th)VO4 core and core + 2 shells NPs is shown 
in Fig. 6-23. The leakage of 227Th from GdVO4 core NPs was 3.3 ± 0.3% after 7 days and then 
decreased to 2.0 ± 0.5% at day 21 [Fig. 6-23(a)]. Although the samples were analyzed for over 30 
days, the activity of 227Th in the dialysate was below the detection limit of the HPGe detector. 
Similarly, the leakage of 227Th from GdVO4 core + 2 shells NPs was <1.5% in the first 12 days in 
dialysis, with no activity detected afterwards [Fig. 6-23(a)]. These results demonstrate that 227Th4+ 
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ions (i) are successfully retained within the tetragonal structure of GdVO4 in comparison to 225Ac3+ 
and (ii) do not easily form Th-cit complexes based on the results presented in section 6.2.1.6. The 
leakage of 223Ra from GdVO4 core NPs was 10 ± 0.7% after one day in dialysis, however, the 
fraction of activity in the dialysate increased to 39.7 ± 2.3% after 2 weeks [Fig. 6-23(b)]. The 
deposition of two nonradioactive GdVO4 shells decreased the leakage of 223Ra to a maximum of 
25.5 ± 1.5% [Fig. 6-23(b)]. As discussed previously, nonradioactive shells act as a barrier against 
the leakage of decay daughters enhancing their retention over that of core NPs.  
 
Fig. 6-23 Leakage of (a) 227Th and (b) 223Ra from GdVO4 core and core + 2 shells NPs synthesized 
at 60 °C for 30 minutes using 1:0.65:0.9 Ln:cit:VO4 and 1:2 core NPs suspension to oligomeric 
species solution volume ratios. 
In Fig. 6-24, the leakage of 227Th and 223Ra from La(227Th)PO4 core and core + 2 shells 
NPs is presented. In LaPO4 core NPs, the leakage of 227Th had a maximum of 2.8 ± 2.8% after 6 
days in dialysis and then it decreased to a minimum of 0.6 ± 0.8% [Fig. 6-24(a)]. The decrease in 
activity over time implies that the fraction of activity measured is related to surface bound 227Th 
rather than leakage from La(227Th)PO4 core NPs. The deposition of two nonradioactive LaPO4 
shells decreased the leakage of 227Th to <0.1% [Fig. 6-24(b)]. It is assumed that the lower leakage 
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of 227Th in La(227Th)PO4 core + 2 shells is attributed to the partial removal of free radionuclides 
during dialysis, the consumption of unreacted species during core-shell synthesis, or both. It is 
expected that the longer heating times (~6 hours) used during core-shell synthesis will promote 
the consumption of unreacted species at the NP surface. The leakage of 223Ra from LaPO4 core 
NPs was 1.8 ± 1.7% after 6 days in dialysis and then it increased to 7.7 ± 12.5% after 23 days [Fig. 
6-24(a)]. The retention of 211Pb was quantitative in La(227Th)PO4 core NPs since almost all the 
activity found in the dialysate originates from 223Ra and only <0.7 ± 0.9% is a consequence of 
211Pb leaking from the NPs. As expected, the leakage of 223Ra decreased to a maximum of 0.13 ± 
0.13% after deposition of two LaPO4 shells [Fig. 6-24(b)]. Similar to core NPs, the retention of 
211Pb was quantitative since less than 0.16 ± 0.5% originated directly from radionuclides leaking 
from the NPs. 
 
Fig. 6-24 Leakage of (a) 227Th and (b) 223Ra from LaPO4 core and core + 2 shells NPs synthesized 
at 90 °C for 3 hours by mixing a solution of La/Na-TPP (1:2 La:Na-TPP volume ratio) with LaPO4 
core NPs suspension at a 1:1 volume ratio (section 3.2). 
As discussed in section 6.2.1.6, the partial retention of 223Ra and 211Pb in GdVO4 and 
LaPO4 core-shell NPs is attributed to the transfer of the recoil energy to the translation of the NP, 
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their implantation in neighbor NPs, and adsorption by surface groups based on their recoil energy 
and range in GdVO4 and LaPO4 compounds. For example, the range of 223Ra (~110 keV) in H2O 
and GdVO4 is ~87 nm and ~27 nm, respectively [193]. Similarly, 223Ra and 211Pb (~140 keV) will 
have a range of 27.0 nm and 32.6 nm in LaPO4, with an estimated density of 5.12 g/cm3 [193]. It 
is expected that the decay daughter will be attenuated by adjacent NPs as well as by water until it 
is implanted on another core or core + 2 shells NP. The retention of decay daughters in both GdVO4 
and LaPO4 core + 2 shells NPs may be enhanced by the formation of aggregates, which facilitate 
their implantation in a neighbor NP. The difference in the in vitro retention of 227Th and 223Ra 
between GdVO4 and LaPO4 could be related to the yield or fraction of NPs in suspension. Although 
GdVO4 core and core + 2 shells NPs had a higher leakage of 223Ra, the fraction of activity released 
could be within the therapeutic window where acceptable myelotoxicity is caused by 223Ra [198]. 
The retention of ~75% of 223Ra activity within GdVO4 core + 2 shells NPs could mitigate the 
myelosuppression caused by free 223Ra cations, which has been observed in rodent studies using 
CD70 targeted 227Th conjugate [115]. 
The radiochemical yield of 227Th was 62% and 81% for Gd(227Th)VO4 core and core + 2 
shells NPs, respectively. La(227Th)PO4 core and core + 2 shells NPs had a radiochemical yield of 
96.7 ± 2.7% and 96.6 ± 0.4%, respectively. The yield obtained for Gd(227Th)VO4 core and core + 
2 shells NPs was lower than that of targeted 227Th radioimmunoconjugates (>95%), however, the 
partial retention of radionuclides, potential increase in specific activity, and promising 
multifunctional properties, make GdVO4 suitable for TRT and theranostic applications. Similarly, 
the ability to quantitatively retain decay daughters in La(227Th)PO4 core + 2 shells NPs represents 
a major advantage for TRT applications. Overall, these results demonstrate the potential of both 
GdVO4 and LaPO4 core-shell NPs as carriers of 227Th for TRT. 
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6.2.3 GdVO4 NPs doped with 223Ra, 225Ac, and 227Th 
GdVO4 NPs doped with 223Ra, 225Ac, and 227Th synthesized as described in section 3.3.2 
were evaluated as radionuclide carriers for TRT based on the simplicity of the synthesis route for 
radiochemical preparations. Prior to the synthesis of radionuclide-doped GdVO4 NPs, the 
flexibility of the tetragonal crystal structure to host multivalent ions was assessed by using La3+, 
Ba2+, Bi3+, Cs+, and Pb2+ as surrogates of 225Ac3+, 223Ra2+, 213Bi3+, 221Fr+, and 211Pb2+, respectively. 
Doping lanthanide-based ceramics with surrogate ions is a common practice to evaluate solid 
solutions for minor actinide immobilization [199], [200]. The presence of second phases was 
evaluated based on the diffraction patterns of the surrogate-doped GdVO4 NPs. The concentration 
of each element found in the dialysate was determined using ICP-OES to assess the ability of 
GdVO4 NPs to host surrogate ions. 
The synthesis of surrogate-doped GdVO4 NPs consisted in the mixing of aqueous solutions 
of LaCl3·7H2O, CsCl, and BiCl3 at 1 at.% or 10 at.% of La, Cs, and Bi ions with respect to Gd. 
This solution was evaporated until dryness at 80 ºC and then mixed with GdCl3 (1 mmol, 0.1 M) 
using a vortex mixer and an ultrasonic bath. In this case, Na3VO4 (1 mmol, 0.1 M, pH = 12.5) was 
added dropwise to the aqueous solution containing Gd, La, Cs, and Bi ions under constant stirring. 
The modification in which GdCl3 and Na3VO4 were mixed is based on the steps followed for the 
synthesis of radionuclide-doped LnPO4 and LnVO4 NPs as presented in previous sections. The pH 
of the solution was adjusted to ~11 using NaOH (1 M) after Na3VO4 was added and then the 
mixture was left under constant stirring for 30 minutes. It is expected that GdVO4 NPs will be 
precipitated by adding Na3VO4 into GdCl3 based on the results obtained in section 5.2.1. The turbid 
suspension was transferred into a dialysis membrane and dialyzed against DI water to remove 
unreacted ions for yield quantification. Similarly, a mixture containing BaCl2·2H2O and PbCl2, at 
1 at.% or 10 at.% of Ba and Pb ions with respect to Gd, was evaporated and mixed with GdCl3. 
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Afterwards, the same steps described above for the synthesis and cleaning of GdVO4 NPs doped 
with La, Cs, and Bi ions were followed. 
For radiochemical synthesis, a 0.1 M HNO3 solution containing ~4.7 µCi, 4.4 µCi, and 
10.1 µCi of 223Ra, 225Ac, and 227Th, respectively, was evaporated to dryness in a conical vial using 
an infrared heat lamp and a hot plate. The addition of chemicals (GdCl3·6H2O and Na3VO4), the 
adjustment of the pH, and stirring were carried out as described above for the surrogate-doped 
GdVO4 NPs. Additionally, a sample of GdVO4 NPs doped with ~34 µCi of 223Ra was synthesized 
by mixing first a Na3VO4 solution with the radionuclides and then adding GdCl3. The pH of the 
suspension was adjusted to ~11 using NaOH (1 M) and allowed to stir for 30 minutes before 
dialysis. In vitro retention of radionuclides over time was assessed as described in section 3.4.7. 
These results have been adapted from a manuscript that is under preparation. 
6.2.3.1 Crystal structure 
The diffraction patterns of surrogate-doped GdVO4 NPs are shown in Fig. 6-25. GdVO4 
NPs doped with either 1 at.% or 10 at.% of Ba and Pb have a tetragonal system with zircon-type 
structure corresponding to GdVO4 (pdf: 00-017-0260). Absence of additional phases in the 
diffraction patterns suggests that both Ba and Pb were successfully and uniformly incorporated 
within the GdVO4 host lattice (Fig. 6-25). This indicates that radionuclides such as 223Ra and 211Pb 
may be retained within GdVO4 NPs.  GdVO4 NPs doped with either 1 at.% or 10 at.% of La, Cs, 
and Bi are characterized by two phases, GdVO4 with a tetragonal system (pdf: 00-017-0260) and 
BiClO with a tetragonal system and space group P4/129 (pdf: 01-085-0861). The presence of the 
BiClO phase, highlighted with *, is clearly observed for 10 at.% of La, Cs, and Bi, whereas for 1 
at.% only the peak ~25.8º can be seen (Fig. 6-25). The presence of this phase is related to the 
tendency of BiCl3 to hydrolyze into BiClO in aqueous media and it may also suggest that Bi ions 
are not retained within the GdVO4 lattice. BiClO is characterized by a yellowish appearance which 
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explains the characteristic color observed after synthesis of surrogate-doped GdVO4 NPs. It is 
assumed that La and Cs are incorporated in the GdVO4 lattice since no additional phases were 
observed (Fig. 6-25). The crystallite size of the surrogate-doped GdVO4 NPs was not affected by 
the composition and concentration of surrogate ions since the values are between 6.9–7.9 nm. 
 
Fig. 6-25 Diffraction patterns of 1 at.% and 10 at.% surrogate-doped GdVO4 NPs synthesized by 
adding a solution of Na3VO4 into GdCl3, while adjusting the pH at 11. 
6.2.3.2 Chemical Yield 
To assess the retention of surrogate ions, surrogate-doped GdVO4 NPs were dialyzed 
against DI water for 20 hours. The chemical yield was calculated for each element based on its 
concentration in the dialysate and dialyzed NPs suspension with respect to the nominal 
concentration. The average chemical yield and standard deviation for Gd, La, Bi, Ba, and Pb are 
summarized in Table 6-6. The chemical yield ~100% of Gd indicates that all Gd cations 
participated in GdVO4 NPs formation. The similar chemical properties and ionic radii between La 
and Ac cations allow the implementation of nonradioactive La as surrogate for the characterization 
and evaluation of Ac-doped compounds. Herein, the chemical yield of La cations was used as a 
tool to assess the radiochemical yield and immobilization of Ac isotopes within GdVO4 NPs. 
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GdVO4 NPs doped with either 1 at.% or 10 at.% of La, Cs, and Bi had a chemical yield ~100% for 
La. These results imply that almost all Ac cations may be retained within GdVO4 NPs. This is 
particularly relevant since ~55 Ci of 225Ac and 69.5 mCi of 227Ac could be retained within GdVO4 
NPs considering the concentration of La cations used. The evaluation of the chemical yield of Cs 
as surrogate of Fr isotopes was not possible because of the low concentrations used and the 
minimum detection limit of Cs by ICP-OES set at 3.2 ppm. The chemical yield of Bi shows an 
increase from 65.4 ± 137.1% to 100.0 ± 37.7% for GdVO4 NPs doped with 1 at.% and 10 at.%, 
respectively. As evidenced from the diffraction patterns, the precipitation of BiClO could be 
responsible for the large standard deviation and difference between both samples and does not 
assure that Bi cations are retained within the NPs.  
Table 6-6 Mean chemical yield and standard deviation of different elements in surrogate-doped 
GdVO4 NPs synthesized by adding a solution of Na3VO4 into GdCl3, while adjusting the pH at 11. 
Sample Gd (%) La (%) Bi (%) Ba (%) Pb (%) 
1 at.% Ba, Pb 100.0 ± 0.5   85.1 ± 7.5 100.0 ± 64.0 
10 at.% Ba, Pb 100.0 ± 2.0   59.6 ± 3.9 91.9 ± 4.4 
1 at.% La, Cs, Bi 99.3 ± 0.7 100.0 ± 1.4 65.4 ± 137.1   
10 at.% La, Cs, Bi 100.0 ± 5.3 100.0 ± 5.5 100.0 ± 37.7   
 
Increasing the concentration of Ba and Pb from 1 at.% to 10 at.% caused a decrease of the 
chemical yield for both elements suggesting that Ra isotopes will be partially retained within 
GdVO4 NPs (Table 6-6). The large standard deviation obtained for 1 at.% of Pb may be related to 
the low concentration of ions used and the detection limit for this element. 
6.2.3.3 In vitro Retention of 223Ra, 225Ac, 227Th, and Decay Daughters  
In Fig. 6-26, the leakage of 223Ra, 225Ac, 227Th, and decay daughters from GdVO4 NPs over 
time is shown. The leakage of 225Ac increased continuously from 17.4 ± 1.2% to 36.7 ± 2.2% after 
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7 days in dialysis suggesting the partial retention of this radionuclide within the GdVO4 NPs [Fig. 
6-26(a)]. This result suggests that using La as surrogates of 225Ac may have its limitations since 
the former was homogeneously retained within GdVO4 NPs based on its chemical yield (Table 
6-6). It is expected that the difference in ionic radii between Ac and Gd as well as the ability of 
tetragonal structures to host mainly actinides with a tetravalent oxidation state may contribute to 
the leakage of 225Ac observed [27]. The leakage of decay daughters, 221Fr and 213Bi, from GdVO4 
NPs is attributed to the recoil energy (100–200 keV) of both radionuclides after α-decay, which is 
significantly greater than the chemical bond energy [81], [201], [202]. The ~50% retention of 221Fr 
in GdVO4 NPs is comparable with the 50% and 60% obtained in LaPO4 and La0.5Gd0.5PO4 core 
NPs after one week [39], [42]. GdVO4 NPs had a quantitative and partial retention of 227Th and its 
decay daughter 223Ra, respectively [Fig. 6-26(b)]. This result supports the potential use of GdVO4 
NPs for the retention or immobilization of long-lived thorium radionuclides such as 228Th (T1/2 = 
1.9 y), 229Th (T1/2 = 7880 y), and 232Th (T1/2 = 1.4 × 1010 y). The leakage of 223Ra, as decay daughter 
of 227Th, reached a maximum of 73 ± 4.0% and then decreased to 35.1 ± 2.0% [Fig. 6-26(b)]. As 
discussed previously, the leakage of decay daughters is related to their high recoil energy and large 
range with respect to the size of GdVO4 NPs [86]. Leakage of 223Ra, as parent radionuclide, from 
GdVO4 NPs is shown in Fig. 6-26 (c) and (d). The difference between both GdVO4 NPs rely in 
the order in which Na3VO4 and GdCl3 aqueous solutions were mixed with 223Ra and decay 
daughters. In Fig. 6-26(c) it is shown the leakage of 223Ra when a Na3VO4 solution was added 
drop-by-drop to a mixture containing Gd and radionuclides cations. GdVO4 NPs showed partial 
retention of 223Ra since ~25% of activity was found in the dialysate, which is consistent to the 
partial retention of Ba ions obtained from the chemical yield experiments of surrogate-doped 
GdVO4 NPs (Table 6-6). The leakage of 223Ra from GdVO4 NPs is almost two times higher to that 
reported for LaPO4 core NPs (12.7%) [38]. The partial retention of 223Ra may be related to (i) the 
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difference in ionic radii between Gd and Ra, (ii) the ability of tetragonal structures to host primarily 
actinides with a tetravalent oxidation state, and/or (ii) the lack of electroneutrality in the GdVO4 
structure (Ln3+ ↔ Me2+ + Me4+) [27].  GdVO4 NPs showed a quantitative retention of 211Pb since 
the activity found in the dialysate originates from the decay of 223Ra and not from 211Pb leaking. 
A significant difference in the retention 223Ra was observed between GdVO4 NPs depending in the 
order in which the chemical reagents were mixed with the radionuclides. The addition of Na3VO4 
directly to 223Ra and decay daughters caused a continuous increase in 223Ra leakage up to 43.6 ± 
2.4%, whereas 211Pb was quantitatively retained [Fig. 6-26(d)]. It is assumed that this difference 
is related to the precipitation of radionuclide species in the form of hydroxides which remain in 
solution because of their slow interaction with [VO4]3– species. Particularly, the precipitation of 
these species is more probable when Na3VO4 is added directly to the radionuclides because of its 
high pH (12.5). The continuous increase of 223Ra activity over time suggests that this radionuclide 
is not present as a free ion but as a complex based on the experiments conducted with La cations 
(section 6.2.1.6). Radiochemical yield for 225Ac-, 227Th-, and 223Ra-doped GdVO4 NPs was 67.7%, 
66.8%, and 70.8%, respectively. The 223Ra-doped GdVO4 NPs suspension prepared by adding 
Na3VO4 directly to the radionuclides had a radiochemical yield of 58.0%. The radiochemical yield 
of 225Ac obtained for GdVO4 is comparable to the 61% and 57.5% reported for La(225Ac)PO4 and 
Ln(225Ac)PO4 NPs, respectively [39], [42].  
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Fig. 6-26 Radionuclide leakage from (a) Gd(225Ac)VO4, (b) Gd(227Th)VO4, and (c) Gd(223Ra)VO4 
NPs synthesized by adding a solution of Na3VO4 into GdCl3 and radionuclides, while adjusting 
the pH at 11. (d) Gd(223Ra)VO4 NPs prepared by adding a solution of GdCl3 into Na3VO4 and 
radionuclides (as reported by Huignard et al. [126]), while adjusting the pH at 11. 
Overall, both GdVO4 NPs prepared by citrate and flow synthesis displayed similar 
retention properties of 225Ac, 227Th, and decay daughters. The leakage of 225Ac from the smaller 
NPs is related to the formation of 225Ac-cit complexes, whereas either the precipitation of Ac(OH)3 
or dissociation of surface bound Ac cations could be responsible for the leakage from the larger 
NPs. The retention of 221Fr was 10% higher for the larger NPs with respect to the smaller NPs 
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because of their large size, tendency to aggregate, and higher yield. These characteristics of the 
larger GdVO4 may promote the implantation of decay daughters in adjacent NPs. The presence of 
citrate groups and hence lower NP yield may be responsible for the leakage of 227Th from the 
smaller NPs, since a quantitative retention was observed from GdVO4 prepared via flow synthesis. 
There was no significant difference regarding the retention of 223Ra as decay daughter between 
both GdVO4 NPs sizes, except for the higher leakage (>50%) observed from the larger NPs in the 
first 2 weeks [Fig. 6-26(b)].  
6.3  Summary 
In this chapter, radionuclide-doped LnPO4 and LnVO4 core-shell NPs were synthesized by 
precipitation routes to assess the in vitro retention of radionuclides for biomedical and engineering 
applications. Radionuclide-doped LnPO4 and LnVO4 core-shell NPs were synthesized with 
specific lanthanide compositions to display properties for multimodal molecular imaging. 
Influence of the lanthanide composition and core-shell structure on the retention of radionuclides 
was studied. Additionally, a comparison between the retention capabilities of LaPO4 and GdVO4 
core-shell NPs was made based on their crystal structures. The key results obtained from the in 
vitro evaluation of radionuclide-doped LnPO4 and LnVO4 core-shell NPs are summarized below: 
§ Retention of 156Eu is dependent on the composition and concentration of lanthanide 
ions within LnPO4 core NPs. An evaluation of the retention properties of GdPO4 and 
lanthanide-doped GdPO4 core NPs revealed that the retention of 156Eu decreased when 
Eu is used as dopant ion. 
§ La(1-x)EuxPO4 and LnPO4 (Ln3+ = La, Ce, Eu, Gd, Tb, Yb, and Lu) core NPs doped with 
85, 89Sr and 156Eu confirmed the influence of lanthanide composition and concentration 
on the retention of radionuclides, particularly 156Eu. At Eu concentrations below 40% 
in La(1-x)EuxPO4, the leakage of 156Eu was ~3 times higher than that observed from 
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EuPO4 core NPs. The leakage of 156Eu from pure LnPO4 core NPs was influenced by 
the difference in ionic radii, where YbPO4 and LuPO4 displayed low retention. The 
retention of strontium isotopes was similar over La(1-x)EuxPO4 and LnPO4 core NPs, 
except for GdPO4 that exhibited a steep increase in leakage because of the electronic 
peculiarities of Gd cations. LnVO4 NPs are expected to follow a similar trend to that 
of LnPO4 based on the difference in ionic radii between radionuclides and Ln3+ ions. 
The dependence of radionuclide retention on Ln3+ ion composition and concentration 
has to be considered during the development of multifunctional platforms. 
§ Formation of 225Ac-citrate complexes is assumed to be the main cause behind the 15–
25% leakage of 225Ac from GdVO4 and Gd0.8Eu0.2VO4 core NPs synthesized via the 
citrate route. The significant increase in 225Ac retention after deposition of two 
nonradioactive shells is related to the consumption of 225Ac-citrate complexes during 
the multi-step synthesis procedure. Gd0.8Eu0.2VO4 and GdVO4 core-shell NPs 
displayed partial retention of decay daughters (221Fr and 213Bi) as well as molecular 
imaging functionalities for FI and/or MRI. These radionuclide-doped LnVO4 NPs have 
promising applications in biological settings as theranostic platforms. 
§ Retention of 227Th was studied for the first time in nano-platforms such as GdVO4 and 
LaPO4 core and core + 2 shells NPs. Leakage of 227Th from both core NPs was ~3%, 
while deposition of two nonradioactive shells increase the retention to >98% and 
>99.9% in GdVO4 and LaPO4, respectively. LaPO4 core NPs retained >90% of 223Ra, 
whereas ~40% leakage of 223Ra was observed for GdVO4 core NPs. Two 
nonradioactive shells enhanced the retention of 223Ra to >99.8% and >75% in LaPO4 
and GdVO4, respectively. Differences in decay daughter retention between LaPO4 and 
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GdVO4 may be related to either the NPs yield, surface chemistry, or particle size 
distribution. 
§ GdVO4 NPs prepared via flow synthesis displayed the ability to host multivalent in 
vivo a-generators radionuclides. Quantitative retention of 227Th and partial retention of 
223Ra and 225Ac as parent radionuclides may be related to the differences in ionic radii, 
the electroneutrality within GdVO4, and the ability of zircon-type structures to host 
mainly tetravalent actinides. Leakage of decay daughters 221Fr and 223Ra is caused by 
their recoil energy and range in GdVO4.  
§ It is expected that LnPO4 and LnVO4 NPs could be doped with multiple radionuclides, 
for both diagnostic and therapeutic applications, based on the ability to host multivalent 
ions of their crystal structures, monoclinic and tetragonal. 
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7 Conclusions and Future Work 
In this work, LnVO4 and LnPO4 NPs were synthesized in aqueous media following multi-
step precipitation procedures for the preparation of core and core-shell structures. These 
procedures do not require specialized equipment such as autoclaves, microwave reactors, or high 
frequency sonicators. The simplicity of the implemented synthesis methods and the ability to 
obtain crystalline LnVO4 and LnPO4 core-shell NPs with particle size below 30 nm, different shape 
(spherical, trapezoidal, ellipsoidal), and good physical stability (stable in suspension) made them 
appealing for the development of multifunctional platforms for biomedical applications as well as 
for radiochemical settings. The composition and concentration of lanthanide ions can be adjusted 
to provide fluorescence and magnetic functionalities, whereas radionuclides can be retained within 
the crystal structure of both LnVO4 and LnPO4 NPs. 
The particle size and size distribution of LnPO4 was controlled by adjusting the 
concentration of Na-TPP, heating time, and temperature during synthesis. Although increasing the 
concentration of Na-TPP enhanced the physical stability and contributed to the formation of LnPO4 
NPs with small and uniform size, a large fraction of polyphosphate species on the NPs surface may 
act as luminescence quenchers. LnPO4 NPs doped with Eu3+ and Ce3+:Tb3+ displayed low 
luminescence emission as a result of their nanocrystalline nature and the large fraction of 
phosphate species used during synthesis. Post-annealing treatments may be considered to enhance 
the crystallinity and hence the luminescence emission of LnPO4 NPs, however, an increase in 
particle size and aggregation may limit their application in biomedical settings. The retention of 
lanthanide and/or therapeutically relevant radionuclides within LnPO4 core NPs was assessed by 
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using 156Eu and 85, 89Sr. Retention of 156Eu in LnPO4 core NPs was influenced by the elemental 
composition and concentration of Eu cations, while the retention of strontium radionuclides was 
similar between the samples tested. The leakage of radionuclides observed was not related to 
dissolution of LnPO4 NPs but rather to radionuclides bound to the NP surface or attached to the 
stabilizing polymeric shell formed by phosphate oligomers. 
LnVO4 NPs displayed small particle size (<10 nm) and narrow size distributions when 
using sodium citrate as complexing agent. Temperature, heating time, and reagents concentration 
can be adjusted to obtain the desired particle size and size distribution. Luminescence emission of 
europium-doped GdVO4 core NPs was better than the one observed for Gd(1-x)EuxPO4 NPs because 
of an efficient energy transfer between [VO4]3– → Eu3+. Gd0.8Eu0.2VO4 core NPs displayed the 
highest luminescence emission without significant concentration quenching among the different 
Eu3+ concentrations studied. GdVO4 core NPs may also be used as MRI contrast agents based on 
their longitudinal proton relaxivity (r1 = 0.805 s–1 mM–1). The successful development of core-
shell structures was achieved by mixing a solution containing lanthanide-citrate-vanadate 
complexes with the LnVO4 core NPs suspensions followed by heating at the specified conditions. 
Larger LnVO4 NPs (20–40 nm) with either trapezoidal, ellipsoidal, or anisotropic shape were 
precipitated by adding LnCl3 into Na3VO4, while adjusting the pH of the solution at different 
values. These particles displayed both luminescence and magnetic properties and the ability to host 
multivalent cations within their crystal structure.  
The in vitro retention of therapeutically relevant radionuclides 223Ra, 225Ac, and 227Th, and 
decay daughters in LaPO4, Gd0.8Eu0.2VO4, and GdVO4 core and core + 2 shells NPs was evaluated. 
The partial in vitro retention of radionuclides demonstrates the potential of Gd0.8Eu0.2VO4 and 
GdVO4 core and core + 2 shells for the development of multifunctional diagnostic and therapeutic 
platforms. The 15–25% leakage observed for 225Ac in core NPs is caused by the presence of this 
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radionuclide as a metal-citrate complex in solution. A high consumption of oligomeric species 
during core-shell synthesis caused a significant decrease in 225Ac leakage (<5%). The large fraction 
of 227Th retained within both core and core + 2 shells exhibits a difference in the retention 
capabilities of LnVO4 NPs based on the valence state of the radionuclides. The influence of the 
valence state in the retention properties of GdVO4 NPs was confirmed by doping the larger 
particles with either 223Ra, 225Ac, or 227Th. Based on these results it was established that tetravalent 
actinides (227Th) may be quantitatively retained, whereas trivalent actinides (225Ac) and alkaline 
earth metals (223Ra) are partially retained. Although the deposition of shells increased the retention 
of both 221Fr and 223Ra, the high recoil energy and large range of decay daughters in LnVO4 are 
the main reason behind radionuclide leakage from both LnVO4 core and core + 2 shells NPs.  
LaPO4 core + 2 shells NPs were able to quantitatively retain both 227Th and first decay daughter 
223Ra as expected from previous studies regarding the in vitro retention of 225Ac and 223Ra in LnPO4 
core and core + 2 shells NPs. The difference in 223Ra retention between LaPO4 and GdVO4 may 
be related to either the fraction of NPs in suspension, their surface chemistry, or their particle size 
distribution. 
The suitable radiochemical synthesis, in vitro retention of radionuclides, fluorescence 
emission, and proton relaxivity encourage the use of LnVO4 core-shell NPs as promising 
theranostic platforms for implementation in multimodal molecular imaging and TRT. 
Enhancement of retention capabilities of decay daughters in LnVO4 NPs must be carried out to 
minimize the toxicity to healthy organs. Alternatives to enhance the retention of radionuclides 
encompass the development of multilayered structures, core-shell NPs, having shells with different 
compositions. A greater number of LnVO4 shells will result in a thicker barrier to promote the 
intrinsic retention of radionuclides.  The same rationale is followed by using a gold shell, which 
may provide the same retention properties with a smaller shell thickness owing the higher stopping 
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power of gold with respect to LnVO4. Deposition of an inorganic shell with ion exchange 
characteristics may reduce the leakage of radionuclides by increasing their reloading. The 
deposition of shells with different composition may also decrease the toxicity of LnVO4 and 
LnPO4 NPs as well as to facilitate their functionalization and antibody conjugation for 
characterization and application in biological settings. 
It is expected that the release of unreacted and surface bound lanthanide ions, particularly 
of Gd3+ ions, from both LnPO4 and LnVO4 NPs may result in in vivo toxicity if intended for 
biomedical applications [66], [203], [204]. Evaluation of efficient cleaning routes to remove 
unreacted species is of utmost importance to prevent unwanted toxicity. Future efforts should focus 
in the functionalization and bioconjugation of both LnPO4 and LnVO4 NPs to assess their in vitro 
and in vivo toxicity. Previous studies on Gd2O3 and GdPO4 have reported significant levels of 
toxicity when bare NPs are used in vivo due to the transmetallation of Gd3+ ions with endogenous 
cations [203], [205], [206]. Surface modification of both LnPO4 and LnVO4 NPs will enhance 
their biocompatibility and prevent the release of Ln cations in vivo [21], [58], [205], [207]. Surface-
functionalized LnPO4 and LnVO4 NPs doped with therapeutically relevant radionuclides should 
also be evaluated in biological settings to assess the response of cancer cells and tumors. 
Simulation of the retention of in vivo α-generators radionuclides and decay daughters 
within LnPO4 and LnVO4 NPs would provide valuable information regarding the mechanism 
behind the retention of radionuclides. Experimental results could be compared with the simulated 
values as has been carried out with polymersomes. The simulation of LnPO4 and LnVO4 NPs 
doped with α-emitting radionuclides could also promote their application in nuclear waste 
management as nuclear waste forms. Development of radionuclide-doped LnPO4 and LnVO4 NPs 
may facilitate the fabrication of ceramic waste forms since their nanometer size would ease the 
densification of ceramic pellets. Besides, both LnPO4 and LnVO4 NPs fulfill other requirements 
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of nuclear waste forms such as good chemical and thermal stability, high thermal conductivity, 
and structural flexibility to accommodate impurities and dopant ions. 
The main contributions of this dissertation are summarized below: 
§ Evaluation and characterization of LnPO4 NPs with different compositions and concentrations 
of Ln3+ ions using a precipitation route that has been implemented for radiochemical settings. 
These LnPO4 NPs could be doped with radionuclides towards the development of theranostic 
platforms for TRT and multimodal molecular imaging. 
§ Recommendation of a Ln:Na-TPP volume ratio that will contribute to develop LnPO4 NPs 
with good physical stability and uniform size distribution. Additionally, heating time and 
temperature could be set at 2 hours and 90 °C to reduce the multistep time-consuming 
procedure for LnPO4 core-shell NPs. 
§ Assessment of the in vitro retention of 227Th and decay daughters (223Ra and 211Pb) in LaPO4 
core and core + 2 shells NPs. The quantitative retention of 227Th and decay daughters is a 
valuable addition to previous results regarding the evaluation of 225Ac and 223, 225Ra in LaPO4 
based on the characteristics of 227Th (i.e. half-life, production, distribution, etc). 
§ Development of a procedure for synthesis of LnVO4 core-shell NPs based on the mixing of 
core NPs suspensions with a fresh lanthanide-citrate-vanadate solution.  
§ Evaluation of LnVO4 core and core-shell NPs as radionuclide carriers (225Ac, 223Ra, and 227Th) 
for TRT. The Gd0.8Eu0.2VO4 and GdVO4 core and core-shell NPs tested for the retention of 
radionuclides have functionalities for FI and/or MRI. Therefore, LnVO4 NPs could be used as 
theranostic platforms for both TRT and multimodal molecular imaging.  
§ Suggestion of LnVO4 core NPs as carriers of short-lived radionuclides (i.e. 68Ga, T1/2 = 68 
minutes) based on the short synthesis time required to precipitate particles with characteristic 
morphology, physical stability, and surface chemistry.
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